
<html lang="en"     class="pb-page"  data-request-id="f382b6ed-4fee-4ce5-a93e-e99c48c4fe93"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/jm2016057;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2012.55.issue-6"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="From Bradykinin B2 Receptor Antagonists to Orally Active and Selective Bradykinin B1 Receptor Antagonists" /></meta><meta name="dc.Creator" content="Martine  Barth" /></meta><meta name="dc.Creator" content="Michel  Bondoux" /></meta><meta name="dc.Creator" content="Jean-Michel  Luccarini" /></meta><meta name="dc.Creator" content="Vincent  Peyrou" /></meta><meta name="dc.Creator" content="Pierre  Dodey" /></meta><meta name="dc.Creator" content="Didier  Pruneau" /></meta><meta name="dc.Creator" content="Christine  Massardier" /></meta><meta name="dc.Creator" content="Jean-Luc  Paquet" /></meta><meta name="dc.Description" content="The bradykinin (BK) B1 receptor is an attractive target for the treatment of chronic pain and inflammation. Starting from a dual B1 and B2 antagonist, novel antagonists were designed that display l..." /></meta><meta name="Description" content="The bradykinin (BK) B1 receptor is an attractive target for the treatment of chronic pain and inflammation. Starting from a dual B1 and B2 antagonist, novel antagonists were designed that display l..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 6, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm2016057" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm2016057" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm2016057" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm2016057" /></link>
        
    
    

<title>From Bradykinin B2 Receptor Antagonists to Orally Active and Selective Bradykinin B1 Receptor Antagonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm2016057" /></meta><meta property="og:title" content="From Bradykinin B2 Receptor Antagonists to Orally Active and Selective Bradykinin B1 Receptor Antagonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0015.jpeg" /></meta><meta property="og:description" content="The bradykinin (BK) B1 receptor is an attractive target for the treatment of chronic pain and inflammation. Starting from a dual B1 and B2 antagonist, novel antagonists were designed that display low-nanomolar affinity for human B1 receptor and selectivity over B2. Initially, potent imidazoline derivatives were studied, but these compounds suffered from low bioavailability. This issue could be overcome by the use of less basic amino derivatives leading to orally active compounds." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm2016057"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm2016057">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm2016057&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm2016057&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm2016057&amp;href=/doi/10.1021/jm2016057" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2574-2584</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm201290v" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm201223m" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">From Bradykinin B2 Receptor Antagonists to Orally Active and Selective Bradykinin B1 Receptor Antagonists</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martine++Barth">Martine Barth</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michel++Bondoux">Michel Bondoux</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Michel++Luccarini">Jean-Michel Luccarini</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vincent++Peyrou">Vincent Peyrou</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pierre++Dodey">Pierre Dodey</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Didier++Pruneau">Didier Pruneau</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Massardier">Christine Massardier</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Luc++Paquet">Jean-Luc Paquet</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Department of Chemical Design and Synthesis, Clinical Candidate Selection, Laboratoires Fournier, 50 Rue de Dijon, 21121 Daix, France</span></div><div class="corresp-info"><strong>*</strong>Phone (33) 380447691. E-mail: <a href="/cdn-cgi/l/email-protection#5835392a2c31363d763a392a2c3018393a3a372c2c763b3735"><span class="__cf_email__" data-cfemail="91fcf0e3e5f8fff4bff3f0e3e5f9d1f0f3f3fee5e5bff2fefc">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm2016057&amp;href=/doi/10.1021%2Fjm2016057" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2574–2584</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 27, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 August 2011</li><li><span class="item_label"><b>Published</b> online</span>6 March 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 March 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm2016057" title="DOI URL">https://doi.org/10.1021/jm2016057</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2574%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMartine%2BBarth%252C%2BMichel%2BBondoux%252C%2BJean-Michel%2BLuccarini%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D6%26contentID%3Djm2016057%26title%3DFrom%2BBradykinin%2BB2%2BReceptor%2BAntagonists%2Bto%2BOrally%2BActive%2Band%2BSelective%2BBradykinin%2BB1%2BReceptor%2BAntagonists%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2584%26publicationDate%3DMarch%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm2016057"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1407</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm2016057" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;From Bradykinin B2 Receptor Antagonists to Orally Active and Selective Bradykinin B1 Receptor Antagonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Martine&quot;,&quot;last_name&quot;:&quot;Barth&quot;},{&quot;first_name&quot;:&quot;Michel&quot;,&quot;last_name&quot;:&quot;Bondoux&quot;},{&quot;first_name&quot;:&quot;Jean-Michel&quot;,&quot;last_name&quot;:&quot;Luccarini&quot;},{&quot;first_name&quot;:&quot;Vincent&quot;,&quot;last_name&quot;:&quot;Peyrou&quot;},{&quot;first_name&quot;:&quot;Pierre&quot;,&quot;last_name&quot;:&quot;Dodey&quot;},{&quot;first_name&quot;:&quot;Didier&quot;,&quot;last_name&quot;:&quot;Pruneau&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Massardier&quot;},{&quot;first_name&quot;:&quot;Jean-Luc&quot;,&quot;last_name&quot;:&quot;Paquet&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;2574-2584&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm2016057&quot;},&quot;abstract&quot;:&quot;The bradykinin (BK) B1 receptor is an attractive target for the treatment of chronic pain and inflammation. Starting from a dual B1 and B2 antagonist, novel antagonists were designed that display low-nanomolar affinity for human B1 receptor and selectivity over B2. Initially, potent imidazoline derivatives were studied, but these compounds suffered from low bioavailability. This issue could be overcome by the use of less basic amino derivatives leading to orally active compounds.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2016057&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2016057" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2016057&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2016057" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2016057&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2016057" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm2016057&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2016057&amp;href=/doi/10.1021/jm2016057" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm2016057" /></input><a href="/doi/pdf/10.1021/jm2016057" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1002 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm2016057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm2016057%26sid%3Dliteratum%253Aachs%26pmid%3D22369198%26genre%3Darticle%26aulast%3DBarth%26date%3D2012%26atitle%3DFrom%2BBradykinin%2BB2%2BReceptor%2BAntagonists%2Bto%2BOrally%2BActive%2Band%2BSelective%2BBradykinin%2BB1%2BReceptor%2BAntagonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D6%26spage%3D2574%26epage%3D2584%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jmcmar.2012.55.issue-6/production/jmcmar.2012.55.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016057&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The bradykinin (BK) B1 receptor is an attractive target for the treatment of chronic pain and inflammation. Starting from a dual B1 and B2 antagonist, novel antagonists were designed that display low-nanomolar affinity for human B1 receptor and selectivity over B2. Initially, potent imidazoline derivatives were studied, but these compounds suffered from low bioavailability. This issue could be overcome by the use of less basic amino derivatives leading to orally active compounds.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12831" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12831" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Kinins are 9–11 amino acid peptides known to be important mediators of pain, inflammation, and cardiovascular homeostasis. They are released in injured tissues from kininogen by activation of plasma or tissue kallikreins.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Kinins exert their biological activities via the activation of two subtypes of G-protein-coupled receptors, namely, B1 and B2 receptors.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a></div><div class="NLM_p">Bradykinin (BK) and Lys0-BK are natural endogenous agonists of BK B2 receptor, while their kininase I hydrolyzed metabolites desArg9-BK and Lys0-desArg9-BK are specific agonists of BK B1 receptors. Whereas B2 receptors are constitutively present in normal tissues, B1 receptors are poorly present in healthy tissues. B1 receptors are highly inducible by tissue injury and treatment by bacterial endotoxin or inflammatory mediators such as cytokines.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a></div><div class="NLM_p">The contribution of B1 receptor activation in inflammation and pain process is supported by the demonstration that B1 receptor knockout mice have a decreased response to nociceptive and proinflammatory stimuli.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The therapeutic interest of B1 receptor blocking is further supported by the pharmacological properties of B1 peptide antagonist desArg9,Leu8-BK.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> A number of experimental studies using B1 receptor antagonists support a major role for B1 receptors in hyperalgesia.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Accordingly identification of selective and effective BK B1 receptor antagonists may have potential for the treatment against chronic inflammation and pain.</div><div class="NLM_p">Our effort to find effective small molecule B1 receptor antagonists was initiated with a high-throughput screen of our in-house compound library. Identified hits belong to our B2 receptor antagonist research program. Only one of them, a benzenesulfonamide derivative (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), showed functional activity. This compound has 18-fold higher affinity for the B2 receptor than for the B1 receptor (B1 <i>K</i><sub>i</sub> = 2.3 μM and B2 <i>K</i><sub>i</sub> = 0.13 μM).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Identified hit.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016057&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Molecular modeling and mutagenesis data showed that the quinoline part of this B2 antagonist interacts simultaneously with Tyr295 in transmembrane spanning domain 7 (TM7) and Trp256 (TM6) in the B2 receptor.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> This sandwich interaction is essential for stabilizing the B2 receptor in its inactive conformation. This essential role of the quinoline was also supported by the dramatic loss of affinity induced by Ala or Phe mutation of Tyr295. Actually, deletion of the quinoline part of the molecule led to <b>1a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) with the loss of B2 antagonist activity while keeping the B1 activity. Compound <b>1a</b> is 20-fold selective for B1 versus B2 receptor with B1 <i>K</i><sub>i</sub> = 2.3 μM and B2 <i>K</i><sub>i</sub> = 43 μM.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Leads after first SAR round.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016057&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The central proline was replaced by various amino acids and dipeptides in order to find new interactions with the receptor. This systematic study led to <b>1b</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) with improved B1 affinity (<i>K</i><sub>i</sub> = 59 nM, p<i>K</i><sub>B</sub> = 6.6). Peptide compounds being potentially prone to peptidase, a peptoid strategy was used. Amino acid side chains were shifted on one amidic nitrogen atom, leading to <b>1c</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) with improved functional activity (<i>K</i><sub>i</sub> = 100 nM, p<i>K</i><sub>B</sub> = 7.5). In order to improve B1 affinity, SAR of the terminal diamino-containing part was done. The result of these investigations was the discovery of a highly potent B1 receptor antagonist <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) (affinity <i>K</i><sub>i</sub> = 1.5 nM and functional activity p<i>K</i><sub>B</sub> = 9.1). Unfortunately, this compound did not appear as a good lead for oral treatment of inflammatory hyperalgesia. It suffered from a high molecular weight (MW = 715), the presence of two basic groups (calculated p<i>K</i><sub>a</sub> of 10.5 and 12), and an important flexibility (number of rotatable bonds, >15). As anticipated, it lacked oral activity. The efforts were thus focused toward reducing both molecular weight and basicity of the compounds while keeping enough affinity for the human B1 receptor. This led to <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) (p<i>K</i><sub>B</sub> = 7.2 and MW = 540). This paper reports structure–activity relationship (SAR) and absorption, distribution, metabolism, and excretion (ADME) optimization of these compounds that lead to potent selective B1 antagonists exhibiting excellent pharmacokinetic profiles.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64540" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64540" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis</h3><div class="NLM_p">The compounds described in this paper, were prepared according to two routes depicted in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Route 2 was specially designed for SAR of the arylsulfonyl part, introducing this moiety in the latest stages.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Arylsulfonamide B1 Antagonists: First Route<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016057&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) CH<sub>3</sub>NHCH<sub>2</sub>CH<sub>2</sub>OH, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt; (b) BrCH<sub>2</sub>COOtBu, <i>n</i>-Bu<sub>4</sub>NCl, 35% NaOH, toluene, rt; (c) MeNH<sub>2</sub>·HCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt; (d) Br-Y-COOEt, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (e) LiOH, THF, H<sub>2</sub>O, rt; (f) EDCI, HOAT, Aamine, CH<sub>2</sub>Cl<sub>2</sub>, rt; (g), TFA, anisole, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Arylsulfonamide B1 Antagonists: Second Route<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016057&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) BrCH<sub>2</sub>COOtBu, <i>n</i>-Bu<sub>4</sub>NCl, 35% NaOH, toluene, rt; (b), TFA, CH<sub>2</sub>Cl<sub>2</sub>; (c) CbzCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt; (d) EDCI, HOAT, amine, CH<sub>2</sub>Cl<sub>2</sub>, rt; (e) H<sub>2</sub>, Pd/C 10%, MeOH, rt; (f) RSO<sub>2</sub>Cl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt; (g) TFA, anisole, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><div class="NLM_p">In Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, esters <b>7</b> were obtained according to two routes depending on the linker Y. For ether containing linker, compounds <b>7</b> were prepared in two steps from commercially or known arylsulfonyl chlorides. The sulfonylation of 2-(methylamino)ethanol, giving <b>6</b>, was followed by O-alkylation with <i>tert</i>-butyl bromoacetate under phase transfer conditions (<i>n</i>-Bu<sub>4</sub>NCl, NaOH, toluene). For all other linkers, compounds <b>7</b> were also synthesized in two steps: sulfonylation of methylamine to give <b>5</b>, followed by N-alkylation with Br-Y-COOR using K<sub>2</sub>CO<sub>3</sub> in DMF at room temperature. Esters <b>7</b> were saponified with lithium hydroxide to give the corresponding acids <b>8</b>. These acids were coupled with various amines (commercially available, synthesized according to Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> or literature<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a>), using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI) and 1-hydroxy-7-azabenzotriazole (HOAT) in dichloromethane to give either final compounds <b>12a</b>–<b>r</b> or intermediates <b>9</b>. Final compounds <b>10</b> were obtained after Boc protective group cleavage of <b>9</b> with trifluoroacetic acid.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Phenylimidazoline Synthons<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016057&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) CbzCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> rt; (b) S, H<sub>2</sub>NCH<sub>2</sub>CH<sub>2</sub>NH<sub>2,</sub> 100 °C; (c) Boc<sub>2</sub>O, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt; (d) H<sub>2</sub>, 10% Pd/C, MeOH, rt.</p></p></figure><div class="NLM_p">In Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, alkylation of Boc-protected 2-(methylamino)ethanol <b>14</b> with <i>tert</i>-butyl bromoacetate gave diprotected amino acid <b>15</b>. Cleavage of both protective groups (<i>tert</i>-butylcarbamate and <i>tert</i>-butyl ester) using TFA followed by protection of the amino residue with benzylcarbamate gave acid <b>17</b> (the synthesis of <b>17</b> starting from <i>N</i>-(benzyloxycarbonyl)-2-aminoethanol was unsuccessful (unpublished results)). Coupling of acid <b>17</b> with amine <b>26</b> (described in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>), using EDCI, HOAT in dichloromethane, was followed by hydrogenolysis of the benzylcarbamate group to give the amine derivative <b>19</b>. Compound <b>19</b> was sulfonylated with commercially available arylsulfonyl chlorides using triethylamine in dichoromethane, followed by Boc group cleavage with TFA, to give final products <b>21</b>.</div><div class="NLM_p last">The 2-phenylimidazoline derivative <b>26</b> was prepared as described in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Benzylcarbamate protection of <b>22</b> was followed by imidazoline formation using 1,2-diaminoethane and sulfur to give <b>24</b>. <i>tert</i>-Butylcarbamate protection of the imadzoline group and final cleavage of Cbz group gave the desired synthon <b>26</b>.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Biological Activity</h3><div class="NLM_p last"><i>K</i><sub>i</sub> values were calculated from concentration curves in competition-binding assays using [<sup>3</sup>H]des-Arg<sup>10</sup>-kallidin as a specific ligand for the B<sub>1</sub> receptor with membrane preparations either from human endothelium kidney cells 293 (HEK293) or from monkey kidney fibroblast cells (COS) expressing the recombinant human or mouse B<sub>1</sub> receptor. p<i>K</i><sub>B</sub> values were calculated from Schild plot obtained from concentration curves of des-Arg<sup>10</sup>-kallidin in the isolated human umbilical vein, mouse fundus.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Inflammation pain models have been previously described.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Hepatic microsomes were used as an in vitro surrogate for in vivo phase I metabolism. Metabolic stability of the different compounds was assessed at 1 μM for 10, 30, or 60 min at 37 °C in the presence of human or mouse liver microsomes. The permeability was measured using 50 μM compound on Caco2 cells.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34825" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34825" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>3</b> was considered as a good starting point in terms of B1 activity. Initially, we chose to optimize the Gly-Gly linker while keeping other parts of the molecule unchanged. A complete series of compounds with various cyclic and linear hydrophobic linkers was synthesized. Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> shows only the most promising compounds. The presence of the ether linker in <b>10d</b>, a nanomolar antagonist (<i>K</i><sub>i</sub> = 2.1 nM), was particularly remarkable. Unfortunately this compound was poorly metabolically stable (8% remaining after 1 h at 1 μM on human microsomes) and showed some degree of cytochrome P450 2D6 (CYP 2D6) inhibition (63% at 5 μM). The main metabolites were hydroxylation of the arylsulfonyl group and N-demethylation of the sulfonamide.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Linker SAR: Binding Affinities and Functional Activities of B1 Receptor Antagonists</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0009.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center"><i>K</i> <sub>i</sub> <a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (nM) (human)</th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>B</sub> <a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> (human)</th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>B</sub> <a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> (mouse)</th><th class="colsep0 rowsep0" align="center">metabolic stability<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a> (human)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CONHCH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">78</td><td class="colsep0 rowsep0" align="left">7.2</td><td class="colsep0 rowsep0" align="left">6.4</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10a</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub></td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">7.3</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10b</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">65</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10c</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">8.5</td><td class="colsep0 rowsep0" align="left">6.4</td><td class="colsep0 rowsep0" align="left">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10d</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>OCH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">9.1</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10e</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH═CH</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">8.7</td><td class="colsep0 rowsep0" align="left">6.4</td><td class="colsep0 rowsep0" align="left">12</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Values represent the numerical average of at least two experiments, interassay variability was ±20%.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Values represent the numerical average of at least two experiments, interassay variability was ±10%.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">% of remaining compound at 30 min.</p></div></div></div><div class="NLM_p">The replacement of the 2,4-dichloro-3-methylphenyl group by a wide variety of different substituted aryl or heteroaryl groups was systematically investigated as a means for both improving metabolic stability and avoiding CYP inhibition. Sixty compounds were synthesized and evaluated on the B<sub>1</sub> receptor. No clear SAR could be drawn; it was just noticed that the most potent compounds have an ortho substituent such as methyl, chlorine, or trifluoromethyl. Calculations of interaction energy, using ab initio methods, were not able to explain SAR and were considered not enough accurate for describing these subtle effects (data not shown). A selection of active compounds is given in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. These modifications led to highly potent compounds down to the subnanomolar range with improved metabolic stability and low CYP interaction (<50% at 5 μM on 2C9, 2D6, and 3A4). Compound <b>21a</b> was selected for evaluation in rodent pain models. Compound <b>21a</b> showed antihyperalgesic activity in rats after sc administration. Compound <b>21a</b> significantly reversed carrageenan-induced thermal hyperalgesia (57% at 3 mg/kg sc) and complete Freund’s adjuvant-induced inflammatory pain (61% at 10 mg/kg sc) and produced at 10 mg/kg sc a reduction in both the phase I and phase II flinching responses induced by formalin in rats (52% and 46%, respectively).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Compound <b>21a</b> reduced bone cancer pain-related behaviors in mice after iv administration.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Unfortunately, <b>21a</b>, having a low oral bioavailability in mice (12%) and rats (0.3%) (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), showed no activity after oral administration in rodent pain model. As this compound was stable on rodent microsomes (80% remaining after 30 min) and had a high exposure after sc administration, it seemed that the limiting factor of the pharmacokinetics (PK) was the permeability (<i>P</i><sub>app</sub> =1.3 × 10<sup>–6</sup> cm/s).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Arylsulfonyl SAR: Binding Affinities and Functional Activities of B1 Receptor Antagonists</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0010.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> <a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (nM) (human)</th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>B</sub> <a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (human)</th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>B</sub> <a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (mouse)</th><th class="colsep0 rowsep0" align="center">metabolic stability<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a> (human)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21a</b></td><td class="colsep0 rowsep0" align="left">2,6-di-Me-4-OMe-Ph</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">9.7</td><td class="colsep0 rowsep0" align="left">8.2</td><td class="colsep0 rowsep0" align="left">57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21b</b></td><td class="colsep0 rowsep0" align="left">2-CF<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">9.2</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10d</b></td><td class="colsep0 rowsep0" align="left">2,4-di-Cl-3Me-Ph</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">9.1</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21c</b></td><td class="colsep0 rowsep0" align="left">2-Me-4-OMe-Ph</td><td class="colsep0 rowsep0" align="left">5.5</td><td class="colsep0 rowsep0" align="left">8.6</td><td class="colsep0 rowsep0" align="left">6.9</td><td class="colsep0 rowsep0" align="left">91<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10f</b></td><td class="colsep0 rowsep0" align="left">2,3-di-Cl-Ph</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">8.8</td><td class="colsep0 rowsep0" align="left">7.2</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10g</b></td><td class="colsep0 rowsep0" align="left">2,6-di-Cl-Ph</td><td class="colsep0 rowsep0" align="left">4.2</td><td class="colsep0 rowsep0" align="left">8.5</td><td class="colsep0 rowsep0" align="left">7.2</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21d</b></td><td class="colsep0 rowsep0" align="left">2-Cl-4-OMe-Ph</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">8.5</td><td class="colsep0 rowsep0" align="left">7.3</td><td class="colsep0 rowsep0" align="left">64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21e</b></td><td class="colsep0 rowsep0" align="left">2-CN-Ph</td><td class="colsep0 rowsep0" align="left">63.5</td><td class="colsep0 rowsep0" align="left">8.1</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">87</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21f</b></td><td class="colsep0 rowsep0" align="left">2-Me-3-Cl-Ph</td><td class="colsep0 rowsep0" align="left">6.8</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21g</b></td><td class="colsep0 rowsep0" align="left">2,6-di-F-Ph</td><td class="colsep0 rowsep0" align="left">142</td><td class="colsep0 rowsep0" align="left">7.6</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">87</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21h</b></td><td class="colsep0 rowsep0" align="left">4-CF3O-Ph</td><td class="colsep0 rowsep0" align="left">85</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">86</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Values represent the numerical average of at least two experiments; interassay variability was ±20%.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Values represent the numerical average of at least two experiments; interassay variability was ±10%.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">% of remaining compound at 30 min.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">% of remaining compound at 10 min.</p></div></div></div><div class="NLM_p">The phenylimidazoline group was suspected to be responsible for the poor permeability. A Caco2 permeability screen was done using 124 analogues (disregarding their B1 activity) bearing or not the phenylimidazoline group. This study showed that unlike phenylimidazoline derivatives, non-phenylimidazoline ones had good permeability. At this step of the project all the work was focused on the replacement of the phenylimidazoline group. The replacement of the imidazoline group was guided by modeling studies. Su et al. have described a homology model of the BK B1 receptor based on the crystal structure of the bovine rhodopsin.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a>In this model, the imidazoline ring interacts with Glu273 and Asp291. Maigret et al. have constructed another homology model based on the crystal structure of bacteriorhodopsin (unpublished data). They found a different binding site with the imidazoline ring interacting with Glu95, His37, and Asn99 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). This is supported by species activity differences. The residue His37 is present in rabbit (His36) but not in rat and mouse in which it is replaced by Tyr36 (rat) and Cys36 (mouse). Actually, our compounds were equipotent on human and rabbit and displayed approximately between 20- and 30-fold loss of activity in rat and mouse: for example, <b>21a</b> p<i>K</i><sub>B</sub> of 9.7 (human), 9.5 (rabbit), 8.2 (mouse), and 8.1 (rat). Our compounds were docked in both models; a better correlation between docking energy and activity was obtained with Maigret’s model than with Su one. The imidazoline ring was replaced by a wide variety of H bond acceptor and/or donor containing groups (like imidazole, oxadiazole, pyrazole, oxazole, thiazole, triazole, amide groups, ether groups, acid derivatives, tetrazole, ...) likely to make hydrogen bond interactions with Asn99, Glu95, or His37. Unfortunately all these modifications led to inactive compounds. These results revealed that a basic group seemed to be mandatory for the activity. The phenylimidazoline group was replaced by several basic amino groups such as substituted piperazine, piperidine. These groups were chosen in order to improve physicochemical parameters such as p<i>K</i><sub>a</sub>, log <i>P</i>, and polar surface area (PSA). These new derivatives have calculated p<i>K</i><sub>a</sub> ranging from 8.5 to 10 (<b>21a</b> calculated p<i>K</i><sub>a</sub> = 9.9), reduced PSA (around 90 Å<sup>2</sup> compared to 109 Å<sup>2</sup> for <b>21a</b>), and improved calculated log <i>P</i> (down to 0.7 compared to 1.6 for <b>21a</b>). More than 70 compounds have been synthesized and evaluated on the human B<sub>1</sub> receptor. The replacement of the phenylimidazoline group by the piperazinoquinuclidine group led to the first potent non-imidazoline derivatives. Compound <b>12a</b> (<i>S</i> isomer) is more potent and metabolically stable than <b>12b</b> (<i>R</i> isomer) but without improvement of permeability (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) and mouse bioavailability (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Among piperazine derivatives, constrained compounds (<b>12c</b>–<b>g</b>) are more potent than flexible ones (<b>12h</b>–<b>j</b>), especially <b>12d</b>, <b>12e</b>, and <b>12f</b> which have an affinity in the nanomolar to subnanomolar range with <i>K</i><sub>i</sub> of 1.6, 0.2, and 0.8 nM, respectively, and a functional activity with p<i>K</i><sub>B</sub> between 8.4 and 8.8. Compounds <b>12d</b> and <b>12e</b> are more stable on human microsomes than <b>21a</b> (77% and 85% remaining versus 57% after incubation at 1 μM for 30 min) with improved bioavailability (18% and 12% versus 0.3% in rat for <b>21a</b>) (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) despite no improvement of permeability on Caco2 cells. Compound <b>12f</b>, which has a better permeability (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) than <b>21a</b>, was not evaluated in PK because of its poor stability on microsomes. Piperidine derivatives were also prepared, leading to highly potent compounds (<b>12l</b> and <b>12o</b>–<b>q</b>) (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) in nanomolar to subnanomolar range with <i>K</i><sub>i</sub> between 3.8 and 0.36 nM. Compounds <b>12o</b>–<b>q</b> have a moderate to low human metabolic stability (of minor level compared to potent piperazine analogues). Compound <b>12l</b> is stable on human microsomes (86% remaining after incubation at 1 μM for 30 min) and exhibits a bioavailability of 38% in mice and 19% in rats (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Unfortunately <b>12l</b> is a strong inhibitor of CYP450 2D6 and was not further evaluated.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Homology model of BK B1 receptor with <b>10d</b> docked in the putative binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016057&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Piperazine SAR: Binding Affinities and Functional Activities of B1 Receptor Antagonists</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0011.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0012.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Values represent the numerical average of at least two experiments; interassay variability was ±20%.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Values represent the numerical average of at least two experiments; interassay variability was ±10%.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">% of remaining compound at 30 min.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Piperidine SAR: Binding Affinities and Functional Activities of B1 Receptor Antagonists</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0013.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0014.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Values represent the numerical average of at least two experiments; interassay variability was ±20%.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Values represent the numerical average of at least two experiments; interassay variability was ±10%.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">% of remaining compound at 30 min.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. PK Profiles of Selected B1 Receptor Antagonists</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">mouse<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="4" align="center">rat<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="rowsep1 colsep0" colspan="4" align="center">dog<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>F</i> <a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> <a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">Cl <a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">Vd <a class="ref internalNav" href="#t5fn7" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center"><i>F</i> <a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> <a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">Cl <a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">Vd <a class="ref internalNav" href="#t5fn7" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center"><i>F</i> <a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> <a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">Cl <a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">Vd <a class="ref internalNav" href="#t5fn7" aria-label="g">g</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21a</b></td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">131</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">27.4</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">6.7</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">23.5</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12d</b></td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">24.1</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">43</td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">12.7</td><td class="colsep0 rowsep0" align="left">2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12e</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">66.7</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12g</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">32.5</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12k</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">19.2</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12l</b></td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">18.8</td><td class="colsep0 rowsep0" align="left">0.79</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12n</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">6.5</td><td class="colsep0 rowsep0" align="left">13.1</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12p</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">12.3</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">17.9</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Male Swiss mice (<i>n</i> = 3): 5 mg/kg po; 1 mg/kg iv. Interanimal variability was less than 20%.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Sprague–Dawley rats (<i>n</i> = 3): 10 mg/kg po; 1 mg/kg iv. Interanimal variability was less than 20%.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Beagle dogs (<i>n</i> = 3): 5 mg/kg po; 1 mg/kg iv. Interanimal variability was less than 20%.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last"><i>F</i> in % oral bioavailability.</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">Half-life in hours.</p></div><div class="footnote" id="t5fn6"><sup>f</sup><p class="last">Cl in mL min<sup>–1</sup> kg<sup>–1</sup>.</p></div><div class="footnote" id="t5fn7"><sup>g</sup><p class="last">Vd in L/kg.</p></div></div></div><div class="NLM_p">Compound <b>12d</b> was selected for further investigation. <b>12d</b> is selective over 65 receptors (including BK B2), 12 ion channels, and 7 enzymes (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>), has no interaction with CYP 450 (9 isoforms) (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>), and has a dog bioavailability of 43% (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, <b>12d</b> orally given in rats at 30 mg/kg, 60 min before formalin injection, significantly reduced the amplitudes of both acute phase and late phase of the response by 61% and 54%, respectively, yielding an approximate ED<sub>50</sub> of 30 mg/kg for the first and second phases. Moreover, <b>12d</b> significantly reversed carrageenan-induced mechanical hyperalgesia in a dose-dependent manner with a maximum activity obtained at 300 mg/kg, giving an approximate ED<sub>50</sub> of 100 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) .The effect obtained with <b>12d</b> at 300 mg/kg was similar to that observed with morphine (8 mg/kg po) and stronger than that observed with diclofenac (20 mg/kg po). Compound <b>12d</b> was more effective in producing antinociceptive action against acute chemical stimulus than mechanical stimulus, which is in accordance with results from BK B<sub>1</sub> knockout (KO) mice.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of <b>12d</b> (30 mg/kg po) on formalin induced flinching in rats. Rats received an intraplantar injection (50 μL) of formalin (2%) into one hind paw. The duration of flinching of the injected paw was recorded continuously immediately thereafter for 60 min. The nociceptive response is divided into two phases, the acute one between 0 and 10 min and the late one between 15 and 60 min. Values are the mean ± SEM; <i>n</i> = 6 rats/group; analysis of variance followed by Student’s <i>t</i> test, (∗) <i>P</i> < 0.05 vs saline.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016057&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of oral administration of <b>12d</b> on the vocalization thresholds due to paw pressure in carrageenan-treated rats. Effect of oral administration of compound <b>12d</b> on the vocalization thresholds due to paw pressure in carrageenan-treated rats. The results are expressed by the mean ± SEM of the area under the time-course curves (AUC) of the variations (postdrug – predrug values of vocalization thresholds), calculated by the trapezoidal method. Rats were treated with vehicle, compound <b>12d</b> (75, 150, and 300 mg/kg), diclofenac (20 mg/kg), or morphine (8 mg/kg) (<i>n</i> = 6–11 per group). Analysis of variance followed by Student’s <i>t</i> test: (∗) <i>p</i> < 0.05 vs vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016057&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Effect of <b>12d</b> (5 μM) for a Range of Specific Receptor Binding and Cell Biology Assays<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">receptor</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center">receptor</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center">receptor or assay</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A<sub>1</sub>(h)</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="left">motilin</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">–16</td><td class="colsep0 rowsep0" align="left">VIP<sub>1</sub> (h) (VPAC1)</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A<sub>2A</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">M<sub>1</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="left">V<sub>1a</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A<sub>3</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="left">M<sub>2</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="left">Ca<sup>2+</sup> channel L</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α<sub>1</sub> (nonselective)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">M<sub>3</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left">(DHP site)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α<sub>2A</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">–4</td><td class="colsep0 rowsep0" align="left">M<sub>4</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">Ca<sup>2+</sup> channel L</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α<sub>2B</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">M<sub>5</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">(diltiazem site)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α<sub>2C</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="left">NK<sub>1</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="left">Ca<sup>2+</sup> channel L</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">β<sub>1</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="left">NK<sub>2</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">–9</td><td class="colsep0 rowsep0" align="left">(verapamil site)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NE transporter</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">NK<sub>3</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left">Ca<sup>2+</sup> channel N</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BZD (central)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="left">Y<sub>1</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="left">K<sup>+</sup><sub>ATP</sub> channel</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bombesine (nonselective)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="left">NT<sub>1</sub> (NTS1)</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">–3</td><td class="colsep0 rowsep0" align="left">K<sup>+</sup><sub>V</sub> channel</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bradykin (B<sub>2</sub>)</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="left">N (neuronal) (BGTX-insensitive)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="left">SK<sup>+</sup><sub>Ca</sub> channel</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CGRP</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">–4</td><td class="colsep0 rowsep0" align="left">N (neuronal) (BGTX-sensitive)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left">Na<sup>+</sup> channel (site 1)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">–8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CB<sub>1</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">–4</td><td class="colsep0 rowsep0" align="left">δ</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left">Na<sup>+</sup> channel (site 2)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CB<sub>2</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left">κ</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">–5</td><td class="colsep0 rowsep0" align="left">Cl<sup>–</sup> channel</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">–2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CCKB (CCK2)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="left">μ</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="left">COX<sub>1</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CRF<sub>1</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">–21</td><td class="colsep0 rowsep0" align="left">OEL1</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">COX<sub>2</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">–18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Dl</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">–5</td><td class="colsep0 rowsep0" align="left">PACAP</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left">PGE<sub>2</sub> secretion</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D2</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">PAF</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="left">PGI<sub>2</sub> secretion</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GABA (nonselective)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">–2</td><td class="colsep0 rowsep0" align="left">PCP</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">–3</td><td class="colsep0 rowsep0" align="left">TXB<sub>2</sub> secretion</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">galanin (nonselective)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left">TXA2/PGH2 (h) (TP)</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">–20</td><td class="colsep0 rowsep0" align="left">NOS inducible</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AMPA</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="left">P2X</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left">NOS constitutive</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kainate</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="left">P2Y</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">–3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NMDA</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left">5-HT<sub>1A</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">glycine (strychnine-sensitive)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">–1</td><td class="colsep0 rowsep0" align="left">3-HT<sub>1B</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">glycine (strychnine-insensitive)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">–4</td><td class="colsep0 rowsep0" align="left">3-HT<sub>3</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">H<sub>1</sub> (central)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="left">3-HT<sub>7</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">–23</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">I<sub>2</sub> (central)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="left">3-HT transporter</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MC<sub>3</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">–3</td><td class="colsep0 rowsep0" align="left">σ (nonselective)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MC<sub>4</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left">glucocorticoid</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">–8</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ML<sub>1</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MAO-A</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">The results are expressed as percent inhibition of control specific binding or control activity (mean values; <i>n</i> = 2).</p></div></div></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Cytochromes P450 inhibition of <b>12d</b><a class="ref internalNav" href="#tbl7-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="9" align="center" char=".">CYP450 (% Inhibition at 5 μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">1A2</th><th class="colsep0 rowsep0" align="center" char=".">2A6</th><th class="colsep0 rowsep0" align="center" char=".">2B6</th><th class="colsep0 rowsep0" align="center" char=".">2C8</th><th class="colsep0 rowsep0" align="center" char=".">2C9</th><th class="colsep0 rowsep0" align="center" char=".">2C19</th><th class="colsep0 rowsep0" align="center" char=".">2D6</th><th class="colsep0 rowsep0" align="center" char=".">2E1</th><th class="colsep0 rowsep0" align="center" char=".">3A4</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">–4</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">–4</td><td class="colsep0 rowsep0" align="char" char=".">–19</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">–2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl7-fn1"><div class="footnote" id="tbl7-fn1"><sup>a</sup><p class="last">Values are the mean, <i>n</i> = 3.</p></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55668" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55668" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Starting from a nonselective BK B1/B2 receptor antagonist, we have identified a novel class of highly and selective potent BK B1 receptor antagonists. Unfortunately these compounds suffered from a lack of permeability. Design and synthesis of less basic compounds led to potent and selective compounds like <b>12d</b>, which has oral antihyperalgesic activity in animal.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11803" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11803" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General</h3><div class="NLM_p last">Reagents and solvents obtained from commercial suppliers are used without further purification unless otherwise stated. <sup>1</sup>H NMR spectra were recorded on a Bruker Avance spectrometer. Chemical shifts are reported in ppm (δ) and were calibrated using the undeuterated solvent resonance as internal standard. Melting points were determined on a hot stage apparatus and are uncorrected. All final compounds were purified to >95% purity as determined by Agilent HP1100 series or Waters ACQUITY high performance liquid chromatography (HPLC) with UV detection at 254 nm using one of the following methods. Method A: X-Terra C18 column (50 mm, 2.1 mm, 3.5 μm, 45 °C); mobile phase, A = H<sub>2</sub>O with 0.05% TFA, B = CH<sub>3</sub>CN with 0.05% TFA; gradient, 10–90% B (0.0–9.0 min); flow rate, 0.6 mL/min. Method B: Uptispher ODB column (50 mm, 2 mm, 3 μm, 45 °C); mobile phase, A = H<sub>2</sub>O with 0.05% TFA, B = CH<sub>3</sub>CN with 0.05% TFA; gradient, 10–90% B (0.0–9 min); flow rate, 0.6 mL/min. Method C: ACQUITY UPLC BEH C18 column (50 mm, 2.1 mm, 1.7 μm, 45 °C); mobile phase, A = H<sub>2</sub>O with 0.1% CH<sub>3</sub>CO<sub>2</sub>H, B = CH<sub>3</sub>CN with 0.1% CH<sub>3</sub>CO<sub>2</sub>H; gradient, 15–95% B (0.0–2.5 min); flow rate, 0.8 mL/min. Low resolution mass spectrometry (MS) data were obtained using a Waters ZQ mass spectrometer or a Waters SQD mass spectrometer operated in electrospray ionization (ESI) mode (positive or negative)</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2,4-Dichloro-3,<i>N</i>-dimethyl-<i>N</i>-(2-hydroxyethyl)benzenesulfonamide, <b>6d</b></h3><div class="NLM_p last">A solution of 2.8 g (37.8 mmol) of 2-methylaminoethanol is prepared in 120 mL of dichloromethane, and 7.5 g (28.9 mmol) of 2,4-dichloro-3-methylbenzenesulfonyl chloride in solution in 30 mL of dichloromethane, and 10.5 mL of triethylamine are added. The reaction mixture is kept under agitation for 15 h at ambient temperature and then washed with a solution of 1 N hydrochloric acid, with a solution of sodium bicarbonate, and then with water. The organic phase is dried over magnesium sulfate and then concentrated under reduced pressure. The residue was used directly in the next step.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>N</i>-(2-Hydroxyethyl)-4-methoxy-<i>N</i>,2,6-trimethylbenzenesulfonamide, <b>6h</b></h3><div class="NLM_p last">Compound <b>6h</b> was prepared as described for <b>6d</b> using 2,6 dimethyl-4-methoxybenzenesulfonyl chloride and 2-methylaminoethanol (colorless oil, 99%). <sup>1</sup>H NMR (300 MHz, DMSO) δ: 6.80 (s, 2H), 4.70 (t, 1H), 3.80 (s, 3H), 3.48 (q, 2H), 3.09 (t, 2H), 2.69 (s, 3H), 2.54 (s, 6H).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> [2-[[(2,4-Dichloro-3-methylphenyl)sulfonyl]methylamino]ethoxy]acetic Acid 1,1-Dimethylethyl Ester, <b>7d</b></h3><div class="NLM_p last">A solution of 100 mg (0.335 mmol) of compound <b>6d</b> is prepared in 4 mL of toluene, and 30 mg (0.111 mmol) of tetrabutylammonium chloride and 4 mL of a 35% aqueous solution of sodium hydroxide are added. The reaction medium is cooled to 10 °C, and an amount of 98 mg (0.5 mmol) of <i>tert</i>-butyl bromoacetate is then added. The mixture is stirred at ambient temperature for 30 min, then hydrolyzed over ice–water. The mixture obtained is extracted with toluene, and the organic phase obtained is dried over magnesium sulfate and concentrated under reduced pressure. The expected product is thus obtained (colorless oil, 87%). <sup>1</sup>H NMR (300 MHz, DMSO) δ: 7.84 (d, 1H), 7.63 (d, 1H), 3.93 (s, 2H), 3.59 (t, 2H), 3.39 (t, 2H), 2.91 (s, 3H), 2.49 (s, 3H), 1.41 (s, 9H).</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> [2-[[(4-Methoxy-2,6-dimethylphenyl)sulfonyl]methylamino]ethoxy]acetic Acid 1,1-Dimethyl Ethyl Ester, <b>7h</b></h3><div class="NLM_p last">Compound <b>7h</b> was prepared as described for <b>7d</b> using <b>6h</b> (colorless oil, 94%). <sup>1</sup>H NMR (250 MHz, DMSO) δ: 6.80 (s, 2H), 3.89 (s, 2H), 3.80 (s, 3H), 3.56 (t, 2H), 3.21 (t, 2H), 2.71 (s, 3H), 2.53 (s, 3H), 1.41 (s, 9H).</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> [2-[[(2,4-Dichloro-3-methylphenyl)sulfonyl]methylamino]ethoxy]acetic Acid, <b>8d</b></h3><div class="NLM_p last">A solution of 1.45 g (3.51 mmol) of the ester <b>7d</b> is prepared in 15 mL of tetrahydrofuran (THF), and 297 mg (7.02 mmol) of lithium hydroxide and 30 mL of water are added. The reaction mixture is stirred for 15 h at ambient temperature. The THF is drawn off under reduced pressure, and an amount of 50 mL of water is added to the residual aqueous phase. The aqueous phase is acidified with the aid of 1 N hydrochloric acid solution and extracted with ethyl acetate. The organic phase obtained is washed with water, dried over magnesium sulfate, and concentrated under reduced pressure. An amount of 1.24 g of the expected acid is thus obtained (colorless oil, 99%). <sup>1</sup>H NMR (300 MHz, DMSO) δ: 12.5 (broad s, 1H), 7.86 (d, 1H), 7.64 (d, 1H), 4.02 (s, 2H), 3.61 (t, 2H), 3.40 (t, 2H), 2.91 (s, 3H), 2.51 (s, 3H).</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> [2-[[(4-Methoxy-2,6-dimethylphenyl)sulfonyl]methylamino]ethoxy]acetic Acid, <b>8h</b></h3><div class="NLM_p last">Compound <b>8h</b> was prepared as described for <b>8d</b> using <b>7h</b> (white solid, 95%). Mp 82 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 6.80 (s, 2H), 3.94 (s, 2H), 3.80 (s, 3H), 3.56 (t, 2H), 3.22 (t, 2H), 2.70 (s, 3H), 2.53 (s, 6H).</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 2-[4-[[[[2-[[(2,4-Dichloro-3-methylphenyl)sulfonyl]methylamino]ethoxy]acetyl]methylamino]methyl]phenyl]-4,5-dihydro-1<i>H</i>-imidazole-1-carboxylic Acid 1,1-Dimethylethyl Ester, <b>9d</b></h3><div class="NLM_p last">A solution of 200 mg (0.565 mmol) of the acid <b>8d</b> is prepared in 15 mL of dichloromethane. Then 120 mg of EDCI and 90 mg of HOAT are added. The mixture is stirred at ambient temperature for 20 min, and an amount of 163 mg (0.565 mmol) of the amine <b>26</b> in solution in 3 mL of dichloromethane is added. The reaction mixture is kept under stirring at ambient temperature for 15 h and diluted with 40 mL of dichloromethane. This organic phase is washed with water, dried over magnesium sulfate, and concentrated under reduced pressure. The oily product obtained is purified by chromatography on silica gel, eluting with a mixture of dichloromethane/methanol (98/2, v/v). An amount of 288 mg of the expected compound is thus obtained as a colorless oil (81%). <sup>1</sup>H NMR (250 MHz, DMSO) δ: 7.87 (t, 1H), 7.62 (m, 1H), 7.44 (m, 2H), 7.24 (d, 2H), 4.51 (s, 2H), 4.19 (d, 2H), 3.83 (m, 4H), 3.62 (m, 2H), 3.43 (m, 2H), 2.85 (m, 6H), 1.18 (s, 9H).</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-[2-[[(2,4-Dichloro-3-methylphenyl)sulfonyl]methylamino]ethoxy]-<i>N</i>-[[4-(4,5-dihydro-1<i>H</i>-imidazol-2-yl)phenyl]methyl]-<i>N</i>-methylacetamide Trifluoroacetate, <b>10d</b></h3><div class="NLM_p last">A mixture of 240 mg of the compound <b>9d</b>, 5 mL of trifluoroacetic acid, 5 mL of dichloromethane, and 41 mg of anisole is prepared, and this mixture is kept under agitation for 15 h at ambient temperature. The solvents are drawn off under reduced pressure and then in the presence of toluene. The residual oil is stirred with isopropyl ether which is then removed. The oily residue is taken up with pure water. The solution is filtered, and the filtrate is lyophilized. An amount of 240 mg of the desired product is thus obtained as a cotton-like white solid (98%). Mp 75 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ: 10.48 (broad, 2H), 7.87 (m, 3H), 7.63 (m, 1H), 7.49 (d, 2H), 4.60 (s, 2H), 4.26 and 4.15 (s, 2H), 4.01 (s, 4H), 3.64 and 3.62 (t, 2H), 3.39 (m, 2H), 2.91 and 2.86 (s, 3H), 2.90 and 2.78 (s, 3H), 2.50 (s, 3H). Analytical HPLC method C: <i>t</i><sub>R</sub> = 1.12 min (97.5%). MS (ESI, [M + H]<sup>+</sup>), <i>m</i>/<i>z</i> 527.3.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 4-Methoxy-<i>N</i>,2,6-trimethyl-<i>N</i>-[2-[2-[4-(1-methyl-4-piperidinyl)-1-piperazinyl]-2-oxoethoxy]ethyl]benzenesulfonamide Bistrifluoroacetate, <b>12d</b></h3><div class="NLM_p last">500 mg (1.51 mmol) of acid <b>8h</b>, 319 mg (1.65 mmol) of EDCI, 2.26 mg (1.65 mg) of HOAT, and 233 μL of triethylamine are mixed in 10 mL of DMF, and this reaction mixture is kept under agitation at ambient temperature for 30 min. An amount of 314 mg (1.61 mmol) of 4-(1-methyl-4-piperidinyl)-1-piperazine is then added, and stirring is carried out for 20 h at ambient temperature. The reaction mixture is poured onto ice–water and extracted with dichloromethane. The organic phase is dried over magnesium sulfate and concentrated under reduced pressure. The oily product obtained is purified by chromatography on silica gel, eluting with a mixture of toluene/isopropanol (95/5, v/v). The basic compound obtained is salified with trifluoroacetic acid to give 877 mg of a colorless paste (74%). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>CN) δ: 6.74 (s, 2H), 4.11 (s, 2H), 3.81 (s, 3H), 3.80 (m, 4H), 3.77 (d, 2H), 3.64 (m, 2H), 3.55 (m, 1H), 3.34 (t, 2H), 3.26 (m, 4H), 3.01 (m, 2H), 2.79 (s, 3H), 2.74 (s, 3H), 2.57 (s, 6H), 2.29 (m, 4H). Analytical HPLC method B: <i>t</i><sub>R</sub> = 3.02 min (99.3%). MS (ESI, [M + H]<sup>+</sup>), <i>m</i>/<i>z</i> 497.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 4-Methoxy-<i>N</i>,2,6-trimethyl-<i>N</i>-[2-[2-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]-2-oxoethoxy]ethyl]benzenesulfonamide Fumarate, <b>12n</b></h3><div class="NLM_p last">Compound <b>12n</b> was prepared as described for <b>12d</b> using 4-(4-methyl-1-piperazinyl)-1-piperidine (white powder, 95%). Mp 90 °C. <sup>1</sup>H NMR (300 MHz, CD3CN) δ: 6.77 (s, 2H), 6.60 (s, 2H), 4.02 (s, 2H), 3.80 (s, 3H), 3.54 (t, 2H), 3.43 (m, 2H), 3.30 (m, 2H), 3.26 (t, 2H), 3.14 (m, 2H), 2.73 (s, 3H), 2.56 (s, 6H), 2.47 (m, 6H), 2.45 (s 3H), 2.38 (m, 1H), 1.90 (m, 2H), 1.68 (m, 2H). Analytical HPLC method B: <i>t</i><sub>R</sub> = 3.71 min (97.6%). MS (ESI, [M + H]<sup>+</sup>), <i>m</i>/<i>z</i> 497.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> [2-[[(1,1-Dimethylethoxy)carbonyl]methylamino]ethoxy]acetic Acid 1,1-Dimethylethyl Ester, <b>15</b></h3><div class="NLM_p last">Compound <b>15</b> was prepared as described for <b>7d</b> starting from (2-hydroxyethyl)methylcarbamic acid <i>tert</i>-butyl ester (yellow oil, 99%). <sup>1</sup>H NMR (250 MHz, DMSO) δ: 3.96 (s, 2H), 3.52 (t, 2H), 3.31 (t, 2H), 2.81 (s, 3H), 1.42 (s, 9H), 1.38 (s, 9H).</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> [2-(Methylamino)ethoxy]acetic Acid Trifluoroacetate, <b>16</b></h3><div class="NLM_p last">A solution of 27.8 g (96 mmol) of <b>15</b> is prepared in 230 mL of dichloromethane. An amount of 20 mL of TFA is added and the mixture stirred overnight at room temperature. The mixture is concentrated under reduced pressure and dried at 45 °C under reduced pressure for 1 h to give the desired product as a yellow oil (99%). <sup>1</sup>H NMR (250 MHz, DMSO) δ: 8.50 (broad s, 1H), 4.09 (s, 2H), 3.70 (m, 2H), 3.11 (m, 2H), 2.60 (m, 3H).</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> [2-[Methyl[(phenylmethoxy)carbonyl]amino]ethoxy]acetic Acid, <b>17</b></h3><div class="NLM_p last">A solution of 25 g (101 mmol) of <b>16</b> is prepared in 400 mL of dichloromethane. Then 35.2 mL (25 mmol) of triethylamine and, dropwise, 15.5 mL of benzyl chloroformate are added at 0 °C. The reaction mixture is stirred for 5 h at ambient temperature. The reaction mixture is hydrolyzed over 200 mL of ice–water and 50 mL of 1 N hydrochloric acid. The separated organic phase is washed with water, then dried over magnesium sulfate and concentrated under reduced pressure. The crude oily product is purified by chromatography on silica gel, eluting with a mixture of toluene/isopropanol/aqueous ammonia (9/1/0.1, v/v/v). An amount of 13.7 g of the desired product is thus obtained as a colorless oil (51%). <sup>1</sup>H NMR (250 MHz, DMSO) δ: 7.33 (m, 5H), 5.06 (s, 2H), 4.10 (s, 2H), 3.58 (t, 2H), 3.49 (m, 2H), 2.90 (d, 3H).</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-[4-(2,8-Dimethyl-3,9-dioxo-11-phenyl-5,10-dioxa-2,8-diazaundec-1-yl)phenyl]-4,5-dihydro-1<i>H</i>-imidazole-1-carboxylic Acid 1,1-Dimethylethyl Ester, <b>18</b></h3><div class="NLM_p last">Compound <b>18</b> was prepared as described for <b>9d</b> using <b>17</b> (yellow oil, 62%). <sup>1</sup>H NMR (250 MHz, DMSO) δ: 7.42–7.22 (m, 9H), 5.05 (s, 2H), 4.51 (s, 2H), 4.21 (s, 2H), 3.84 (m, 4H), 3.58 (m, 2H), 3.45 (m, 2H), 2.88 (m, 6H), 1.17 (s, 9H).</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 4,5-Dihydro-2-[4-[[methyl[[2-(methylamino)ethoxy]acetyl]amino]methyl]phenyl]-1<i>H</i>-imidazole-1-carboxylic Acid 1,1-Dimethylethyl Ester, <b>19</b></h3><div class="NLM_p last">A solution of 11.7 g (22 mmol) of <b>18</b> is prepared in 200 mL of methanol. An amount of 1.2 g of Pd/C 10% is added, and the mixture is hydrogenated at room temperature and atmospheric pressure for 3 h. The catalyst is eliminated by filtration, and the filtrate is concentrated under reduce pressure. The crude product is purified by chromatography on NH<sub>2</sub> silica gel, eluting with a mixture of dichloromethane/MeOH (99/1, v/v). An amount of 6 g of the desired product is thus obtained as a colorless oil (91%). <sup>1</sup>H NMR (250 MHz, DMSO) δ: 7.41 (d, 2H), 7.26 (d, 2H), 4.53 (d, 2H), 4.20 (d, 2H), 3.84 (m, 4H), 3.50 (m, 2H), 2.86 (s, 3H), 2.63 (m, 2H), 2.26 (d, 3H), 1.18 (s, 9H).</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 4,5-Dihydro-2-[4-[[[[2-[[(4-methoxy-2,6-dimethylphenyl)sulfonyl]methylamino]ethoxy]acetyl]methylamino]methyl]phenyl]-1<i>H</i>-imidazole-1-carboxylic Acid 1,1-Dimethylethyl Ester, <b>20a</b></h3><div class="NLM_p last">A solution of 100 mg (0.24 mmol) of amine <b>19</b> is prepared in 3 mL of dichloromethane. Then 34 μL of Et<sub>3</sub>N and 52 mg (0.22 mmol) of 4-methoxy-2,6-dimethylphenylsulfonyl chloride are added, and the mixture is stirred at room temperature for 2 h. The mixture is poured onto water and extracted with dichloromethane. The organic phase is dried on magnesium sulfate and concentrated under reduced pressure. The crude product is purified by chromatography on silica gel, eluting with a mixture of dichloromethane/MeOH (99/1, v/v). An amount of 99 mg of the desired product is thus obtained as a colorless oil (74%). <sup>1</sup>H NMR (300 MHz, DMSO) δ: 7.43 (m, 2H), 7.22 (d, 2H), 6.80 (s, 2H), 4.50 (s, 2H), 4.16 and 4.13 (s, 2H), 3.84 (m, 4H), 3.79 (s, 3H), 3.57 (m, 2H), 3.26 (m, 2H), 2.80 and 2.76 (s, 3H), 2.71 and 2.68 (s, 3H), 2.53 (s, 6H), 1.18 (s, 9H).</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-[[4-(4,5-Dihydro-1<i>H</i>-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl)sulfonyl]methylamino]ethoxy]-<i>N</i>-methylacetamide Trifluoroacetate, <b>21a</b></h3><div class="NLM_p last">Compound <b>21a</b> was prepared as described for <b>10d</b> using <b>20a</b> (pasty solid, 99%). <sup>1</sup>H NMR (250 MHz, DMSO) δ: 10.48 (broad s, 2H), 7.89 (d, 2H), 7.48 (d, 2H), 6.79 (s, 2H), 4.59 (s, 2H), 4.15 (d, 2H), 4.01 (s, 4H), 3.79 (s, 3H), 3.59 (m, 2H), 3.24 (m, 2H), 2.71 (m, 6H), 2.53 (s, 6H). Analytical HPLC method A: <i>t</i><sub>R</sub> = 3.39 min (99.6%). MS (ESI, [M + H]<sup>+</sup>), <i>m</i>/<i>z</i> 503.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Competition Binding Assay to the Human or Mouse Recombinant B1 Receptor</h3><div class="NLM_p last">HEK 293 cells stably expressing the human<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> or mouse B1 receptor were grown in Dulbecco’s modified Eagle’s medium containing 4.5 g/L glucose, 1% Glutamax (v/v), 1% nonessential amino acid (v/v), 1 mM sodium pyruvate, 100 mg/mL penicillin, 100 mg/mL streptomycin, and 10% fetal bovine serum. HEK 293 cells were rinsed twice with Ca<sup>2+</sup>/Mg<sup>2+</sup>-free ice-cold PBS and scraped from the dishes with a rubber policeman in 5 mL of binding buffer [25 mM 2-{[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino}ethanesulfonic acid (TES), 1 mM 1,10-phenanthroline, 140 mg/mL bacitracin, and 0.1% bovine serum albumin at pH 7.4]. They were homogenized with a Polytron (Kinematica, Lucerne, Switzerland) and centrifuged at 40000<i>g</i> for 20 min. The pellet was then resuspended in binding buffer and stored in liquid nitrogen. Binding experiments were performed at room temperature with a 20–40 μg of membrane protein/assay in binding buffer. For saturation experiments, [<sup>3</sup>H]des-Arg10-KD (0.1–5 nM) was incubated for 1 h in a final volume of 500 μL. The assay was terminated by filtration on Whatman GF/B filters presoaked for 2 h in 0.1% polyethyleneimide (w/v). Filters were rinsed three times with 5 mL of ice-cold 50 mM TES, and the radioactivity was determined by liquid scintillation counting in 5 mL of Optima Gold (Packard, Rungis, France). Nonspecific binding was determined in the presence of 10 μM des-Arg10-kallidin. Competition binding experiments were carried out in the presence of [<sup>3</sup>H]des-Arg10-kallidin at a dose equal to the KD in competition with various concentrations of compound. All assays were carried out in duplicate. Protein concentration was measured by the method of Bradford.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Competition Binding Assay to the Human Recombinant B2 Receptor</h3><div class="NLM_p last">Chinese hamster ovary (CHO) K1 cells expressing the human B2 receptor (Hess et al., 1992) were maintained in Ham’s F12 medium containing 10% fetal calf serum, 4.5 g/L glucose, 100 mg/L streptomycin, and 105 units/L penicillin. CHO cells were rinsed twice with Ca<sup>2+</sup>/Mg<sup>2+</sup>-free ice-cold phosphate-buffered saline and scraped from the dishes with a rubber policeman in 5 mL of binding buffer (25 mM TES, 1 mM 1,10-phenanthroline, 140 mg/mL bacitracin, and 0.1% bovine serum albumin) at pH 6.8. They were homogenized with a Polytron (Kinematica) and centrifuged at 40000<i>g</i> for 20 min. The pellet was then resuspended in binding buffer and stored in liquid nitrogen. Binding experiments were performed at room temperature with 20–40 μg of membrane protein/assay in binding buffer. For saturation experiments, [<sup>3</sup>H]bradykinin (0.1–5 nM) was incubated for 90 min in a final volume of 500 μL. The assay was terminated by filtration on Whatman GF/B filters presoaked for 2 h in 0.1% polyethyleneimide (w/v). Filters were rinsed three times with 5 mL of ice-cold 50 mM TES, and the radioactivity was determined by liquid scintillation counting in 5 mL of Optima Gold (Packard). Nonspecific binding was determined in the presence of 10 μM bradykinin. Competition binding experiments were carried out in the presence of [<sup>3</sup>H]bradykinin at a dose equal to the KD in competition with various concentrations of compound for 90 min at room temperature. All assays were carried out in duplicate. Protein concentration was measured by the method of Bradford.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Human Umbilical Vein</h3><div class="NLM_p last">With the approval of the Ethical Committee of Clinique Ste Marthe (Dijon, France), human umbilical cords were collected postdelivery and immediately placed in Krebs’ solution of the following composition: 119 mM NaCl, 4.7 mM KCl, 1.5 mM MgSO<sub>4</sub>, 2.5 mM CaCl<sub>2</sub>, 1.2 mM KH<sub>2</sub>PO<sub>4</sub>, 25 mM NaHCO<sub>3</sub>, 5.5 mM glucose, and 0.026 mM EDTA. Umbilical vein rings (3–4 mm in length) were incubated overnight in 20 mL jacketed organ baths containing Dulbecco’s modified Eagle’s cell culture medium supplemented with 1% fetal calf serum and penicillin (10 IU/mL)–streptomycin (10 μg/mL) maintained at 37 °C and bubbled with 95% O<sub>2</sub> and 5% CO<sub>2</sub> to induce kinin B1 receptor. Then they were set up in 8 mL jacketed organ baths containing Krebs’ solution maintained at 37 °C and bubbled with 95% O<sub>2</sub> and 5% CO<sub>2</sub>. Strips were left unstretched for 1 h, during which the bath fluid was changed every 15 min with fresh solution. Strips were then stretched to 1 g. All rings were contracted by KPSS (Krebs’ solution in which NaCl was replaced by KCl) to assess their contractility. After the samples were washed twice with normal Krebs’ solution and returned to baseline, captopril (10 μM), <span class="smallcaps smallerCapital">dl</span>-thiorphan (1 μM), mepyramine (1 μM), atropine (1 μM), indomethacin (3 μM), NG-nitro-<span class="smallcaps smallerCapital">l</span>-arginine (30 μM), and nifedipine (0.1 μM) were added into the organ bath. After 30 min vehicle or compound was injected into the bath, and after 30 min of incubation concentration–response curves to des-Arg10-kallidin were obtained. At the end of the experiments, after repetitive washes, the baseline level was reestablished and the maximal contraction of each vein segment was elicited by adding U46619 (1 μM), a thromboxane A2 mimetic. Each ring was used for a single concentration–response curve. The contractile responses to agonists were expressed as a percentage of the maximal contraction to U46619.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Mouse Fundus</h3><div class="NLM_p last">Male Swiss mice weighing 25–35 g were sacrificed by a CO<sub>2</sub> intoxication, and the stomach was removed and immediately placed in Krebs’ solution of the following composition: 119 mM NaCl, 4.7 mM KCl, 1.5 mM MgSO<sub>4</sub>, 2.5 mM CaCl<sub>2</sub>, 1.2 mM KH<sub>2</sub>PO<sub>4</sub>, 25 mM NaHCO<sub>3</sub>, 5.5 mM glucose, and 0.026 mM EDTA. The fundus was dissected free, and segments were suspended under a resting tension of 1 g in 8 mL jacketed organ baths containing Krebs’ solution maintained at 37 °C and bubbled with 95% O<sub>2</sub> and 5% CO<sub>2</sub>. After a 4 h resting period, the maximal contraction was measured in each segment by adding carbachol (10 μM). After the samples were washed twice with Krebs’ solution and returned to baseline, captopril (10 μM), <span class="smallcaps smallerCapital">dl</span>-thiorphan (1 μM), mepyramine (1 μM), and indomethacin (3 μM) were added to the organ bath. After 30 min, vehicle or compound was applied to the organ bath. This mixture was incubated for 30 min, and concentration–response curves to des-Arg10-kallidin were obtained. Each segment was used for a single concentration–response curve. The contractile responses to des-Arg10-kallidin were expressed as a percentage of the maximal contraction to carbachol.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40"><a href="/doi/suppl/10.1021/jm2016057">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12117" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12117" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures for all intermediates <b>5a</b>, <b>6f</b>,<b>g</b>, <b>7a</b>–<b>c</b>,<b>e</b>–<b>g</b>, <b>8a</b>–<b>c</b>,<b>e</b>–<b>g</b>, <b>9a</b>–<b>c</b>,<b>e</b>–<b>h</b>, <b>10a</b>–<b>c</b>,<b>e</b>–<b>g</b>, <b>12a</b>–<b>c</b>,<b>e</b>–<b>m</b>,<b>o</b>–<b>r</b>, <b>20b</b>–<b>h</b>, <b>21b</b>–<b>h</b>, and <b>23</b>–<b>26</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm2016057/suppl_file/jm2016057_si_001.pdf">jm2016057_si_001.pdf (154.62 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm2016057" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50025" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50025" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martine Barth</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical Design and Synthesis, Clinical
Candidate Selection, Laboratoires Fournier, 50 Rue de Dijon, 21121 Daix, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#84e9e5f6f0edeae1aae6e5f6f0ecc4e5e6e6ebf0f0aae7ebe9"><span class="__cf_email__" data-cfemail="7e131f0c0a17101b501c1f0c0a163e1f1c1c110a0a501d1113">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michel Bondoux</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical Design and Synthesis, Clinical
Candidate Selection, Laboratoires Fournier, 50 Rue de Dijon, 21121 Daix, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Michel Luccarini</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical Design and Synthesis, Clinical
Candidate Selection, Laboratoires Fournier, 50 Rue de Dijon, 21121 Daix, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincent Peyrou</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical Design and Synthesis, Clinical
Candidate Selection, Laboratoires Fournier, 50 Rue de Dijon, 21121 Daix, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pierre Dodey</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical Design and Synthesis, Clinical
Candidate Selection, Laboratoires Fournier, 50 Rue de Dijon, 21121 Daix, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Didier Pruneau</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical Design and Synthesis, Clinical
Candidate Selection, Laboratoires Fournier, 50 Rue de Dijon, 21121 Daix, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Massardier</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical Design and Synthesis, Clinical
Candidate Selection, Laboratoires Fournier, 50 Rue de Dijon, 21121 Daix, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Luc Paquet</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical Design and Synthesis, Clinical
Candidate Selection, Laboratoires Fournier, 50 Rue de Dijon, 21121 Daix, France</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i41" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i41"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i42" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i42"> Abbreviations Used</h2><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">BK</td><td class="NLM_def"><p class="first last">bradykinin</p></td></tr><tr><td class="NLM_term">COS</td><td class="NLM_def"><p class="first last">monkey kidney fibroblast cells</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl)carbodiimide</p></td></tr><tr><td class="NLM_term">HEK293</td><td class="NLM_def"><p class="first last">human endothelium kidney 293</p></td></tr><tr><td class="NLM_term">HOAT</td><td class="NLM_def"><p class="first last">1-hydroxy-7-azabenzotriazole</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">polar surface area</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TM</td><td class="NLM_def"><p class="first last">transmembrane spanning domain</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58078" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58078" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 16 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Bhoola, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worthy, K.</span><span> </span><span class="NLM_article-title">Bioregulation of kinins: kallikreins, kininogens and kininases</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1992&pages=1-80&author=K.+D.+Bhoolaauthor=C.+D.+Figueroaauthor=K.+Worthy&title=Bioregulation+of+kinins%3A+kallikreins%2C+kininogens+and+kininases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhoola%26aufirst%3DK.%2BD.%26aulast%3DFigueroa%26aufirst%3DC.%2BD.%26aulast%3DWorthy%26aufirst%3DK.%26atitle%3DBioregulation%2520of%2520kinins%253A%2520kallikreins%252C%2520kininogens%2520and%2520kininases%26jtitle%3DPharmacol.%2520Rev.%26date%3D1992%26volume%3D44%26spage%3D1%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barabé, J.</span><span> </span><span class="NLM_article-title">Pharmacology of bradykinin and related kinins</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1980&pages=1-46&author=D.+Regoliauthor=J.+Barab%C3%A9&title=Pharmacology+of+bradykinin+and+related+kinins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DBarab%25C3%25A9%26aufirst%3DJ.%26atitle%3DPharmacology%2520of%2520bradykinin%2520and%2520related%2520kinins%26jtitle%3DPharmacol.%2520Rev.%26date%3D1980%26volume%3D32%26spage%3D1%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nsa Allogho, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobeil, F. J.</span><span> </span><span class="NLM_article-title">Bradykinin receptors and their antagonists</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1016%2FS0014-2999%2898%2900165-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=9650825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADyaK1cXivVGisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=1998&pages=1-10&author=D.+Regoliauthor=S.+Nsa+Alloghoauthor=A.+Rizziauthor=F.+J.+Gobeil&title=Bradykinin+receptors+and+their+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Bradykinin receptors and their antagonists</span></div><div class="casAuthors">Regoli, Domenico; Nsa Allogho, Suzanne; Rizzi, Anna; Gobeil, Fernand, Jr.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review, with 87 refs.  Bradykinin and related kinins act on two receptor types, named B1 and B2.  Initially identified in classical bioassays, these receptors have been cloned and characterized in binding assays performed on plasma membranes of cells expressing the native or the transfected human kinin B1 or B2 receptor types.  The two classification criteria recommended by Schild, namely the order of potency of agonists and the actual affinity of antagonists have been found to be applicable for receptor classification based not on data only from bioassays but also from other approaches (binding assays, mol. biol. techniques).  The order of potency for agonists was found with naturally occurring peptides (the kinins, their desArg9-metabolites) and with selective agonists (e.g., [Hyp3]bradykinin, [Aib7]bradykinin): the findings obtained with agonists could be validated with various antagonists.  Crit. evaluation of the initial compds., typified by D-Arg-[Hyp3, d-Phe7]bradykinin, has indicated that they are short-acting, partial agonists, non-selective for the bradykinin B2 receptor because they can be metabolized to desArg9-fragments that act on the kinin B1 receptor.  Use of such compds. has given rise to misunderstandings, esp. with regard to new receptor types (e.g., type B3), the existence of which was not confirmed by mol. cloning.  A second generation of antagonists, represented by d-Arg[Hyp3,Thi5,d-Tic7,Oic8]bradykinin (HOE 140) has been found resistant to degrdn., long-acting in vivo, selective and specific for the B2 receptor and potent in all species tested.  HOE 140 has been used successfully in basic pharmacol., in animal physiopathologies involving kinins and their receptors and even in clin. studies.  A third generation of non-peptide B2 receptor antagonists, whose prototype is FR 173657 ((E)-3-(6-acetamido-3-pyridyl)-N-[N-2-4-dichloro-3-[(2-methyl-8-quinolinyl)oxymethyl]phenyl]-N-methylamino carbonyl-Me acrylamide) is now emerging and may represent substantial progress since FR 173657 is a potent orally active, selective and specific antagonist of the human and other species B2 receptors.  There is also progress regarding antagonists for the B1 receptor.  The initial compds., esp. Lys-[Leu8]desArg9-bradykinin remain among of the most potent, specific and selective B1 antagonists which, however, show partial agonistic effects in some B1 receptor subtypes (e.g., the mouse).  Progress has been made with AcLys-[D-βNal7, Ile8]desArg9-bradykinin (R 715) and Lys-Lys-[Hyp3, Cpg5, d-Tic7,Cpg8]desArg9-bradykinin (B 9958) which are pure B1 antagonists in humans and rabbits; both peptides have shown resistance to degrdn. by peptidases and have little if any, residual agonistic activity on mouse and rat B1 receptors.  No non-peptide antagonists are yet available for the B1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIMrTVFwpWibVg90H21EOLACvtfcHk0lh6ysNyrtxF8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXivVGisL0%253D&md5=6d4eb69a3d9be345fd876604543131e8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2898%2900165-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252898%252900165-4%26sid%3Dliteratum%253Aachs%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DNsa%2BAllogho%26aufirst%3DS.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DGobeil%26aufirst%3DF.%2BJ.%26atitle%3DBradykinin%2520receptors%2520and%2520their%2520antagonists%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D348%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Marceau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachvarov, D. R.</span><span> </span><span class="NLM_article-title">The B<sub>1</sub> receptors for kinins</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1998&pages=357-386&author=F.+Marceauauthor=J.+F.+Hessauthor=D.+R.+Bachvarov&title=The+B1+receptors+for+kinins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarceau%26aufirst%3DF.%26aulast%3DHess%26aufirst%3DJ.%2BF.%26aulast%3DBachvarov%26aufirst%3DD.%2BR.%26atitle%3DThe%2520B1%2520receptors%2520for%2520kinins%26jtitle%3DPharmacol.%2520Rev.%26date%3D1998%26volume%3D50%26spage%3D357%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hall, J. M.</span><span> </span><span class="NLM_article-title">Bradykinin receptors: pharmacological properties and biological roles</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1016%2F0163-7258%2892%2990016-S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=1338478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADyaK3sXksVWjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1992&pages=131-190&author=J.+M.+Hall&title=Bradykinin+receptors%3A+pharmacological+properties+and+biological+roles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Bradykinin receptors: Pharmacological properties and biological roles</span></div><div class="casAuthors">Hall, Judith M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-90</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    </div><div class="casAbstract">A review, with 364 refs., on the properties of bradykinin B1 and B2 receptors and the potential therapeutic applications of drugs acting at these sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwyMOPtpGNJbVg90H21EOLACvtfcHk0ljdTorddWv9gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXksVWjsbo%253D&md5=3a9cd1a63348687e348cd6ba09ca7ad7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0163-7258%2892%2990016-S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-7258%252892%252990016-S%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DJ.%2BM.%26atitle%3DBradykinin%2520receptors%253A%2520pharmacological%2520properties%2520and%2520biological%2520roles%26jtitle%3DPharmacol.%2520Ther.%26date%3D1992%26volume%3D56%26spage%3D131%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Pesquero, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araujo, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heppenstall, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, J. A.,  Jr</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walther, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesquero, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paiva, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calixto, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewin, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, M.</span><span> </span><span class="NLM_article-title">Hypoalgesia and altered inflammatory responses in mice lacking kinin B<sub>1</sub> receptors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">8140</span><span class="NLM_x">–</span> <span class="NLM_lpage">8145</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=8140-8145&author=J.+B.+Pesqueroauthor=R.+C.+Araujoauthor=P.+A.+Heppenstallauthor=J.+A.+Silvaauthor=T.+Waltherauthor=S.+M.+Oliveiraauthor=J.+L.+Pesqueroauthor=A.+C.+Paivaauthor=J.+B.+Calixtoauthor=G.+R.+Lewinauthor=M.+Bader&title=Hypoalgesia+and+altered+inflammatory+responses+in+mice+lacking+kinin+B1+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPesquero%26aufirst%3DJ.%2BB.%26aulast%3DAraujo%26aufirst%3DR.%2BC.%26aulast%3DHeppenstall%26aufirst%3DP.%2BA.%26aulast%3DSilva%26aufirst%3DJ.%2BA.%26aulast%3DWalther%26aufirst%3DT.%26aulast%3DOliveira%26aufirst%3DS.%2BM.%26aulast%3DPesquero%26aufirst%3DJ.%2BL.%26aulast%3DPaiva%26aufirst%3DA.%2BC.%26aulast%3DCalixto%26aufirst%3DJ.%2BB.%26aulast%3DLewin%26aufirst%3DG.%2BR.%26aulast%3DBader%26aufirst%3DM.%26atitle%3DHypoalgesia%2520and%2520altered%2520inflammatory%2520responses%2520in%2520mice%2520lacking%2520kinin%2520B1%2520receptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D8140%26epage%3D8145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Perkins, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dray, A.</span><span> </span><span class="NLM_article-title">Antinociceptive activity of the bradykinin B<sub>1</sub> and B<sub>2</sub> receptor antagonists, des-Arg<sup>9</sup>[Leu<sup>8</sup>]-BK and Hoe 140, in two models of persistent hyperalgesia in the rat</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1993&pages=191-197&author=M.+N.+Perkinsauthor=E.+Campbellauthor=A.+Dray&title=Antinociceptive+activity+of+the+bradykinin+B1+and+B2+receptor+antagonists%2C+des-Arg9%5BLeu8%5D-BK+and+Hoe+140%2C+in+two+models+of+persistent+hyperalgesia+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerkins%26aufirst%3DM.%2BN.%26aulast%3DCampbell%26aufirst%3DE.%26aulast%3DDray%26aufirst%3DA.%26atitle%3DAntinociceptive%2520activity%2520of%2520the%2520bradykinin%2520B1%2520and%2520B2%2520receptor%2520antagonists%252C%2520des-Arg9%255BLeu8%255D-BK%2520and%2520Hoe%2520140%252C%2520in%2520two%2520models%2520of%2520persistent%2520hyperalgesia%2520in%2520the%2520rat%26jtitle%3DPain%26date%3D1993%26volume%3D53%26spage%3D191%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Rupniak, N. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borkowski, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, J. F.</span><span> </span><span class="NLM_article-title">Effects of the bradykinin B<sub>1</sub> receptor antagonist des-Arg<sup>9</sup>[Leu<sup>8</sup>]bradykinin and genetic disruption of the B<sub>2</sub> receptor on nociception in rats and mice</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1997&pages=89-97&author=N.+M.+J.+Rupniakauthor=S.+Boyceauthor=J.+K.+Webbauthor=A.+R.+Williamsauthor=E.+J.+Carlsonauthor=R.+G.+Hillauthor=J.+A.+Borkowskiauthor=J.+F.+Hess&title=Effects+of+the+bradykinin+B1+receptor+antagonist+des-Arg9%5BLeu8%5Dbradykinin+and+genetic+disruption+of+the+B2+receptor+on+nociception+in+rats+and+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRupniak%26aufirst%3DN.%2BM.%2BJ.%26aulast%3DBoyce%26aufirst%3DS.%26aulast%3DWebb%26aufirst%3DJ.%2BK.%26aulast%3DWilliams%26aufirst%3DA.%2BR.%26aulast%3DCarlson%26aufirst%3DE.%2BJ.%26aulast%3DHill%26aufirst%3DR.%2BG.%26aulast%3DBorkowski%26aufirst%3DJ.%2BA.%26aulast%3DHess%26aufirst%3DJ.%2BF.%26atitle%3DEffects%2520of%2520the%2520bradykinin%2520B1%2520receptor%2520antagonist%2520des-Arg9%255BLeu8%255Dbradykinin%2520and%2520genetic%2520disruption%2520of%2520the%2520B2%2520receptor%2520on%2520nociception%2520in%2520rats%2520and%2520mice%26jtitle%3DPain%26date%3D1997%26volume%3D71%26spage%3D89%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Corrêa, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calixto, J. B.</span><span> </span><span class="NLM_article-title">Evidence for participation of B<sub>1</sub> and B<sub>2</sub> kinin receptors in formalin-induced nociceptive response in the mouse</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1111%2Fj.1476-5381.1993.tb13791.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=8220879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADyaK2cXkslGnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1993&pages=193-198&author=C.+R.+Corr%C3%AAaauthor=J.+B.+Calixto&title=Evidence+for+participation+of+B1+and+B2+kinin+receptors+in+formalin-induced+nociceptive+response+in+the+mouse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse</span></div><div class="casAuthors">Correa, Clovis R.; Calixto, Joao B.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-8</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">This study was designed to investigate the role of bradykinin (BK), as well as the subtype of BK receptors involved, in formalin-induced hindpaw pain in the mouse by use of selective B1 and B2 receptor antagonists.  In addn., the authors have analyzed whether or not BK may be involved in formalin-induced hindpaw edema in the mouse.  The pretreatment of animals with captopril (2 and 5 mg kg-1, s.c.) significantly increase the first and the second phases of formalin-induced pain.  Co-injection of the selective B1 receptor antagonist des-Arg9[Leu8]-BK (0.2-0.4 nmol/paw), together with formalin, caused graded and similar inhibitions of both phases of formalin-induced pain.  Similar results were obtained with B2 antagonists NPC 349 (D-Arg[Hyp3,Thi5,8-D-Phe7]-BK) and NPC 567 (D-Arg[Hyp3,D-Phe7]-BK) (0.2 and 0.6 nmol/paw).  Higher concns. of these antagonists (1 nmol/paw) failed to antagonize formalin-induced pain.  The new potent and selective B2 receptor antagonists, Hoe 140 (D-Arg[Hyp3,Thi5,D-Tic7,Oic8]-BK), NPC 17731 (D-Arg[Hyp3, trans-4-propoxy-D-proline (trans thiophenyl)7, Oic8]-BK), and NPC 17761 (D-Arg[Hyp3, trans-4-propoxy-D-proline (trans thiophenyl)7, Oic8]-BK) (0.02 to 1.0 nmol/paw), also caused significant inhibitions of both phases of formalin-induced pain.  When Hoe 140 was injected s.c. 30 min before formalin injection (9.9 and 99 nmol kg-1), it significantly attenuated both phases of formalin-induced pain.  The putative non-peptide BK antagonist, MV 8612 (1.6 to 9.6 nmol/paw), but not MV 8608 (5.5 to 33 nmol/paw), caused a graded inhibition of both phases of formalin-induced pain, being, however, more active against the first phase.  The pretreatment of animals with morphine (2.6 to 13 μmol kg-1, s.c.) caused dose-dependent and equipotent inhibitions of both phases of formalin-induced pain.  In contrast, indomethacin (2.7 to 27 μmol kg-1) antagonized only the second phase of formalin-induced pain.  The B2 receptor antagonists, Hoe 140, NPC 17731, NPC 17761, NPC 349 and NPC 567, all caused a significant inhibition of formalin-induced hindpaw edema.  A similar inhibition was also obsd. with indomethacin but not with captopril or morphine.  The authors' results provide strong evidence for the important role of endogenous BK, acting through both B1 and B2 receptors, in the genesis of both phases of formalin-induced persistent pain in the mouse.  In addn., the current results also demonstrate that the inflammatory edema assocd. with the later phase of formalin-induced pain seems to be mediated by endogenous BK, via activation of B2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA410KvdTexrVg90H21EOLACvtfcHk0ljdTorddWv9gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslGnsw%253D%253D&md5=c998e81791522a24ac9af95b0827d046</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1993.tb13791.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1993.tb13791.x%26sid%3Dliteratum%253Aachs%26aulast%3DCorr%25C3%25AAa%26aufirst%3DC.%2BR.%26aulast%3DCalixto%26aufirst%3DJ.%2BB.%26atitle%3DEvidence%2520for%2520participation%2520of%2520B1%2520and%2520B2%2520kinin%2520receptors%2520in%2520formalin-induced%2520nociceptive%2520response%2520in%2520the%2520mouse%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D110%26spage%3D193%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Perkins, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, D.</span><span> </span><span class="NLM_article-title">Induction of bradykinin B<sub>1</sub> receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">1441</span><span class="NLM_x">–</span> <span class="NLM_lpage">1444</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1111%2Fj.1476-5381.1993.tb13982.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=8306084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADyaK2cXhtVSlt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1993&pages=1441-1444&author=M.+N.+Perkinsauthor=D.+Kelly&title=Induction+of+bradykinin+B1+receptors+in+vivo+in+a+model+of+ultra-violet+irradiation-induced+thermal+hyperalgesia+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of bradykinin B1 receptors in vivo in a model of ultraviolet irradiation-induced thermal hyperalgesia in the rat</span></div><div class="casAuthors">Perkins, M. N.; Kelly, D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1441-4</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The role of bradykinin B1 receptors in the thermal hyperalgesia following unilateral UV irradn. of the hindpaw of rats has been investigated.  In nonirradiated (naive) animals, the R1 receptor agonist des-Arg9-bradykinin and bradykinin (BK) (up to 1 μmol/kg i.v.) had no effect on withdrawal latency to a noxious heat stimulus when administered 60 min before testing.  Following exposure of one hindpaw to strong UV irradn., the withdrawal latency of the UV-treated paw to radiant noxious heat fell by a max. of 50% after 48 h.  There was no redn. in latency in the contralateral paw.  Des-Arg9-BK (1-100 mmol/kg i.v.) administered 24 h after UV exposure caused a further dose-dependent fall (50% redn. from saline injected animals at 100 nmol/kg i.v.) in withdrawal latency in the UV-treated paw when measured 60 min after injection.  The withdrawal latency of the contralateral paw was also reduced, but to a lesser extent following des-Arg9-BK (100 nmol/kg i.v.) with a max. redn. of 19%.  Bradykinin also induced a further redn. in withdrawal latency (33% redn. at 1 μmol/kg), although it was not as effective as des-Arg9-BK.  Bradykinin did not reduce the withdrawal latency in the contralateral paw.  The hyperalgesic action of both des-Arg9-BK (10 nmol/kg i.v.) and bradykinin (100 nmol/kg, i.v.) were antagonized by the B1 receptor antagonist, des-Arg9,Leu8-BK (200 nmol/kg i.v.) but not by the B2 receptor antagonist, HOE 140 (0.5 μmol/kg i.v.).  The results suggest that in conditions of inflammatory hyperalgesia, bradykinin B1 receptors are induced both locally and distant to the inflamed area, activation of which leads to further thermal hyperalgesia.  In addn., in these conditions bradykinin appears to act predominantly via B1 receptors, presumably after degrdn. to des-Arg9-BK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr29HPKaHx_dLVg90H21EOLACvtfcHk0lhFac7SIANNAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhtVSlt74%253D&md5=19b5eaaa028947c5e602872bb1511b02</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1993.tb13982.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1993.tb13982.x%26sid%3Dliteratum%253Aachs%26aulast%3DPerkins%26aufirst%3DM.%2BN.%26aulast%3DKelly%26aufirst%3DD.%26atitle%3DInduction%2520of%2520bradykinin%2520B1%2520receptors%2520in%2520vivo%2520in%2520a%2520model%2520of%2520ultra-violet%2520irradiation-induced%2520thermal%2520hyperalgesia%2520in%2520the%2520rat%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D110%26spage%3D1441%26epage%3D1444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Davis, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, M. N.</span><span> </span><span class="NLM_article-title">Induction of B<sub>1</sub> receptors in vivo in a model of persistent inflammatory mechanical hyperalgesia in the rat</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1994&pages=127-133&author=A.+J.+Davisauthor=M.+N.+Perkins&title=Induction+of+B1+receptors+in+vivo+in+a+model+of+persistent+inflammatory+mechanical+hyperalgesia+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DA.%2BJ.%26aulast%3DPerkins%26aufirst%3DM.%2BN.%26atitle%3DInduction%2520of%2520B1%2520receptors%2520in%2520vivo%2520in%2520a%2520model%2520of%2520persistent%2520inflammatory%2520mechanical%2520hyperalgesia%2520in%2520the%2520rat%26jtitle%3DNeuropharmacology%26date%3D1994%26volume%3D33%26spage%3D127%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Davis, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, M. N.</span><span> </span><span class="NLM_article-title">The involvement of bradykinin B<sub>1</sub> and B<sub>2</sub> receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1111%2Fj.1476-5381.1994.tb16174.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=7812634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADyaK2cXlslOns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1994&pages=63-68&author=A.+J.+Davisauthor=M.+N.+Perkins&title=The+involvement+of+bradykinin+B1+and+B2+receptor+mechanisms+in+cytokine-induced+mechanical+hyperalgesia+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">The involvement of bradykinin B1 and B2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat</span></div><div class="casAuthors">Davis, A. J.; Perkins, M. N.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-8</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">Interleukin-1β (IL-1β), IL-2 and IL-8 induced a mech. hyperalgesia following intra-articular (i.artic.) injection into rat knee joints, whereas IL-6 and tumor necrosis factor α (TNF-α) were without effect.  Co-administration of IL-1 receptor antagonist (0.1 μg) with IL-1β (1 u), IL-2 (10 u) or IL-8 (0.1 u) prevented the subsequent development of the hyperalgesia.  Co-administration of desArg9Leu8BK (0.5-5 nmol) with IL-1β (1 u), IL-2 (10 u) or IL-8 (0.1 u) reduced the level of hyperalgesia at 1, 4 and 6 h post administration, whereas Hoe 140 (5 pmol) antagonized the hyperalgesia only at the 1 h time point.  The i.v. administration of desArg9Leu8BK (10 nmol kg-1) or Hoe 140 (100 pmol kg-1) following IL-1β (1 u), IL-2 (10 u), or IL-8 (0.1 u) reversed the subsequent hyperalgesia.  Administration of desArg9BK into joints 24 h after pre-treatment with IL-1β (1 u) produced analgesia at low doses (50 pmol) and hyperalgesia at a higher does (0.5 nmol).  Both these effects were blocked by desArg9Leu8BK (0.5 nmol).  Administration of des Arg9BK (0.5 nmol i.artic.) to animals 24 h after pre-treatment with IL-2 (1-100 u) or IL-8 (0.1-10 u) had no effect on the load tolerated by the treated joint.  Administration of indomethacin (1 mg kg-1, s.c.) prior to IL-1β (1 u i.artic.) prevented the development of hyperalgesia.  Administration of desArg9BK (5 pmol-0.5 nmol, i.artic.) to animals 24 h after indomethacin and IL-1β pretreatment had no effect on the load tolerated by the treated joint.  These data suggest that both bradykinin B1 and B2 receptors are involved in the induction and maintenance of cytokine-induced hyperalgesia.  They also show that the induction of B1 receptor-mediated hyperalgesia requires both cyclo-oxygenase products and IL-1 in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCJEIbpiGIq7Vg90H21EOLACvtfcHk0lhFac7SIANNAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlslOns7k%253D&md5=88451e9f11c8a3bb4581db2b1739b310</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1994.tb16174.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1994.tb16174.x%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DA.%2BJ.%26aulast%3DPerkins%26aufirst%3DM.%2BN.%26atitle%3DThe%2520involvement%2520of%2520bradykinin%2520B1%2520and%2520B2%2520receptor%2520mechanisms%2520in%2520cytokine-induced%2520mechanical%2520hyperalgesia%2520in%2520the%2520rat%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D113%26spage%3D63%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Bélichard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouthillier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachvarov, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruneau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marceau, F.</span><span> </span><span class="NLM_article-title">Inflammatory hyperalgesia induced by zymosan in the plantar tissue of the rat: effect of kinin receptor antagonists</span> <span class="citation_source-journal">Immunopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9e&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1016%2FS0162-3109%2899%2900165-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9e&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=10647872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9e&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtV2htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2000&pages=139-147&author=P.+B%C3%A9lichardauthor=M.+Landryauthor=J.+Bouthillierauthor=D.+R.+Bachvarovauthor=D.+Pruneauauthor=F.+Marceau&title=Inflammatory+hyperalgesia+induced+by+zymosan+in+the+plantar+tissue+of+the+rat%3A+effect+of+kinin+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9eR"><div class="casContent"><span class="casTitleNuber">9e</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory hyperalgesia induced by zymosan in the plantar tissue of the rat: effect of kinin receptor antagonists</span></div><div class="casAuthors">Belichard, P.; Landry, M.; Faye, P.; Bachvarov, D. R.; Bouthillier, J.; Pruneau, D.; Marceau, F.</div><div class="citationInfo"><span class="NLM_cas:title">Immunopharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-147</span>CODEN:
                <span class="NLM_cas:coden">IMMUDP</span>;
        ISSN:<span class="NLM_cas:issn">0162-3109</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The Randall-Selitto paradigm (maximal tolerated pressure externally applied by a mech. device) was used to develop a rat model of localized inflammatory hyperalgesia in order to compare the analgesic effects of bradykinin (BK) B1 and B2 receptor antagonists and of a non-steroidal anti-inflammatory drug (NSAID).  Intra-plantar injection of zymosan (12.5 mg per paw) induced a considerable inflammation as evidenced from gross and histol. evaluation and a mech. hyperalgesia at 6 h.  The contralateral paw of zymosan-treated animals or saline vehicle-injected paws did not exhibit a decreased pressure tolerance, relative to pre-injection measurements.  Since the B1 receptor may be induced under inflammatory situations, we examd. the amt. of corresponding mRNA using quant. RT-PCR.  We found a significant increase of B1 receptor mRNA in the zymosan - but not the saline-injected paw at 6 h.  Drugs were given s.c. 2 h before the 6 h readings to test their analgesic potential.  The kinin B1 receptor antagonists [Leu8]des-Arg9-BK (3-30 nmol/kg) and R-715 (100 nmol/kg), the B2 receptor antagonists Hoe 140 (15 nmol/kg) and LF 16.0687 (3 and 10 mg/kg), as well as the NSAID diclofenac sodium (1 and 3 mg/kg) significantly reversed zymosan-induced hyperalgesia.  We conclude that zymosan-induced hyperalgesia is a model suitable for the rapid evaluation of analgesic drugs with a peripheral site of action interfering either with kinin receptors or with prostanoid formation.  In this regard, results of the present study confirm that blocking kinin B1 receptors is a novel approach for treatment of inflammatory pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgXxQLrWsIzbVg90H21EOLACvtfcHk0ljIwL99HxM8PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtV2htA%253D%253D&md5=f8be41897facbdf86b4148bb64d8c39a</span></div><a href="/servlet/linkout?suffix=cit9e&amp;dbid=16384&amp;doi=10.1016%2FS0162-3109%2899%2900165-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0162-3109%252899%252900165-4%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A9lichard%26aufirst%3DP.%26aulast%3DLandry%26aufirst%3DM.%26aulast%3DBouthillier%26aufirst%3DJ.%26aulast%3DBachvarov%26aufirst%3DD.%2BR.%26aulast%3DPruneau%26aufirst%3DD.%26aulast%3DMarceau%26aufirst%3DF.%26atitle%3DInflammatory%2520hyperalgesia%2520induced%2520by%2520zymosan%2520in%2520the%2520plantar%2520tissue%2520of%2520the%2520rat%253A%2520effect%2520of%2520kinin%2520receptor%2520antagonists%26jtitle%3DImmunopharmacology%26date%3D2000%26volume%3D46%26spage%3D139%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Bélichard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luccarini, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defrêne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faye, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franck, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duclos, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquet, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruneau, D.</span><span> </span><span class="NLM_article-title">Pharmacological and molecular evidence for kinin B<sub>1</sub> receptor expression in urinary bladder of cyclophosphamide-treated rats</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9f&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1038%2Fsj.bjp.0702769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9f&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=10498854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9f&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADyaK1MXmt1Wjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=1999&pages=213-219&author=P.+B%C3%A9lichardauthor=J.+M.+Luccariniauthor=E.+Defr%C3%AAneauthor=P.+Fayeauthor=R.+M.+Franckauthor=H.+Duclosauthor=J.+L.+Paquetauthor=D.+Pruneau&title=Pharmacological+and+molecular+evidence+for+kinin+B1+receptor+expression+in+urinary+bladder+of+cyclophosphamide-treated+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9fR"><div class="casContent"><span class="casTitleNuber">9f</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological and molecular evidence for kinin B1 receptor expression in urinary bladder of cyclophosphamide-treated rats</span></div><div class="casAuthors">Belichard, P.; Luccarini, J. M.; Defrene, E.; Faye, P.; Franck, R. M.; Duclos, H.; Paquet, J. L.; Pruneau, D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">213-219</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">In the present study, we developed an exptl. model of cystitis induced by cyclophosphamide (CYP).  In order to characterize des-Arg9-BK-induced contraction on the urinary bladder (UB) during the development of inflammation and to quantify kinin B1 receptor gene expression using a quant. RT-PCR technique.  In the presence of peptidase inhibitors captopril (10 μM), DL-thiorphan (1 μM) and DL-2-mercaptomethyl-3-guanidino-ethylthiopropanoic acid (MERGEPTA 5 μM), bradykinin (BK) (0.3-3,000 nM) evoked a concn.-dependent contraction of rat UB which was not different between the CYP- and vehicle-treated groups.  Unlike BK, des-Arg9-BK (0.3-100,000 nM) did not contract UB from vehicle-treated rats but contracted vigorously bladder strips from CYP-treated rats 14, 24 and 168 h after treatment.  In UB of 24 h treated rat, the pD2 value of des-Arg9-BK was 7.3±0.1.  The cyclo-oxygenase inhibitor indomethacin (3 μM) reduced by 30% the maximal response of des-Arg9-BK.  Both the kinin B1 receptor antagonists des-Arg9-[Leu8]BK (10 μM) and des-Arg10-Hoe 140 (10 μM) produced a rightward shift of the concn.-response curve to des-Arg9-BK yielding pKB values of 6.8±0.2 and 7.2±0.1, resp., while the kinin B2 receptor antagonist Hoe 140 (1 μM) had no effect.  After CYP treatment, mRNA coding for the kinin B1 receptor appeared predominantly in UB.  In this organ, the induction was progressive, reaching a max. 48 h after CYP treatment.  In conclusion, the present study provides strong evidence for an induction of kinin B1 receptors in UB of CYP-treated rats.  This was assocd. at a mol. level with an increase in mRNA expression of the gene coding for the kinin B1 receptor.  This kinin receptor displayed the whole features of a classical rat kinin B1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrWPeGEOVi_rVg90H21EOLACvtfcHk0ljIwL99HxM8PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmt1Wjs78%253D&md5=a0c024025dfbe9764f78af84aa1f4f59</span></div><a href="/servlet/linkout?suffix=cit9f&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702769%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A9lichard%26aufirst%3DP.%26aulast%3DLuccarini%26aufirst%3DJ.%2BM.%26aulast%3DDefr%25C3%25AAne%26aufirst%3DE.%26aulast%3DFaye%26aufirst%3DP.%26aulast%3DFranck%26aufirst%3DR.%2BM.%26aulast%3DDuclos%26aufirst%3DH.%26aulast%3DPaquet%26aufirst%3DJ.%2BL.%26aulast%3DPruneau%26aufirst%3DD.%26atitle%3DPharmacological%2520and%2520molecular%2520evidence%2520for%2520kinin%2520B1%2520receptor%2520expression%2520in%2520urinary%2520bladder%2520of%2520cyclophosphamide-treated%2520rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D128%26spage%3D213%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Couture, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrisson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianna, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloutier, F.</span><span> </span><span class="NLM_article-title">Kinins receptors in pain and inflammation</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">429</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9g&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1016%2FS0014-2999%2801%2901318-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9g&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=11698039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9g&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotFWitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=429&publication_year=2001&pages=161-176&author=R.+Coutureauthor=M.+Harrissonauthor=R.+M.+Viannaauthor=F.+Cloutier&title=Kinins+receptors+in+pain+and+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9gR"><div class="casContent"><span class="casTitleNuber">9g</span><div class="casTitle"><span class="NLM_cas:atitle">Kinin receptors in pain and inflammation</span></div><div class="casAuthors">Couture, Rejean; Harrisson, Madelaine; Vianna, Rose Mari; Cloutier, Frank</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">429</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">161-176</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Kinins are among the most potent autacoids involved in inflammatory, vascular and pain processes.  These short-lived peptides, including bradykinin, kallidin and T-kinin, are generated during tissue injury and noxious stimulation.  However, emerging evidence also suggests that kinins are stored in neuronal elements of the central nervous system (CNS) where they are thought to play a role as neuromediators in various cerebral functions, particularly in the control of nociceptive information.  Kinins exert their biol. effects through the activation of two transmembrane G-protein-coupled receptors, denoted bradykinin B1 and B2.  Whereas the B2 receptor is constitutive and activated by the parent mols., the B1 receptor is generally underexpressed in normal tissues and is activated by kinins deprived of the C-terminal Arg (des-Arg9-kinins).  The induction and increased expression of B1 receptor occur following tissue injury or after treatment with bacterial endotoxins or cytokines such as interleukin-1β and tumor necrosis factor-α.  This review summarizes the most recent data from various animal models which convey support for a role of B2 receptors in the acute phase of the inflammatory and pain response, and for a role of B1 receptors in the chronic phase of the response.  The B1 receptor may exert a strategic role in inflammatory diseases with an immune component (diabetes, asthma, rheumatoid arthritis and multiple sclerosis).  New information is provided regarding the role of sensory mechanisms subserving spinal hyperalgesia and intrapleural neutrophil migration that occur upon B1 receptor activation in streptozotocin-treated rats, a model of insulin-dependent diabetes mellitus in which the B1 receptor seems to be rapidly overexpressed.  Although it is widely accepted that the blockade of kinin receptors with specific antagonists could be of benefit in the treatment of somatic and visceral inflammation and pain, recent mol. and functional evidence suggests that the activation of B1 receptors with an agonist may afford a novel therapeutic approach in the CNS inflammatory demyelinating disorder encountered in multiple sclerosis by reducing immune cell infiltration (T-lymphocytes) into the brain.  Hence, the B1 receptor may exert either a protective or detrimental effect depending on the inflammatory disease.  This dual function of the B1 receptor deserves to be investigated further.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxNpkKCSFTi7Vg90H21EOLACvtfcHk0lgunxo8cb8G9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotFWitr0%253D&md5=acc53b3b578815d82a8b424429642173</span></div><a href="/servlet/linkout?suffix=cit9g&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2801%2901318-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252801%252901318-8%26sid%3Dliteratum%253Aachs%26aulast%3DCouture%26aufirst%3DR.%26aulast%3DHarrisson%26aufirst%3DM.%26aulast%3DVianna%26aufirst%3DR.%2BM.%26aulast%3DCloutier%26aufirst%3DF.%26atitle%3DKinins%2520receptors%2520in%2520pain%2520and%2520inflammation%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D429%26spage%3D161%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Eckert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segond von Banchet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, M.</span><span> </span><span class="NLM_article-title">Spatio-temporal pattern of induction of bradykinin receptors and inflammation in rats dorsal root ganglia after unilateral nerve ligation</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">487</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1999&pages=487-497&author=A.+Eckertauthor=G.+Segond+von+Banchetauthor=S.+Sopperauthor=M.+Petersen&title=Spatio-temporal+pattern+of+induction+of+bradykinin+receptors+and+inflammation+in+rats+dorsal+root+ganglia+after+unilateral+nerve+ligation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEckert%26aufirst%3DA.%26aulast%3DSegond%2Bvon%2BBanchet%26aufirst%3DG.%26aulast%3DSopper%26aufirst%3DS.%26aulast%3DPetersen%26aufirst%3DM.%26atitle%3DSpatio-temporal%2520pattern%2520of%2520induction%2520of%2520bradykinin%2520receptors%2520and%2520inflammation%2520in%2520rats%2520dorsal%2520root%2520ganglia%2520after%2520unilateral%2520nerve%2520ligation%26jtitle%3DPain%26date%3D1999%26volume%3D83%26spage%3D487%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Ferreira, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesquero, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araujo, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calixto, J. B.</span><span> </span><span class="NLM_article-title">Evidence for the participation of kinins in Freund’s adjuvant-induced inflammatory and nociceptive responses in kinin B(1) and B(2) receptor knockout mice</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1006</span><span class="NLM_x">–</span> <span class="NLM_lpage">1012</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=1006-1012&author=J.+Ferreiraauthor=M.+M.+Camposauthor=J.+B.+Pesqueroauthor=R.+C.+Araujoauthor=M.+Baderauthor=J.+B.+Calixto&title=Evidence+for+the+participation+of+kinins+in+Freund%E2%80%99s+adjuvant-induced+inflammatory+and+nociceptive+responses+in+kinin+B%281%29+and+B%282%29+receptor+knockout+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerreira%26aufirst%3DJ.%26aulast%3DCampos%26aufirst%3DM.%2BM.%26aulast%3DPesquero%26aufirst%3DJ.%2BB.%26aulast%3DAraujo%26aufirst%3DR.%2BC.%26aulast%3DBader%26aufirst%3DM.%26aulast%3DCalixto%26aufirst%3DJ.%2BB.%26atitle%3DEvidence%2520for%2520the%2520participation%2520of%2520kinins%2520in%2520Freund%25E2%2580%2599s%2520adjuvant-induced%2520inflammatory%2520and%2520nociceptive%2520responses%2520in%2520kinin%2520B%25281%2529%2520and%2520B%25282%2529%2520receptor%2520knockout%2520mice%26jtitle%3DNeuropharmacology%26date%3D2001%26volume%3D41%26spage%3D1006%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Fox, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wotherson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNair, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, J.</span><span> </span><span class="NLM_article-title">Regulation and function of spinal and peripheral neuronal B1 bradykinin receptors in inflammatory mechanical hyperalgesia</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2003&pages=683-691&author=A.+Foxauthor=G.+Wothersonauthor=K.+McNairauthor=L.+Hudsonauthor=S.+Patelauthor=C.+Gentryauthor=J.+Winter&title=Regulation+and+function+of+spinal+and+peripheral+neuronal+B1+bradykinin+receptors+in+inflammatory+mechanical+hyperalgesia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DA.%26aulast%3DWotherson%26aufirst%3DG.%26aulast%3DMcNair%26aufirst%3DK.%26aulast%3DHudson%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DGentry%26aufirst%3DC.%26aulast%3DWinter%26aufirst%3DJ.%26atitle%3DRegulation%2520and%2520function%2520of%2520spinal%2520and%2520peripheral%2520neuronal%2520B1%2520bradykinin%2520receptors%2520in%2520inflammatory%2520mechanical%2520hyperalgesia%26jtitle%3DPain%26date%3D2003%26volume%3D104%26spage%3D683%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Gabra, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirois, P.</span><span> </span><span class="NLM_article-title">Role of bradykinin B1 receptors in diabetes-induced hyperalgesia in streptozotocin-treated mice</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">457</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9k&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1016%2FS0014-2999%2802%2902658-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9k&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=12464357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9k&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADC%252BD38XptFerur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=457&publication_year=2002&pages=115-124&author=B.+H.+Gabraauthor=P.+Sirois&title=Role+of+bradykinin+B1+receptors+in+diabetes-induced+hyperalgesia+in+streptozotocin-treated+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9kR"><div class="casContent"><span class="casTitleNuber">9k</span><div class="casTitle"><span class="NLM_cas:atitle">Role of bradykinin B1 receptors in diabetes-induced hyperalgesia in streptozotocin-treated mice</span></div><div class="casAuthors">Gabra, Bichoy H.; Sirois, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">457</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">115-124</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Insulin-dependent diabetes mellitus (type-1 diabetes) is an inflammatory autoimmune disease assocd. with vascular permeability changes leading to many complications including nephropathy, retinopathy, hypertension, hyperalgesia and neuropathy.  The bradykinin B1 receptor was recently found to be upregulated during the development of the diabetes and to be involved in its complications.  Kinins are known to be important mediators of a variety of biol. effects including cardiovascular homeostasis, inflammation and nociception.  In the present study, we studied the effect of the selective B1 receptor agonist, des-Arg9-bradykinin, and its specific antagonists, Ac-Lys-[d-β Nal7, Ile8]des-Arg9-bradykinin (R-715) and Ac-Orn-[Oic2, αMe Phe5, d-β Nal7, Ile8]des-Arg9-bradykinin (R-954), on diabetic hyperalgesia.  Diabetes was induced in male CD-1 mice by injecting a single high dose of streptozotocin (200 mg kg-1, i.p.) and the nociception was assessed using the hot plate and the tail flick tests, 1 wk following the injection of streptozotocin.  Our results showed that induction of diabetes by streptozotocin provoked a marked hyperalgesia in diabetic mice expressed as about 11% decrease in hot plate reaction time and 26% decrease in tail flick reaction time.  Following acute administration of R-715 (200-800 μg kg-1, i.p.) and R-954 (50-600 μg kg-1, i.p.), this hyperalgesic activity was blocked and the hot plate and tail flick latencies of diabetic mice returned to normal values obsd. in control healthy mice.  In addn., the acute administration of des-Arg9-bradykinin (200-600 μg kg-1, i.p.) significantly potentiated diabetes-induced hyperalgesia, an effect that was totally reversed by R-715 (1.6-2.4 mg kg-1, i.p.) and R-954 (0.8-1.6 mg kg-1, i.p.).  These results provide a major evidence for the implication of the bradykinin B1 receptors in the development of hyperalgesia assocd. with diabetes and suggest a novel approach to the treatment of this diabetic complication using the bradykinin B1 receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqth8OkNO_PibVg90H21EOLACvtfcHk0lgunxo8cb8G9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptFerur0%253D&md5=16c5089423a1483cd77b566d89dcd3db</span></div><a href="/servlet/linkout?suffix=cit9k&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2902658-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252902658-4%26sid%3Dliteratum%253Aachs%26aulast%3DGabra%26aufirst%3DB.%2BH.%26aulast%3DSirois%26aufirst%3DP.%26atitle%3DRole%2520of%2520bradykinin%2520B1%2520receptors%2520in%2520diabetes-induced%2520hyperalgesia%2520in%2520streptozotocin-treated%2520mice%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D457%26spage%3D115%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">McNair, K.; Kesingland, A.; Urban, L.; Fox, A.</span><span> </span><span class="NLM_article-title">The Role of Central and Pheripheral Bradykinin B1 Receptors in Model of Neuropathic and Inflammatory Pain in the Rat</span> <span class="citation_source-book">British Journal of Pharmacology. Proceedings Supplement</span>; British Pharmacological Society: London,<span class="NLM_x"> </span><span class="NLM_year">2001</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">134</span>, p  <span class="NLM_fpage">158P</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=158P&author=K.+McNair&author=A.+Kesingland&author=L.+Urban&author=A.+Fox&title=British+Journal+of+Pharmacology.+Proceedings+Supplement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMcNair%26aufirst%3DK.%26atitle%3DThe%2520Role%2520of%2520Central%2520and%2520Pheripheral%2520Bradykinin%2520B1%2520Receptors%2520in%2520Model%2520of%2520Neuropathic%2520and%2520Inflammatory%2520Pain%2520in%2520the%2520Rat%26btitle%3DBritish%2520Journal%2520of%2520Pharmacology.%2520Proceedings%2520Supplement%26date%3D2001%26volume%3D134%26spage%3D158P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Levy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zochodne, D. W.</span><span> </span><span class="NLM_article-title">Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2000&pages=265-271&author=D.+Levyauthor=D.+W.+Zochodne&title=Increased+mRNA+expression+of+the+B1+and+B2+bradykinin+receptors+and+antinociceptive+effects+of+their+antagonists+in+an+animal+model+of+neuropathic+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevy%26aufirst%3DD.%26aulast%3DZochodne%26aufirst%3DD.%2BW.%26atitle%3DIncreased%2520mRNA%2520expression%2520of%2520the%2520B1%2520and%2520B2%2520bradykinin%2520receptors%2520and%2520antinociceptive%2520effects%2520of%2520their%2520antagonists%2520in%2520an%2520animal%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DPain%26date%3D2000%26volume%3D86%26spage%3D265%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Ossipov, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malan, T. P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span> </span><span class="NLM_article-title">Spinal and supraspinal mechanisms of neuropathic pain</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">909</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=909&publication_year=2000&pages=12-24&author=M.+H.+Ossipovauthor=J.+Laiauthor=T.+P.+Malanauthor=F.+Porreca&title=Spinal+and+supraspinal+mechanisms+of+neuropathic+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9n&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOssipov%26aufirst%3DM.%2BH.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DMalan%26aufirst%3DT.%2BP.%26aulast%3DPorreca%26aufirst%3DF.%26atitle%3DSpinal%2520and%2520supraspinal%2520mechanisms%2520of%2520neuropathic%2520pain%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2000%26volume%3D909%26spage%3D12%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Dressen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garofalo, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hom, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagodzinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marugg, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neintzel, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiss, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szoke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wone, D. W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span> </span><span class="NLM_article-title">Preparation and optimization of a series of 3-carboxamido-5-phenylacylaminopyrazole bradykinin B1 receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5161</span><span class="NLM_x">–</span> <span class="NLM_lpage">5167</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051292n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5161-5167&author=D.+Dressenauthor=A.+W.+Garofaloauthor=J.+Hawkinsonauthor=D.+Homauthor=J.+Jagodzinskiauthor=J.+L.+Maruggauthor=M.+L.+Neintzelauthor=M.+A.+Pleissauthor=B.+Szokeauthor=J.+S.+Tungauthor=D.+W.+G.+Woneauthor=J.+Wuauthor=H.+Zhang&title=Preparation+and+optimization+of+a+series+of+3-carboxamido-5-phenylacylaminopyrazole+bradykinin+B1+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9o&amp;dbid=16384&amp;doi=10.1021%2Fjm051292n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051292n%26sid%3Dliteratum%253Aachs%26aulast%3DDressen%26aufirst%3DD.%26aulast%3DGarofalo%26aufirst%3DA.%2BW.%26aulast%3DHawkinson%26aufirst%3DJ.%26aulast%3DHom%26aufirst%3DD.%26aulast%3DJagodzinski%26aufirst%3DJ.%26aulast%3DMarugg%26aufirst%3DJ.%2BL.%26aulast%3DNeintzel%26aufirst%3DM.%2BL.%26aulast%3DPleiss%26aufirst%3DM.%2BA.%26aulast%3DSzoke%26aufirst%3DB.%26aulast%3DTung%26aufirst%3DJ.%2BS.%26aulast%3DWone%26aufirst%3DD.%2BW.%2BG.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DPreparation%2520and%2520optimization%2520of%2520a%2520series%2520of%25203-carboxamido-5-phenylacylaminopyrazole%2520bradykinin%2520B1%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5161%26epage%3D5167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Su, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinney, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramson, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, N. J.</span><span> </span><span class="NLM_article-title">2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3946</span><span class="NLM_x">–</span> <span class="NLM_lpage">3952</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800199h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3946-3952&author=D.+S.+Suauthor=J.+L.+Limauthor=E.+Tinneyauthor=B.+L.+Wanauthor=K.+L.+Murphyauthor=D.+R.+Reissauthor=M.+Harrellauthor=S.+S.+O%E2%80%99Malleyauthor=R.+W.+Ramsonauthor=R.+S.+L.+Changauthor=D.+J.+Pettiboneauthor=J.+Yuauthor=C.+Tangauthor=T.+Prueksaritanontauthor=R.+M.+Freidingerauthor=M.+G.+Bockauthor=N.+J.+Anthony&title=2-Aminobenzophenones+as+a+novel+class+of+bradykinin+B1+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9p&amp;dbid=16384&amp;doi=10.1021%2Fjm800199h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800199h%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DD.%2BS.%26aulast%3DLim%26aufirst%3DJ.%2BL.%26aulast%3DTinney%26aufirst%3DE.%26aulast%3DWan%26aufirst%3DB.%2BL.%26aulast%3DMurphy%26aufirst%3DK.%2BL.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DHarrell%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DS.%2BS.%26aulast%3DRamson%26aufirst%3DR.%2BW.%26aulast%3DChang%26aufirst%3DR.%2BS.%2BL.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DBock%26aufirst%3DM.%2BG.%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26atitle%3D2-Aminobenzophenones%2520as%2520a%2520novel%2520class%2520of%2520bradykinin%2520B1%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3946%26epage%3D3952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Player, M. R.</span><span> </span><span class="NLM_article-title">Bradykinin B1 receptors antagonists as potential therapeutic agent for pain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5383</span><span class="NLM_x">–</span> <span class="NLM_lpage">5399</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1000776" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5383-5399&author=H.+Huangauthor=M.+R.+Player&title=Bradykinin+B1+receptors+antagonists+as+potential+therapeutic+agent+for+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9q&amp;dbid=16384&amp;doi=10.1021%2Fjm1000776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1000776%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DPlayer%26aufirst%3DM.%2BR.%26atitle%3DBradykinin%2520B1%2520receptors%2520antagonists%2520as%2520potential%2520therapeutic%2520agent%2520for%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5383%26epage%3D5399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9r"><span><span class="NLM_label">(r) </span><span class="NLM_contrib-group">Fincham, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bressan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fattori, D.</span><span> </span><span class="NLM_article-title">Bradykinin receptor antagonists: a review of the patent literature 2005–2008</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">919</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9r&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1517%2F13543770902994389" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9r&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=19552510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9r&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1eqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=919-941&author=C.+I.+Finchamauthor=A.+Bressanauthor=M.+Parisauthor=C.+Rossiauthor=D.+Fattori&title=Bradykinin+receptor+antagonists%3A+a+review+of+the+patent+literature+2005%E2%80%932008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9rR"><div class="casContent"><span class="casTitleNuber">9r</span><div class="casTitle"><span class="NLM_cas:atitle">Bradykinin receptor antagonists - a review of the patent literature 2005 - 2008</span></div><div class="casAuthors">Fincham, Christopher I.; Bressan, Alessandro; Paris, Marielle; Rossi, Cristina; Fattori, Daniela</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">919-941</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  For >20 years, pharmaceutical companies and academic centers have been developing bradykinin antagonists.  The patent literature on these mols. (up to and including 2004) has been analyzed previously in this journal in two review articles.  The aim of this review is to provide an update (from 2005 to early 2009) on the patenting activity in the field of bradykinin antagonists (including patents on their formulation).  Where possible, the information from the patents has been supplemented with that from the primary literature, clin. trial databases and company websites in an attempt to give a more complete picture.  In the past 4 years, nearly 50 new patents have been filed on bradykinin antagonists, in the case of several filings, only the original source has been considered in this anal., the vast majority of these (>93%) on B1 antagonists.  However, despite this large amt. of work, only one compd., icatibant, a hydrophilic decapeptide selective for the B2 receptor, has reached the market, although it needs to be administered parenterally.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro7cnYKi778bVg90H21EOLACvtfcHk0liVhD6mi2n8ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1eqtLk%253D&md5=acc208bc3d2d7265c8c4d037f8a719e8</span></div><a href="/servlet/linkout?suffix=cit9r&amp;dbid=16384&amp;doi=10.1517%2F13543770902994389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770902994389%26sid%3Dliteratum%253Aachs%26aulast%3DFincham%26aufirst%3DC.%2BI.%26aulast%3DBressan%26aufirst%3DA.%26aulast%3DParis%26aufirst%3DM.%26aulast%3DRossi%26aufirst%3DC.%26aulast%3DFattori%26aufirst%3DD.%26atitle%3DBradykinin%2520receptor%2520antagonists%253A%2520a%2520review%2520of%2520the%2520patent%2520literature%25202005%25E2%2580%25932008%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D919%26epage%3D941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Marie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruneau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquet, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siatka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larguier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponce, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassault, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groblewski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maigret, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnafous, J. C.</span><span> </span><span class="NLM_article-title">Control of conformational equilibria in the human B2 bradykinin receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">41100</span><span class="NLM_x">–</span> <span class="NLM_lpage">41111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=41100-41111&author=J.+Marieauthor=E.+Richardauthor=D.+Pruneauauthor=J.+L.+Paquetauthor=C.+Siatkaauthor=R.+Larguierauthor=C.+Ponceauthor=P.+Vassaultauthor=T.+Groblewskiauthor=B.+Maigretauthor=J.+C.+Bonnafous&title=Control+of+conformational+equilibria+in+the+human+B2+bradykinin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarie%26aufirst%3DJ.%26aulast%3DRichard%26aufirst%3DE.%26aulast%3DPruneau%26aufirst%3DD.%26aulast%3DPaquet%26aufirst%3DJ.%2BL.%26aulast%3DSiatka%26aufirst%3DC.%26aulast%3DLarguier%26aufirst%3DR.%26aulast%3DPonce%26aufirst%3DC.%26aulast%3DVassault%26aufirst%3DP.%26aulast%3DGroblewski%26aufirst%3DT.%26aulast%3DMaigret%26aufirst%3DB.%26aulast%3DBonnafous%26aufirst%3DJ.%2BC.%26atitle%3DControl%2520of%2520conformational%2520equilibria%2520in%2520the%2520human%2520B2%2520bradykinin%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D41100%26epage%3D41111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Barth, M.; Bondoux, M.; Dodey, P.; Massardier, C.; Thomas, D.; Luccarini, J. M.</span><span> </span><span class="NLM_article-title">Benzenesulphonamide Derivatives, Method for Production and Use Thereof for Treatment of Pain</span>. WO 2004087700,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Barth&author=M.+Bondoux&author=P.+Dodey&author=C.+Massardier&author=D.+Thomas&author=J.+M.+Luccarini&title=Benzenesulphonamide+Derivatives%2C+Method+for+Production+and+Use+Thereof+for+Treatment+of+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarth%26aufirst%3DM.%26atitle%3DBenzenesulphonamide%2520Derivatives%252C%2520Method%2520for%2520Production%2520and%2520Use%2520Thereof%2520for%2520Treatment%2520of%2520Pain%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyrou, V</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luccarini, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junien, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruneau, D.</span><span> </span><span class="NLM_article-title">Antinociceptive pharmacology of <i>N</i>-[[4-(4,5-dihyro-1<i>H</i>-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl)sulfonyl]methylamino]ethoxy]-<i>N</i>-methylacetamide, fumarate, a novel nonpeptidic bradykinin B1 receptor antagonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1124%2Fjpet.105.098368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=16565167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFymtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2006&pages=195-205&author=F.+Porrecaauthor=T.+W.+Vanderahauthor=W.+Guoauthor=M.+Barthauthor=P.+Dodeyauthor=V+Peyrouauthor=J.+M.+Luccariniauthor=J.+L.+Junienauthor=D.+Pruneau&title=Antinociceptive+pharmacology+of+N-%5B%5B4-%284%2C5-dihyro-1H-imidazol-2-yl%29phenyl%5Dmethyl%5D-2-%5B2-%5B%5B%284-methoxy-2%2C6-dimethylphenyl%29sulfonyl%5Dmethylamino%5Dethoxy%5D-N-methylacetamide%2C+fumarate%2C+a+novel+nonpeptidic+bradykinin+B1+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive pharmacology of N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl)sulfonyl]methylamino]ethoxy]-N-methylacetamide, fumarate (LF22-0542), a novel nonpeptidic bradykinin B1 receptor antagonist</span></div><div class="casAuthors">Porreca, F.; Vanderah, T. W.; Guo, W.; Barth, M.; Dodey, P.; Peyrou, V.; Luccarini, J. M.; Junien, J.-L.; Pruneau, D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">195-205</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The antinociceptive pharmacol. of N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl) sulfonyl]methylamino]ethoxy]-N-methylacetamide fumarate (LF22-0542), a novel nonpeptidic B1 antagonist, was characterized.  LF22-0542 showed high affinity for human and mouse B1 receptors with virtually no affinity for the human B2 receptor; a selectivity index of at least 4000 times was obtained when LF22-0542 was profiled throughout binding or cell biol. assays on 64 other G-protein-coupled receptor, 10 ion channels, and seven enzymes.  LF22-0542 was a competitive B1 receptor antagonist and elicited significant antinociceptive actions in the mouse acetic acid-induced writhing assay, as well as in the second phases of formalin-induced nociception in mice and in both the first and second phases of the formalin response in rats.  LF22-0542 was active after s.c. but not p.o. administration.  In B1 receptor knockout (KO) mice, acetic acid and formalin responses were significantly reduced and LF22-0542 had no addnl. effects in these animals.  LF22-0542 alleviated thermal hypersensitivity in both acute (carrageenan) and persistent inflammatory (complete Freund's adjuvant) pain models in rats.  LF22-0542 produced a full reversal of exptl. neuropathic thermal hypersensitivity but was inactive in reversing nerve injury-induced tactile hypersensitivity in rats.  In agreement with this observation, B1 KO mice subjected to peripheral nerve injury did not show thermal hypersensitivity but developed nerve injury-induced tactile hypersensitivity normally.  The data demonstrate the antihyperalgesic actions of a selective systemically administered B1 receptor antagonist and suggest the utility of this class of agents for the treatment of inflammatory pain states and for some aspects of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ_8GEvRI5obVg90H21EOLACvtfcHk0liN_DKw5wcpMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFymtr8%253D&md5=71a4842dba19157f23fdea8e1a5b4c7d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.098368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.098368%26sid%3Dliteratum%253Aachs%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DBarth%26aufirst%3DM.%26aulast%3DDodey%26aufirst%3DP.%26aulast%3DPeyrou%26aufirst%3DV%26aulast%3DLuccarini%26aufirst%3DJ.%2BM.%26aulast%3DJunien%26aufirst%3DJ.%2BL.%26aulast%3DPruneau%26aufirst%3DD.%26atitle%3DAntinociceptive%2520pharmacology%2520of%2520N-%255B%255B4-%25284%252C5-dihyro-1H-imidazol-2-yl%2529phenyl%255Dmethyl%255D-2-%255B2-%255B%255B%25284-methoxy-2%252C6-dimethylphenyl%2529sulfonyl%255Dmethylamino%255Dethoxy%255D-N-methylacetamide%252C%2520fumarate%252C%2520a%2520novel%2520nonpeptidic%2520bradykinin%2520B1%2520receptor%2520antagonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D318%26spage%3D195%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Sevcik, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halvorson, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsay, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantyh, P. W.</span><span> </span><span class="NLM_article-title">Analgesic efficacy of bradykinin B1 antagonists in a murine bone cancer pain model</span> <span class="citation_source-journal">J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">775</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1016%2Fj.jpain.2005.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=16275602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SrurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=771-775&author=M.+A.+Sevcikauthor=J.+R.+Ghilardiauthor=K.+G.+Halvorsonauthor=T.+H.+Lindsayauthor=K.+Kubotaauthor=P.+W.+Mantyh&title=Analgesic+efficacy+of+bradykinin+B1+antagonists+in+a+murine+bone+cancer+pain+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Analgesic Efficacy of Bradykinin B1 Antagonists in a Murine Bone Cancer Pain Model</span></div><div class="casAuthors">Sevcik, Molly A.; Ghilardi, Joseph R.; Halvorson, Kyle G.; Lindsay, Theodore H.; Kubota, Kazufumi; Mantyh, Patrick W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">771-775</span>CODEN:
                <span class="NLM_cas:coden">JPOAB5</span>;
        ISSN:<span class="NLM_cas:issn">1526-5900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Cancer pain is a significant clin. problem because it is the first symptom of disease in 20% to 50% of all cancer patients, and 75% to 90% of patients with advanced or terminal cancer must cope with chronic pain syndromes related to failed treatment and/or tumor progression.  One of the most difficult to treat cancer pains is metastatic invasion of the skeleton that can generate ongoing and bone breakthrough pain, which represents one of the most debilitating cancer-related events.  Because bradykinin has been shown to be released in response to tissue injury and plays a significant role in driving acute and chronic inflammatory pain, we focused on bradykinin antagonists in a model of bone cancer pain.  In our model of bone cancer, which involves the injection and confinement of 2472 sarcoma cells to the mouse femur, pharmacol. blockade of the bradykinin B1 receptor is effective in reducing pain-related behaviors at both early and advanced stages of bone cancer.  Perspective: Bone cancer pain can be severe and difficult to control fully.  With a mouse model of bone cancer pain we demonstrate that pharmacol. blockade of the bradykinin B1 receptor is effective in reducing bone cancer pain-related behaviors, suggesting that B1 antagonists might be useful in attenuating bone cancer pain in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx4QHDiQL8RLVg90H21EOLACvtfcHk0liN_DKw5wcpMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SrurrO&md5=6bb3c755a07447ba3397d928419e0107</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2005.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2005.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DSevcik%26aufirst%3DM.%2BA.%26aulast%3DGhilardi%26aufirst%3DJ.%2BR.%26aulast%3DHalvorson%26aufirst%3DK.%2BG.%26aulast%3DLindsay%26aufirst%3DT.%2BH.%26aulast%3DKubota%26aufirst%3DK.%26aulast%3DMantyh%26aufirst%3DP.%2BW.%26atitle%3DAnalgesic%2520efficacy%2520of%2520bradykinin%2520B1%2520antagonists%2520in%2520a%2520murine%2520bone%2520cancer%2520pain%2520model%26jtitle%3DJ.%2520Pain%26date%3D2005%26volume%3D6%26spage%3D771%26epage%3D775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Su, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPardo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ransom, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, M. G.</span><span> </span><span class="NLM_article-title">Discovery of a potent, non-peptide bradykinin B1 receptor antagonist</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">7516</span><span class="NLM_x">–</span> <span class="NLM_lpage">7517</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0353457" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=7516-7517&author=D.+S.+Suauthor=M.+K.+Markowitzauthor=R.+M.+DiPardoauthor=K.+L.+Murphyauthor=C.+M.+Harrellauthor=S.+S.+O%E2%80%99Malleyauthor=R.+W.+Ransomauthor=R.+S.+L.+Changauthor=S.+Haauthor=F.+J.+Hessauthor=D.+J.+Pettiboneauthor=G.+S.+Masonauthor=S.+Boyceauthor=R.+M.+Freidingerauthor=M.+G.+Bock&title=Discovery+of+a+potent%2C+non-peptide+bradykinin+B1+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja0353457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0353457%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DD.%2BS.%26aulast%3DMarkowitz%26aufirst%3DM.%2BK.%26aulast%3DDiPardo%26aufirst%3DR.%2BM.%26aulast%3DMurphy%26aufirst%3DK.%2BL.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DS.%2BS.%26aulast%3DRansom%26aufirst%3DR.%2BW.%26aulast%3DChang%26aufirst%3DR.%2BS.%2BL.%26aulast%3DHa%26aufirst%3DS.%26aulast%3DHess%26aufirst%3DF.%2BJ.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DMason%26aufirst%3DG.%2BS.%26aulast%3DBoyce%26aufirst%3DS.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DBock%26aufirst%3DM.%2BG.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520non-peptide%2520bradykinin%2520B1%2520receptor%2520antagonist%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D7516%26epage%3D7517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Bastian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loillier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquet, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruneau, D.</span><span> </span><span class="NLM_article-title">Stable expression of human kinin B<sub>1</sub> receptor in 293 cells: pharmacological and functional characterization</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1038%2Fsj.bjp.0701380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=9313952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADyaK2sXmtlyqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=1997&pages=393-399&author=S.+Bastianauthor=B.+Loillierauthor=J.+L.+Paquetauthor=D.+Pruneau&title=Stable+expression+of+human+kinin+B1+receptor+in+293+cells%3A+pharmacological+and+functional+characterization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Stable expression of human kinin B1 receptor in 293 cells: pharmacological and functional characterization</span></div><div class="casAuthors">Bastian, S.; Loillier, B.; Paquet, J. L.; Pruneau, D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">393-399</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">The authors compared the binding properties of [3H]-desArg10-[Leu9]-kallidin, a radiolabeled kinin B1 receptor antagonist, to membranes from IMR-90 human embryonic fibroblasts and from 293 cells transiently or stably transfected with the human B1 receptor.  The dissocn. const. (KD) of [3H]-desArg10-[Leu9]-kallidin and the affinity of several kinin receptor agonists and antagonists were similar between the native and cloned receptor, either transiently or stably expressed in 293 cells.  In IMR-90 cells, the rank order to potency was that expected for a kinin B1 receptor.  The receptors transiently or stably expressed in 293 cells were fully functional with respect to their signaling properties.  Phosphoinositide hydrolysis was increased in a concn.-dependent manner by the B1 receptor agonist, desArg10-kallidin.  Functional coupling to the calcium pathway was also demonstrated for the native and stably expressed human B1 receptor.  In conclusion, the established stable and functional 293 cell clone may provide an important tool for further anal. of the mol. mechanisms involved in binding activation, and coupling of the kinin B1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr494AwChIKN7Vg90H21EOLACvtfcHk0lhByZQvJtR7Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtlyqsb0%253D&md5=6936385b715a97010559bddd5f2b9103</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0701380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0701380%26sid%3Dliteratum%253Aachs%26aulast%3DBastian%26aufirst%3DS.%26aulast%3DLoillier%26aufirst%3DB.%26aulast%3DPaquet%26aufirst%3DJ.%2BL.%26aulast%3DPruneau%26aufirst%3DD.%26atitle%3DStable%2520expression%2520of%2520human%2520kinin%2520B1%2520receptor%2520in%2520293%2520cells%253A%2520pharmacological%2520and%2520functional%2520characterization%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D122%26spage%3D393%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Bradford, M. M.</span><span> </span><span class="NLM_article-title">A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein–dye binding</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1976&pages=248-254&author=M.+M.+Bradford&title=A+rapid+and+sensitive+method+for+quantification+of+microgram+quantities+of+protein+utilizing+the+principle+of+protein%E2%80%93dye+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBradford%26aufirst%3DM.%2BM.%26atitle%3DA%2520rapid%2520and%2520sensitive%2520method%2520for%2520quantification%2520of%2520microgram%2520quantities%2520of%2520protein%2520utilizing%2520the%2520principle%2520of%2520protein%25E2%2580%2593dye%2520binding%26jtitle%3DAnal.%2520Biochem.%26date%3D1976%26volume%3D72%26spage%3D248%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9a','cit9b','cit9c','cit9d','cit9e','cit9f','cit9g','cit9h','cit9i','cit9j','cit9k','cit9l','cit9m','cit9n','cit9o','cit9p','cit9q','cit9r'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yiou  Wang</span>, <span class="hlFld-ContribAuthor ">Bingxue  Zhang</span>, <span class="hlFld-ContribAuthor ">Yibing  Huang</span>, <span class="hlFld-ContribAuthor ">Wenjun  Yao</span>, <span class="hlFld-ContribAuthor ">Fei  Tao</span>, <span class="hlFld-ContribAuthor ">Yuxin  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Bradykinin Receptor Inhibitors Inhibit Proliferation and Promote the Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the ERK Pathway. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (13)
                                     , 3915. <a href="https://doi.org/10.3390/molecules26133915" title="DOI URL">https://doi.org/10.3390/molecules26133915</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26133915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26133915%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNovel%252BBradykinin%252BReceptor%252BInhibitors%252BInhibit%252BProliferation%252Band%252BPromote%252Bthe%252BApoptosis%252Bof%252BHepatocellular%252BCarcinoma%252BCells%252Bby%252BInhibiting%252Bthe%252BERK%252BPathway%26aulast%3DWang%26aufirst%3DYiou%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D13%26spage%3D3915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mehdi  Mahmudpour</span>, <span class="hlFld-ContribAuthor ">Jamshid  Roozbeh</span>, <span class="hlFld-ContribAuthor ">Mohsen  Keshavarz</span>, <span class="hlFld-ContribAuthor ">Shokrollah  Farrokhi</span>, <span class="hlFld-ContribAuthor ">Iraj  Nabipour</span>. </span><span class="cited-content_cbyCitation_article-title">COVID-19 cytokine storm: The anger of inflammation. </span><span class="cited-content_cbyCitation_journal-name">Cytokine</span><span> <strong>2020,</strong> <em>133 </em>, 155151. <a href="https://doi.org/10.1016/j.cyto.2020.155151" title="DOI URL">https://doi.org/10.1016/j.cyto.2020.155151</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cyto.2020.155151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cyto.2020.155151%26sid%3Dliteratum%253Aachs%26jtitle%3DCytokine%26atitle%3DCOVID-19%252Bcytokine%252Bstorm%25253A%252BThe%252Banger%252Bof%252Binflammation%26aulast%3DMahmudpour%26aufirst%3DMehdi%26date%3D2020%26volume%3D133%26spage%3D155151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph  Lau</span>, <span class="hlFld-ContribAuthor ">Julie  Rousseau</span>, <span class="hlFld-ContribAuthor ">Daniel  Kwon</span>, <span class="hlFld-ContribAuthor ">François  Bénard</span>, <span class="hlFld-ContribAuthor ">Kuo-Shyan  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">A Systematic Review of Molecular Imaging Agents Targeting Bradykinin B1 and B2 Receptors. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2020,</strong> <em>13 </em>
                                    (8)
                                     , 199. <a href="https://doi.org/10.3390/ph13080199" title="DOI URL">https://doi.org/10.3390/ph13080199</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph13080199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph13080199%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DA%252BSystematic%252BReview%252Bof%252BMolecular%252BImaging%252BAgents%252BTargeting%252BBradykinin%252BB1%252Band%252BB2%252BReceptors%26aulast%3DLau%26aufirst%3DJoseph%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D8%26spage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fatimunnisa  Qadri</span>, <span class="hlFld-ContribAuthor ">Michael  Bader</span>. </span><span class="cited-content_cbyCitation_article-title">Kinin B1 receptors as a therapeutic target for inflammation. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2018,</strong> <em>22 </em>
                                    (1)
                                     , 31-44. <a href="https://doi.org/10.1080/14728222.2018.1409724" title="DOI URL">https://doi.org/10.1080/14728222.2018.1409724</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2018.1409724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2018.1409724%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DKinin%252BB1%252Breceptors%252Bas%252Ba%252Btherapeutic%252Btarget%252Bfor%252Binflammation%26aulast%3DQadri%26aufirst%3DFatimunnisa%26date%3D2018%26date%3D2017%26volume%3D22%26issue%3D1%26spage%3D31%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Humberto M.  Spindola</span>, <span class="hlFld-ContribAuthor ">Rogério  Grando</span>, <span class="hlFld-ContribAuthor ">Mariana C.  Figueiredo</span>, <span class="hlFld-ContribAuthor ">Rosana  Basting</span>, <span class="hlFld-ContribAuthor ">N.C.A.  Queiroz</span>, <span class="hlFld-ContribAuthor ">Ângelo  de Fátima</span>, <span class="hlFld-ContribAuthor ">João E.  de Carvalho</span>, <span class="hlFld-ContribAuthor ">Zaijie J.  Wang</span>, <span class="hlFld-ContribAuthor ">M.A.  Foglio</span>. </span><span class="cited-content_cbyCitation_article-title">Derivatives of furanditerpenes from Pterodon genus: Pharmacological studies disclose their potential as chronic pain relief in mice. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2017,</strong> <em>804 </em>, 68-77. <a href="https://doi.org/10.1016/j.ejphar.2017.03.030" title="DOI URL">https://doi.org/10.1016/j.ejphar.2017.03.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2017.03.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2017.03.030%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DDerivatives%252Bof%252Bfuranditerpenes%252Bfrom%252BPterodon%252Bgenus%25253A%252BPharmacological%252Bstudies%252Bdisclose%252Btheir%252Bpotential%252Bas%252Bchronic%252Bpain%252Brelief%252Bin%252Bmice%26aulast%3DSpindola%26aufirst%3DHumberto%2BM.%26date%3D2017%26volume%3D804%26spage%3D68%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rafael Cypriano  Dutra</span>. </span><span class="cited-content_cbyCitation_article-title">Kinin receptors: Key regulators of autoimmunity. </span><span class="cited-content_cbyCitation_journal-name">Autoimmunity Reviews</span><span> <strong>2017,</strong> <em>16 </em>
                                    (2)
                                     , 192-207. <a href="https://doi.org/10.1016/j.autrev.2016.12.011" title="DOI URL">https://doi.org/10.1016/j.autrev.2016.12.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.autrev.2016.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.autrev.2016.12.011%26sid%3Dliteratum%253Aachs%26jtitle%3DAutoimmunity%2520Reviews%26atitle%3DKinin%252Breceptors%25253A%252BKey%252Bregulators%252Bof%252Bautoimmunity%26aulast%3DDutra%26aufirst%3DRafael%2BCypriano%26date%3D2017%26volume%3D16%26issue%3D2%26spage%3D192%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Megan L.  Falsetta</span>, <span class="hlFld-ContribAuthor ">David C.  Foster</span>, <span class="hlFld-ContribAuthor ">Collynn F.  Woeller</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Pollock</span>, <span class="hlFld-ContribAuthor ">Adrienne D.  Bonham</span>, <span class="hlFld-ContribAuthor ">Constantine G.  Haidaris</span>, <span class="hlFld-ContribAuthor ">Richard P.  Phipps</span>. </span><span class="cited-content_cbyCitation_article-title">A Role for Bradykinin Signaling in Chronic Vulvar Pain. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Pain</span><span> <strong>2016,</strong> <em>17 </em>
                                    (11)
                                     , 1183-1197. <a href="https://doi.org/10.1016/j.jpain.2016.07.007" title="DOI URL">https://doi.org/10.1016/j.jpain.2016.07.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpain.2016.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpain.2016.07.007%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Pain%26atitle%3DA%252BRole%252Bfor%252BBradykinin%252BSignaling%252Bin%252BChronic%252BVulvar%252BPain%26aulast%3DFalsetta%26aufirst%3DMegan%2BL.%26date%3D2016%26volume%3D17%26issue%3D11%26spage%3D1183%26epage%3D1197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhengxing  Zhang</span>, <span class="hlFld-ContribAuthor ">Hsiou-Ting  Kuo</span>, <span class="hlFld-ContribAuthor ">Joseph  Lau</span>, <span class="hlFld-ContribAuthor ">Silvia  Jenni</span>, <span class="hlFld-ContribAuthor ">Chengcheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Jutta  Zeisler</span>, <span class="hlFld-ContribAuthor ">François  Bénard</span>, <span class="hlFld-ContribAuthor ">Kuo-Shyan  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of 18F-labeled bradykinin B1 receptor-targeting small molecules for PET imaging. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (16)
                                     , 4095-4100. <a href="https://doi.org/10.1016/j.bmcl.2016.06.066" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.06.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.06.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.06.066%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252B18F-labeled%252Bbradykinin%252BB1%252Breceptor-targeting%252Bsmall%252Bmolecules%252Bfor%252BPET%252Bimaging%26aulast%3DZhang%26aufirst%3DZhengxing%26date%3D2016%26volume%3D26%26issue%3D16%26spage%3D4095%26epage%3D4100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathias  Hallberg</span>. </span><span class="cited-content_cbyCitation_article-title">Neuropeptides: Metabolism to Bioactive Fragments and the Pharmacology of Their Receptors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2015,</strong> <em>35 </em>
                                    (3)
                                     , 464-519. <a href="https://doi.org/10.1002/med.21323" title="DOI URL">https://doi.org/10.1002/med.21323</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21323%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DNeuropeptides%25253A%252BMetabolism%252Bto%252BBioactive%252BFragments%252Band%252Bthe%252BPharmacology%252Bof%252BTheir%252BReceptors%26aulast%3DHallberg%26aufirst%3DMathias%26date%3D2015%26date%3D2014%26volume%3D35%26issue%3D3%26spage%3D464%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mary Beth  Babos</span>, <span class="hlFld-ContribAuthor ">Brittany  Grady</span>, <span class="hlFld-ContribAuthor ">Warren  Wisnoff</span>, <span class="hlFld-ContribAuthor ">Christy  McGhee</span>. </span><span class="cited-content_cbyCitation_article-title">Pathophysiology of pain. </span><span class="cited-content_cbyCitation_journal-name">Disease-a-Month</span><span> <strong>2013,</strong> <em>59 </em>
                                    (10)
                                     , 330-358. <a href="https://doi.org/10.1016/j.disamonth.2013.05.003" title="DOI URL">https://doi.org/10.1016/j.disamonth.2013.05.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.disamonth.2013.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.disamonth.2013.05.003%26sid%3Dliteratum%253Aachs%26jtitle%3DDisease-a-Month%26atitle%3DPathophysiology%252Bof%252Bpain%26aulast%3DBabos%26aufirst%3DMary%2BBeth%26date%3D2013%26volume%3D59%26issue%3D10%26spage%3D330%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric T  Whalley</span>, <span class="hlFld-ContribAuthor ">Carlos D  Figueroa</span>, <span class="hlFld-ContribAuthor ">Lajos  Gera</span>, <span class="hlFld-ContribAuthor ">Kanti D  Bhoola</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and therapeutic potential of kinin receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2012,</strong> <em>7 </em>
                                    (12)
                                     , 1129-1148. <a href="https://doi.org/10.1517/17460441.2012.729038" title="DOI URL">https://doi.org/10.1517/17460441.2012.729038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2012.729038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2012.729038%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DDiscovery%252Band%252Btherapeutic%252Bpotential%252Bof%252Bkinin%252Breceptor%252Bantagonists%26aulast%3DWhalley%26aufirst%3DEric%2BT%26date%3D2012%26date%3D2012%26volume%3D7%26issue%3D12%26spage%3D1129%26epage%3D1148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niraldo  Paulino</span>, <span class="hlFld-ContribAuthor ">Amarilis  Scremin Paulino</span>, <span class="hlFld-ContribAuthor ">Priscila  Vaultier</span>, <span class="hlFld-ContribAuthor ">Laura  Pisco</span>, <span class="hlFld-ContribAuthor ">Carolina  Passarelli</span>, <span class="hlFld-ContribAuthor ">José  Matheus de Freitas Costa</span>, <span class="hlFld-ContribAuthor ">Dirk  Michalik</span>, <span class="hlFld-ContribAuthor ">Paulo  Celso Pardi</span>, <span class="hlFld-ContribAuthor ">José  Agustín Quincoces Suárez</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of Antinociceptive and Anti-Inflammatory Effects of Synthetic O-Prenylated Phenolic Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Pharmacy</span><span> <strong>2012,</strong> <em>03 </em>
                                    (03)
                                     , 348-357. <a href="https://doi.org/10.4236/pp.2012.33047" title="DOI URL">https://doi.org/10.4236/pp.2012.33047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4236/pp.2012.33047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4236%2Fpp.2012.33047%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Pharmacy%26atitle%3DEvaluation%252Bof%252BAntinociceptive%252Band%252BAnti-Inflammatory%252BEffects%252Bof%252BSynthetic%252BO-Prenylated%252BPhenolic%252BDerivatives%26aulast%3DPaulino%26aufirst%3DNiraldo%26date%3D2012%26volume%3D03%26issue%3D03%26spage%3D348%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016057&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Identified hit.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016057&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Leads after first SAR round.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016057&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Arylsulfonamide B1 Antagonists: First Route<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016057&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) CH<sub>3</sub>NHCH<sub>2</sub>CH<sub>2</sub>OH, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt; (b) BrCH<sub>2</sub>COOtBu, <i>n</i>-Bu<sub>4</sub>NCl, 35% NaOH, toluene, rt; (c) MeNH<sub>2</sub>·HCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt; (d) Br-Y-COOEt, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (e) LiOH, THF, H<sub>2</sub>O, rt; (f) EDCI, HOAT, Aamine, CH<sub>2</sub>Cl<sub>2</sub>, rt; (g), TFA, anisole, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Arylsulfonamide B1 Antagonists: Second Route<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016057&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) BrCH<sub>2</sub>COOtBu, <i>n</i>-Bu<sub>4</sub>NCl, 35% NaOH, toluene, rt; (b), TFA, CH<sub>2</sub>Cl<sub>2</sub>; (c) CbzCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt; (d) EDCI, HOAT, amine, CH<sub>2</sub>Cl<sub>2</sub>, rt; (e) H<sub>2</sub>, Pd/C 10%, MeOH, rt; (f) RSO<sub>2</sub>Cl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt; (g) TFA, anisole, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Phenylimidazoline Synthons<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016057&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) CbzCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> rt; (b) S, H<sub>2</sub>NCH<sub>2</sub>CH<sub>2</sub>NH<sub>2,</sub> 100 °C; (c) Boc<sub>2</sub>O, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt; (d) H<sub>2</sub>, 10% Pd/C, MeOH, rt.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Homology model of BK B1 receptor with <b>10d</b> docked in the putative binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016057&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of <b>12d</b> (30 mg/kg po) on formalin induced flinching in rats. Rats received an intraplantar injection (50 μL) of formalin (2%) into one hind paw. The duration of flinching of the injected paw was recorded continuously immediately thereafter for 60 min. The nociceptive response is divided into two phases, the acute one between 0 and 10 min and the late one between 15 and 60 min. Values are the mean ± SEM; <i>n</i> = 6 rats/group; analysis of variance followed by Student’s <i>t</i> test, (∗) <i>P</i> < 0.05 vs saline.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016057&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/medium/jm-2011-016057_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of oral administration of <b>12d</b> on the vocalization thresholds due to paw pressure in carrageenan-treated rats. Effect of oral administration of compound <b>12d</b> on the vocalization thresholds due to paw pressure in carrageenan-treated rats. The results are expressed by the mean ± SEM of the area under the time-course curves (AUC) of the variations (postdrug – predrug values of vocalization thresholds), calculated by the trapezoidal method. Rats were treated with vehicle, compound <b>12d</b> (75, 150, and 300 mg/kg), diclofenac (20 mg/kg), or morphine (8 mg/kg) (<i>n</i> = 6–11 per group). Analysis of variance followed by Student’s <i>t</i> test: (∗) <i>p</i> < 0.05 vs vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-6/jm2016057/production/images/large/jm-2011-016057_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016057&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57164" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57164" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 16 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Bhoola, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worthy, K.</span><span> </span><span class="NLM_article-title">Bioregulation of kinins: kallikreins, kininogens and kininases</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1992&pages=1-80&author=K.+D.+Bhoolaauthor=C.+D.+Figueroaauthor=K.+Worthy&title=Bioregulation+of+kinins%3A+kallikreins%2C+kininogens+and+kininases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhoola%26aufirst%3DK.%2BD.%26aulast%3DFigueroa%26aufirst%3DC.%2BD.%26aulast%3DWorthy%26aufirst%3DK.%26atitle%3DBioregulation%2520of%2520kinins%253A%2520kallikreins%252C%2520kininogens%2520and%2520kininases%26jtitle%3DPharmacol.%2520Rev.%26date%3D1992%26volume%3D44%26spage%3D1%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barabé, J.</span><span> </span><span class="NLM_article-title">Pharmacology of bradykinin and related kinins</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1980&pages=1-46&author=D.+Regoliauthor=J.+Barab%C3%A9&title=Pharmacology+of+bradykinin+and+related+kinins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DBarab%25C3%25A9%26aufirst%3DJ.%26atitle%3DPharmacology%2520of%2520bradykinin%2520and%2520related%2520kinins%26jtitle%3DPharmacol.%2520Rev.%26date%3D1980%26volume%3D32%26spage%3D1%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nsa Allogho, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobeil, F. J.</span><span> </span><span class="NLM_article-title">Bradykinin receptors and their antagonists</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1016%2FS0014-2999%2898%2900165-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=9650825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADyaK1cXivVGisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=1998&pages=1-10&author=D.+Regoliauthor=S.+Nsa+Alloghoauthor=A.+Rizziauthor=F.+J.+Gobeil&title=Bradykinin+receptors+and+their+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Bradykinin receptors and their antagonists</span></div><div class="casAuthors">Regoli, Domenico; Nsa Allogho, Suzanne; Rizzi, Anna; Gobeil, Fernand, Jr.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review, with 87 refs.  Bradykinin and related kinins act on two receptor types, named B1 and B2.  Initially identified in classical bioassays, these receptors have been cloned and characterized in binding assays performed on plasma membranes of cells expressing the native or the transfected human kinin B1 or B2 receptor types.  The two classification criteria recommended by Schild, namely the order of potency of agonists and the actual affinity of antagonists have been found to be applicable for receptor classification based not on data only from bioassays but also from other approaches (binding assays, mol. biol. techniques).  The order of potency for agonists was found with naturally occurring peptides (the kinins, their desArg9-metabolites) and with selective agonists (e.g., [Hyp3]bradykinin, [Aib7]bradykinin): the findings obtained with agonists could be validated with various antagonists.  Crit. evaluation of the initial compds., typified by D-Arg-[Hyp3, d-Phe7]bradykinin, has indicated that they are short-acting, partial agonists, non-selective for the bradykinin B2 receptor because they can be metabolized to desArg9-fragments that act on the kinin B1 receptor.  Use of such compds. has given rise to misunderstandings, esp. with regard to new receptor types (e.g., type B3), the existence of which was not confirmed by mol. cloning.  A second generation of antagonists, represented by d-Arg[Hyp3,Thi5,d-Tic7,Oic8]bradykinin (HOE 140) has been found resistant to degrdn., long-acting in vivo, selective and specific for the B2 receptor and potent in all species tested.  HOE 140 has been used successfully in basic pharmacol., in animal physiopathologies involving kinins and their receptors and even in clin. studies.  A third generation of non-peptide B2 receptor antagonists, whose prototype is FR 173657 ((E)-3-(6-acetamido-3-pyridyl)-N-[N-2-4-dichloro-3-[(2-methyl-8-quinolinyl)oxymethyl]phenyl]-N-methylamino carbonyl-Me acrylamide) is now emerging and may represent substantial progress since FR 173657 is a potent orally active, selective and specific antagonist of the human and other species B2 receptors.  There is also progress regarding antagonists for the B1 receptor.  The initial compds., esp. Lys-[Leu8]desArg9-bradykinin remain among of the most potent, specific and selective B1 antagonists which, however, show partial agonistic effects in some B1 receptor subtypes (e.g., the mouse).  Progress has been made with AcLys-[D-βNal7, Ile8]desArg9-bradykinin (R 715) and Lys-Lys-[Hyp3, Cpg5, d-Tic7,Cpg8]desArg9-bradykinin (B 9958) which are pure B1 antagonists in humans and rabbits; both peptides have shown resistance to degrdn. by peptidases and have little if any, residual agonistic activity on mouse and rat B1 receptors.  No non-peptide antagonists are yet available for the B1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIMrTVFwpWibVg90H21EOLACvtfcHk0liLS3fdanCy6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXivVGisL0%253D&md5=6d4eb69a3d9be345fd876604543131e8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2898%2900165-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252898%252900165-4%26sid%3Dliteratum%253Aachs%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DNsa%2BAllogho%26aufirst%3DS.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DGobeil%26aufirst%3DF.%2BJ.%26atitle%3DBradykinin%2520receptors%2520and%2520their%2520antagonists%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D348%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Marceau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachvarov, D. R.</span><span> </span><span class="NLM_article-title">The B<sub>1</sub> receptors for kinins</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1998&pages=357-386&author=F.+Marceauauthor=J.+F.+Hessauthor=D.+R.+Bachvarov&title=The+B1+receptors+for+kinins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarceau%26aufirst%3DF.%26aulast%3DHess%26aufirst%3DJ.%2BF.%26aulast%3DBachvarov%26aufirst%3DD.%2BR.%26atitle%3DThe%2520B1%2520receptors%2520for%2520kinins%26jtitle%3DPharmacol.%2520Rev.%26date%3D1998%26volume%3D50%26spage%3D357%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hall, J. M.</span><span> </span><span class="NLM_article-title">Bradykinin receptors: pharmacological properties and biological roles</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1016%2F0163-7258%2892%2990016-S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=1338478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADyaK3sXksVWjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1992&pages=131-190&author=J.+M.+Hall&title=Bradykinin+receptors%3A+pharmacological+properties+and+biological+roles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Bradykinin receptors: Pharmacological properties and biological roles</span></div><div class="casAuthors">Hall, Judith M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-90</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    </div><div class="casAbstract">A review, with 364 refs., on the properties of bradykinin B1 and B2 receptors and the potential therapeutic applications of drugs acting at these sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwyMOPtpGNJbVg90H21EOLACvtfcHk0liDWxrVElR_QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXksVWjsbo%253D&md5=3a9cd1a63348687e348cd6ba09ca7ad7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0163-7258%2892%2990016-S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-7258%252892%252990016-S%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DJ.%2BM.%26atitle%3DBradykinin%2520receptors%253A%2520pharmacological%2520properties%2520and%2520biological%2520roles%26jtitle%3DPharmacol.%2520Ther.%26date%3D1992%26volume%3D56%26spage%3D131%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Pesquero, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araujo, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heppenstall, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, J. A.,  Jr</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walther, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesquero, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paiva, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calixto, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewin, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, M.</span><span> </span><span class="NLM_article-title">Hypoalgesia and altered inflammatory responses in mice lacking kinin B<sub>1</sub> receptors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">8140</span><span class="NLM_x">–</span> <span class="NLM_lpage">8145</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=8140-8145&author=J.+B.+Pesqueroauthor=R.+C.+Araujoauthor=P.+A.+Heppenstallauthor=J.+A.+Silvaauthor=T.+Waltherauthor=S.+M.+Oliveiraauthor=J.+L.+Pesqueroauthor=A.+C.+Paivaauthor=J.+B.+Calixtoauthor=G.+R.+Lewinauthor=M.+Bader&title=Hypoalgesia+and+altered+inflammatory+responses+in+mice+lacking+kinin+B1+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPesquero%26aufirst%3DJ.%2BB.%26aulast%3DAraujo%26aufirst%3DR.%2BC.%26aulast%3DHeppenstall%26aufirst%3DP.%2BA.%26aulast%3DSilva%26aufirst%3DJ.%2BA.%26aulast%3DWalther%26aufirst%3DT.%26aulast%3DOliveira%26aufirst%3DS.%2BM.%26aulast%3DPesquero%26aufirst%3DJ.%2BL.%26aulast%3DPaiva%26aufirst%3DA.%2BC.%26aulast%3DCalixto%26aufirst%3DJ.%2BB.%26aulast%3DLewin%26aufirst%3DG.%2BR.%26aulast%3DBader%26aufirst%3DM.%26atitle%3DHypoalgesia%2520and%2520altered%2520inflammatory%2520responses%2520in%2520mice%2520lacking%2520kinin%2520B1%2520receptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D8140%26epage%3D8145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Perkins, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dray, A.</span><span> </span><span class="NLM_article-title">Antinociceptive activity of the bradykinin B<sub>1</sub> and B<sub>2</sub> receptor antagonists, des-Arg<sup>9</sup>[Leu<sup>8</sup>]-BK and Hoe 140, in two models of persistent hyperalgesia in the rat</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1993&pages=191-197&author=M.+N.+Perkinsauthor=E.+Campbellauthor=A.+Dray&title=Antinociceptive+activity+of+the+bradykinin+B1+and+B2+receptor+antagonists%2C+des-Arg9%5BLeu8%5D-BK+and+Hoe+140%2C+in+two+models+of+persistent+hyperalgesia+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerkins%26aufirst%3DM.%2BN.%26aulast%3DCampbell%26aufirst%3DE.%26aulast%3DDray%26aufirst%3DA.%26atitle%3DAntinociceptive%2520activity%2520of%2520the%2520bradykinin%2520B1%2520and%2520B2%2520receptor%2520antagonists%252C%2520des-Arg9%255BLeu8%255D-BK%2520and%2520Hoe%2520140%252C%2520in%2520two%2520models%2520of%2520persistent%2520hyperalgesia%2520in%2520the%2520rat%26jtitle%3DPain%26date%3D1993%26volume%3D53%26spage%3D191%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Rupniak, N. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borkowski, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, J. F.</span><span> </span><span class="NLM_article-title">Effects of the bradykinin B<sub>1</sub> receptor antagonist des-Arg<sup>9</sup>[Leu<sup>8</sup>]bradykinin and genetic disruption of the B<sub>2</sub> receptor on nociception in rats and mice</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1997&pages=89-97&author=N.+M.+J.+Rupniakauthor=S.+Boyceauthor=J.+K.+Webbauthor=A.+R.+Williamsauthor=E.+J.+Carlsonauthor=R.+G.+Hillauthor=J.+A.+Borkowskiauthor=J.+F.+Hess&title=Effects+of+the+bradykinin+B1+receptor+antagonist+des-Arg9%5BLeu8%5Dbradykinin+and+genetic+disruption+of+the+B2+receptor+on+nociception+in+rats+and+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRupniak%26aufirst%3DN.%2BM.%2BJ.%26aulast%3DBoyce%26aufirst%3DS.%26aulast%3DWebb%26aufirst%3DJ.%2BK.%26aulast%3DWilliams%26aufirst%3DA.%2BR.%26aulast%3DCarlson%26aufirst%3DE.%2BJ.%26aulast%3DHill%26aufirst%3DR.%2BG.%26aulast%3DBorkowski%26aufirst%3DJ.%2BA.%26aulast%3DHess%26aufirst%3DJ.%2BF.%26atitle%3DEffects%2520of%2520the%2520bradykinin%2520B1%2520receptor%2520antagonist%2520des-Arg9%255BLeu8%255Dbradykinin%2520and%2520genetic%2520disruption%2520of%2520the%2520B2%2520receptor%2520on%2520nociception%2520in%2520rats%2520and%2520mice%26jtitle%3DPain%26date%3D1997%26volume%3D71%26spage%3D89%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Corrêa, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calixto, J. B.</span><span> </span><span class="NLM_article-title">Evidence for participation of B<sub>1</sub> and B<sub>2</sub> kinin receptors in formalin-induced nociceptive response in the mouse</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1111%2Fj.1476-5381.1993.tb13791.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=8220879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADyaK2cXkslGnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1993&pages=193-198&author=C.+R.+Corr%C3%AAaauthor=J.+B.+Calixto&title=Evidence+for+participation+of+B1+and+B2+kinin+receptors+in+formalin-induced+nociceptive+response+in+the+mouse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse</span></div><div class="casAuthors">Correa, Clovis R.; Calixto, Joao B.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-8</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">This study was designed to investigate the role of bradykinin (BK), as well as the subtype of BK receptors involved, in formalin-induced hindpaw pain in the mouse by use of selective B1 and B2 receptor antagonists.  In addn., the authors have analyzed whether or not BK may be involved in formalin-induced hindpaw edema in the mouse.  The pretreatment of animals with captopril (2 and 5 mg kg-1, s.c.) significantly increase the first and the second phases of formalin-induced pain.  Co-injection of the selective B1 receptor antagonist des-Arg9[Leu8]-BK (0.2-0.4 nmol/paw), together with formalin, caused graded and similar inhibitions of both phases of formalin-induced pain.  Similar results were obtained with B2 antagonists NPC 349 (D-Arg[Hyp3,Thi5,8-D-Phe7]-BK) and NPC 567 (D-Arg[Hyp3,D-Phe7]-BK) (0.2 and 0.6 nmol/paw).  Higher concns. of these antagonists (1 nmol/paw) failed to antagonize formalin-induced pain.  The new potent and selective B2 receptor antagonists, Hoe 140 (D-Arg[Hyp3,Thi5,D-Tic7,Oic8]-BK), NPC 17731 (D-Arg[Hyp3, trans-4-propoxy-D-proline (trans thiophenyl)7, Oic8]-BK), and NPC 17761 (D-Arg[Hyp3, trans-4-propoxy-D-proline (trans thiophenyl)7, Oic8]-BK) (0.02 to 1.0 nmol/paw), also caused significant inhibitions of both phases of formalin-induced pain.  When Hoe 140 was injected s.c. 30 min before formalin injection (9.9 and 99 nmol kg-1), it significantly attenuated both phases of formalin-induced pain.  The putative non-peptide BK antagonist, MV 8612 (1.6 to 9.6 nmol/paw), but not MV 8608 (5.5 to 33 nmol/paw), caused a graded inhibition of both phases of formalin-induced pain, being, however, more active against the first phase.  The pretreatment of animals with morphine (2.6 to 13 μmol kg-1, s.c.) caused dose-dependent and equipotent inhibitions of both phases of formalin-induced pain.  In contrast, indomethacin (2.7 to 27 μmol kg-1) antagonized only the second phase of formalin-induced pain.  The B2 receptor antagonists, Hoe 140, NPC 17731, NPC 17761, NPC 349 and NPC 567, all caused a significant inhibition of formalin-induced hindpaw edema.  A similar inhibition was also obsd. with indomethacin but not with captopril or morphine.  The authors' results provide strong evidence for the important role of endogenous BK, acting through both B1 and B2 receptors, in the genesis of both phases of formalin-induced persistent pain in the mouse.  In addn., the current results also demonstrate that the inflammatory edema assocd. with the later phase of formalin-induced pain seems to be mediated by endogenous BK, via activation of B2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA410KvdTexrVg90H21EOLACvtfcHk0lgoDBuuCeQkXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslGnsw%253D%253D&md5=c998e81791522a24ac9af95b0827d046</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1993.tb13791.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1993.tb13791.x%26sid%3Dliteratum%253Aachs%26aulast%3DCorr%25C3%25AAa%26aufirst%3DC.%2BR.%26aulast%3DCalixto%26aufirst%3DJ.%2BB.%26atitle%3DEvidence%2520for%2520participation%2520of%2520B1%2520and%2520B2%2520kinin%2520receptors%2520in%2520formalin-induced%2520nociceptive%2520response%2520in%2520the%2520mouse%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D110%26spage%3D193%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Perkins, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, D.</span><span> </span><span class="NLM_article-title">Induction of bradykinin B<sub>1</sub> receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">1441</span><span class="NLM_x">–</span> <span class="NLM_lpage">1444</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1111%2Fj.1476-5381.1993.tb13982.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=8306084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADyaK2cXhtVSlt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1993&pages=1441-1444&author=M.+N.+Perkinsauthor=D.+Kelly&title=Induction+of+bradykinin+B1+receptors+in+vivo+in+a+model+of+ultra-violet+irradiation-induced+thermal+hyperalgesia+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of bradykinin B1 receptors in vivo in a model of ultraviolet irradiation-induced thermal hyperalgesia in the rat</span></div><div class="casAuthors">Perkins, M. N.; Kelly, D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1441-4</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The role of bradykinin B1 receptors in the thermal hyperalgesia following unilateral UV irradn. of the hindpaw of rats has been investigated.  In nonirradiated (naive) animals, the R1 receptor agonist des-Arg9-bradykinin and bradykinin (BK) (up to 1 μmol/kg i.v.) had no effect on withdrawal latency to a noxious heat stimulus when administered 60 min before testing.  Following exposure of one hindpaw to strong UV irradn., the withdrawal latency of the UV-treated paw to radiant noxious heat fell by a max. of 50% after 48 h.  There was no redn. in latency in the contralateral paw.  Des-Arg9-BK (1-100 mmol/kg i.v.) administered 24 h after UV exposure caused a further dose-dependent fall (50% redn. from saline injected animals at 100 nmol/kg i.v.) in withdrawal latency in the UV-treated paw when measured 60 min after injection.  The withdrawal latency of the contralateral paw was also reduced, but to a lesser extent following des-Arg9-BK (100 nmol/kg i.v.) with a max. redn. of 19%.  Bradykinin also induced a further redn. in withdrawal latency (33% redn. at 1 μmol/kg), although it was not as effective as des-Arg9-BK.  Bradykinin did not reduce the withdrawal latency in the contralateral paw.  The hyperalgesic action of both des-Arg9-BK (10 nmol/kg i.v.) and bradykinin (100 nmol/kg, i.v.) were antagonized by the B1 receptor antagonist, des-Arg9,Leu8-BK (200 nmol/kg i.v.) but not by the B2 receptor antagonist, HOE 140 (0.5 μmol/kg i.v.).  The results suggest that in conditions of inflammatory hyperalgesia, bradykinin B1 receptors are induced both locally and distant to the inflamed area, activation of which leads to further thermal hyperalgesia.  In addn., in these conditions bradykinin appears to act predominantly via B1 receptors, presumably after degrdn. to des-Arg9-BK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr29HPKaHx_dLVg90H21EOLACvtfcHk0lgoDBuuCeQkXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhtVSlt74%253D&md5=19b5eaaa028947c5e602872bb1511b02</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1993.tb13982.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1993.tb13982.x%26sid%3Dliteratum%253Aachs%26aulast%3DPerkins%26aufirst%3DM.%2BN.%26aulast%3DKelly%26aufirst%3DD.%26atitle%3DInduction%2520of%2520bradykinin%2520B1%2520receptors%2520in%2520vivo%2520in%2520a%2520model%2520of%2520ultra-violet%2520irradiation-induced%2520thermal%2520hyperalgesia%2520in%2520the%2520rat%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D110%26spage%3D1441%26epage%3D1444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Davis, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, M. N.</span><span> </span><span class="NLM_article-title">Induction of B<sub>1</sub> receptors in vivo in a model of persistent inflammatory mechanical hyperalgesia in the rat</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1994&pages=127-133&author=A.+J.+Davisauthor=M.+N.+Perkins&title=Induction+of+B1+receptors+in+vivo+in+a+model+of+persistent+inflammatory+mechanical+hyperalgesia+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DA.%2BJ.%26aulast%3DPerkins%26aufirst%3DM.%2BN.%26atitle%3DInduction%2520of%2520B1%2520receptors%2520in%2520vivo%2520in%2520a%2520model%2520of%2520persistent%2520inflammatory%2520mechanical%2520hyperalgesia%2520in%2520the%2520rat%26jtitle%3DNeuropharmacology%26date%3D1994%26volume%3D33%26spage%3D127%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Davis, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, M. N.</span><span> </span><span class="NLM_article-title">The involvement of bradykinin B<sub>1</sub> and B<sub>2</sub> receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1111%2Fj.1476-5381.1994.tb16174.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=7812634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADyaK2cXlslOns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1994&pages=63-68&author=A.+J.+Davisauthor=M.+N.+Perkins&title=The+involvement+of+bradykinin+B1+and+B2+receptor+mechanisms+in+cytokine-induced+mechanical+hyperalgesia+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">The involvement of bradykinin B1 and B2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat</span></div><div class="casAuthors">Davis, A. J.; Perkins, M. N.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-8</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">Interleukin-1β (IL-1β), IL-2 and IL-8 induced a mech. hyperalgesia following intra-articular (i.artic.) injection into rat knee joints, whereas IL-6 and tumor necrosis factor α (TNF-α) were without effect.  Co-administration of IL-1 receptor antagonist (0.1 μg) with IL-1β (1 u), IL-2 (10 u) or IL-8 (0.1 u) prevented the subsequent development of the hyperalgesia.  Co-administration of desArg9Leu8BK (0.5-5 nmol) with IL-1β (1 u), IL-2 (10 u) or IL-8 (0.1 u) reduced the level of hyperalgesia at 1, 4 and 6 h post administration, whereas Hoe 140 (5 pmol) antagonized the hyperalgesia only at the 1 h time point.  The i.v. administration of desArg9Leu8BK (10 nmol kg-1) or Hoe 140 (100 pmol kg-1) following IL-1β (1 u), IL-2 (10 u), or IL-8 (0.1 u) reversed the subsequent hyperalgesia.  Administration of desArg9BK into joints 24 h after pre-treatment with IL-1β (1 u) produced analgesia at low doses (50 pmol) and hyperalgesia at a higher does (0.5 nmol).  Both these effects were blocked by desArg9Leu8BK (0.5 nmol).  Administration of des Arg9BK (0.5 nmol i.artic.) to animals 24 h after pre-treatment with IL-2 (1-100 u) or IL-8 (0.1-10 u) had no effect on the load tolerated by the treated joint.  Administration of indomethacin (1 mg kg-1, s.c.) prior to IL-1β (1 u i.artic.) prevented the development of hyperalgesia.  Administration of desArg9BK (5 pmol-0.5 nmol, i.artic.) to animals 24 h after indomethacin and IL-1β pretreatment had no effect on the load tolerated by the treated joint.  These data suggest that both bradykinin B1 and B2 receptors are involved in the induction and maintenance of cytokine-induced hyperalgesia.  They also show that the induction of B1 receptor-mediated hyperalgesia requires both cyclo-oxygenase products and IL-1 in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCJEIbpiGIq7Vg90H21EOLACvtfcHk0lixvi68THKikg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlslOns7k%253D&md5=88451e9f11c8a3bb4581db2b1739b310</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1994.tb16174.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1994.tb16174.x%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DA.%2BJ.%26aulast%3DPerkins%26aufirst%3DM.%2BN.%26atitle%3DThe%2520involvement%2520of%2520bradykinin%2520B1%2520and%2520B2%2520receptor%2520mechanisms%2520in%2520cytokine-induced%2520mechanical%2520hyperalgesia%2520in%2520the%2520rat%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D113%26spage%3D63%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Bélichard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouthillier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachvarov, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruneau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marceau, F.</span><span> </span><span class="NLM_article-title">Inflammatory hyperalgesia induced by zymosan in the plantar tissue of the rat: effect of kinin receptor antagonists</span> <span class="citation_source-journal">Immunopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9e&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1016%2FS0162-3109%2899%2900165-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9e&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=10647872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9e&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtV2htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2000&pages=139-147&author=P.+B%C3%A9lichardauthor=M.+Landryauthor=J.+Bouthillierauthor=D.+R.+Bachvarovauthor=D.+Pruneauauthor=F.+Marceau&title=Inflammatory+hyperalgesia+induced+by+zymosan+in+the+plantar+tissue+of+the+rat%3A+effect+of+kinin+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9eR"><div class="casContent"><span class="casTitleNuber">9e</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory hyperalgesia induced by zymosan in the plantar tissue of the rat: effect of kinin receptor antagonists</span></div><div class="casAuthors">Belichard, P.; Landry, M.; Faye, P.; Bachvarov, D. R.; Bouthillier, J.; Pruneau, D.; Marceau, F.</div><div class="citationInfo"><span class="NLM_cas:title">Immunopharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-147</span>CODEN:
                <span class="NLM_cas:coden">IMMUDP</span>;
        ISSN:<span class="NLM_cas:issn">0162-3109</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The Randall-Selitto paradigm (maximal tolerated pressure externally applied by a mech. device) was used to develop a rat model of localized inflammatory hyperalgesia in order to compare the analgesic effects of bradykinin (BK) B1 and B2 receptor antagonists and of a non-steroidal anti-inflammatory drug (NSAID).  Intra-plantar injection of zymosan (12.5 mg per paw) induced a considerable inflammation as evidenced from gross and histol. evaluation and a mech. hyperalgesia at 6 h.  The contralateral paw of zymosan-treated animals or saline vehicle-injected paws did not exhibit a decreased pressure tolerance, relative to pre-injection measurements.  Since the B1 receptor may be induced under inflammatory situations, we examd. the amt. of corresponding mRNA using quant. RT-PCR.  We found a significant increase of B1 receptor mRNA in the zymosan - but not the saline-injected paw at 6 h.  Drugs were given s.c. 2 h before the 6 h readings to test their analgesic potential.  The kinin B1 receptor antagonists [Leu8]des-Arg9-BK (3-30 nmol/kg) and R-715 (100 nmol/kg), the B2 receptor antagonists Hoe 140 (15 nmol/kg) and LF 16.0687 (3 and 10 mg/kg), as well as the NSAID diclofenac sodium (1 and 3 mg/kg) significantly reversed zymosan-induced hyperalgesia.  We conclude that zymosan-induced hyperalgesia is a model suitable for the rapid evaluation of analgesic drugs with a peripheral site of action interfering either with kinin receptors or with prostanoid formation.  In this regard, results of the present study confirm that blocking kinin B1 receptors is a novel approach for treatment of inflammatory pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgXxQLrWsIzbVg90H21EOLACvtfcHk0lixvi68THKikg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtV2htA%253D%253D&md5=f8be41897facbdf86b4148bb64d8c39a</span></div><a href="/servlet/linkout?suffix=cit9e&amp;dbid=16384&amp;doi=10.1016%2FS0162-3109%2899%2900165-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0162-3109%252899%252900165-4%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A9lichard%26aufirst%3DP.%26aulast%3DLandry%26aufirst%3DM.%26aulast%3DBouthillier%26aufirst%3DJ.%26aulast%3DBachvarov%26aufirst%3DD.%2BR.%26aulast%3DPruneau%26aufirst%3DD.%26aulast%3DMarceau%26aufirst%3DF.%26atitle%3DInflammatory%2520hyperalgesia%2520induced%2520by%2520zymosan%2520in%2520the%2520plantar%2520tissue%2520of%2520the%2520rat%253A%2520effect%2520of%2520kinin%2520receptor%2520antagonists%26jtitle%3DImmunopharmacology%26date%3D2000%26volume%3D46%26spage%3D139%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Bélichard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luccarini, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defrêne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faye, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franck, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duclos, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquet, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruneau, D.</span><span> </span><span class="NLM_article-title">Pharmacological and molecular evidence for kinin B<sub>1</sub> receptor expression in urinary bladder of cyclophosphamide-treated rats</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9f&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1038%2Fsj.bjp.0702769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9f&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=10498854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9f&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADyaK1MXmt1Wjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=1999&pages=213-219&author=P.+B%C3%A9lichardauthor=J.+M.+Luccariniauthor=E.+Defr%C3%AAneauthor=P.+Fayeauthor=R.+M.+Franckauthor=H.+Duclosauthor=J.+L.+Paquetauthor=D.+Pruneau&title=Pharmacological+and+molecular+evidence+for+kinin+B1+receptor+expression+in+urinary+bladder+of+cyclophosphamide-treated+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9fR"><div class="casContent"><span class="casTitleNuber">9f</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological and molecular evidence for kinin B1 receptor expression in urinary bladder of cyclophosphamide-treated rats</span></div><div class="casAuthors">Belichard, P.; Luccarini, J. M.; Defrene, E.; Faye, P.; Franck, R. M.; Duclos, H.; Paquet, J. L.; Pruneau, D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">213-219</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">In the present study, we developed an exptl. model of cystitis induced by cyclophosphamide (CYP).  In order to characterize des-Arg9-BK-induced contraction on the urinary bladder (UB) during the development of inflammation and to quantify kinin B1 receptor gene expression using a quant. RT-PCR technique.  In the presence of peptidase inhibitors captopril (10 μM), DL-thiorphan (1 μM) and DL-2-mercaptomethyl-3-guanidino-ethylthiopropanoic acid (MERGEPTA 5 μM), bradykinin (BK) (0.3-3,000 nM) evoked a concn.-dependent contraction of rat UB which was not different between the CYP- and vehicle-treated groups.  Unlike BK, des-Arg9-BK (0.3-100,000 nM) did not contract UB from vehicle-treated rats but contracted vigorously bladder strips from CYP-treated rats 14, 24 and 168 h after treatment.  In UB of 24 h treated rat, the pD2 value of des-Arg9-BK was 7.3±0.1.  The cyclo-oxygenase inhibitor indomethacin (3 μM) reduced by 30% the maximal response of des-Arg9-BK.  Both the kinin B1 receptor antagonists des-Arg9-[Leu8]BK (10 μM) and des-Arg10-Hoe 140 (10 μM) produced a rightward shift of the concn.-response curve to des-Arg9-BK yielding pKB values of 6.8±0.2 and 7.2±0.1, resp., while the kinin B2 receptor antagonist Hoe 140 (1 μM) had no effect.  After CYP treatment, mRNA coding for the kinin B1 receptor appeared predominantly in UB.  In this organ, the induction was progressive, reaching a max. 48 h after CYP treatment.  In conclusion, the present study provides strong evidence for an induction of kinin B1 receptors in UB of CYP-treated rats.  This was assocd. at a mol. level with an increase in mRNA expression of the gene coding for the kinin B1 receptor.  This kinin receptor displayed the whole features of a classical rat kinin B1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrWPeGEOVi_rVg90H21EOLACvtfcHk0lgHYGu2i1eqmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmt1Wjs78%253D&md5=a0c024025dfbe9764f78af84aa1f4f59</span></div><a href="/servlet/linkout?suffix=cit9f&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702769%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A9lichard%26aufirst%3DP.%26aulast%3DLuccarini%26aufirst%3DJ.%2BM.%26aulast%3DDefr%25C3%25AAne%26aufirst%3DE.%26aulast%3DFaye%26aufirst%3DP.%26aulast%3DFranck%26aufirst%3DR.%2BM.%26aulast%3DDuclos%26aufirst%3DH.%26aulast%3DPaquet%26aufirst%3DJ.%2BL.%26aulast%3DPruneau%26aufirst%3DD.%26atitle%3DPharmacological%2520and%2520molecular%2520evidence%2520for%2520kinin%2520B1%2520receptor%2520expression%2520in%2520urinary%2520bladder%2520of%2520cyclophosphamide-treated%2520rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D128%26spage%3D213%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Couture, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrisson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianna, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloutier, F.</span><span> </span><span class="NLM_article-title">Kinins receptors in pain and inflammation</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">429</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9g&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1016%2FS0014-2999%2801%2901318-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9g&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=11698039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9g&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotFWitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=429&publication_year=2001&pages=161-176&author=R.+Coutureauthor=M.+Harrissonauthor=R.+M.+Viannaauthor=F.+Cloutier&title=Kinins+receptors+in+pain+and+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9gR"><div class="casContent"><span class="casTitleNuber">9g</span><div class="casTitle"><span class="NLM_cas:atitle">Kinin receptors in pain and inflammation</span></div><div class="casAuthors">Couture, Rejean; Harrisson, Madelaine; Vianna, Rose Mari; Cloutier, Frank</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">429</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">161-176</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Kinins are among the most potent autacoids involved in inflammatory, vascular and pain processes.  These short-lived peptides, including bradykinin, kallidin and T-kinin, are generated during tissue injury and noxious stimulation.  However, emerging evidence also suggests that kinins are stored in neuronal elements of the central nervous system (CNS) where they are thought to play a role as neuromediators in various cerebral functions, particularly in the control of nociceptive information.  Kinins exert their biol. effects through the activation of two transmembrane G-protein-coupled receptors, denoted bradykinin B1 and B2.  Whereas the B2 receptor is constitutive and activated by the parent mols., the B1 receptor is generally underexpressed in normal tissues and is activated by kinins deprived of the C-terminal Arg (des-Arg9-kinins).  The induction and increased expression of B1 receptor occur following tissue injury or after treatment with bacterial endotoxins or cytokines such as interleukin-1β and tumor necrosis factor-α.  This review summarizes the most recent data from various animal models which convey support for a role of B2 receptors in the acute phase of the inflammatory and pain response, and for a role of B1 receptors in the chronic phase of the response.  The B1 receptor may exert a strategic role in inflammatory diseases with an immune component (diabetes, asthma, rheumatoid arthritis and multiple sclerosis).  New information is provided regarding the role of sensory mechanisms subserving spinal hyperalgesia and intrapleural neutrophil migration that occur upon B1 receptor activation in streptozotocin-treated rats, a model of insulin-dependent diabetes mellitus in which the B1 receptor seems to be rapidly overexpressed.  Although it is widely accepted that the blockade of kinin receptors with specific antagonists could be of benefit in the treatment of somatic and visceral inflammation and pain, recent mol. and functional evidence suggests that the activation of B1 receptors with an agonist may afford a novel therapeutic approach in the CNS inflammatory demyelinating disorder encountered in multiple sclerosis by reducing immune cell infiltration (T-lymphocytes) into the brain.  Hence, the B1 receptor may exert either a protective or detrimental effect depending on the inflammatory disease.  This dual function of the B1 receptor deserves to be investigated further.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxNpkKCSFTi7Vg90H21EOLACvtfcHk0lgHYGu2i1eqmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotFWitr0%253D&md5=acc53b3b578815d82a8b424429642173</span></div><a href="/servlet/linkout?suffix=cit9g&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2801%2901318-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252801%252901318-8%26sid%3Dliteratum%253Aachs%26aulast%3DCouture%26aufirst%3DR.%26aulast%3DHarrisson%26aufirst%3DM.%26aulast%3DVianna%26aufirst%3DR.%2BM.%26aulast%3DCloutier%26aufirst%3DF.%26atitle%3DKinins%2520receptors%2520in%2520pain%2520and%2520inflammation%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D429%26spage%3D161%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Eckert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segond von Banchet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, M.</span><span> </span><span class="NLM_article-title">Spatio-temporal pattern of induction of bradykinin receptors and inflammation in rats dorsal root ganglia after unilateral nerve ligation</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">487</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1999&pages=487-497&author=A.+Eckertauthor=G.+Segond+von+Banchetauthor=S.+Sopperauthor=M.+Petersen&title=Spatio-temporal+pattern+of+induction+of+bradykinin+receptors+and+inflammation+in+rats+dorsal+root+ganglia+after+unilateral+nerve+ligation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEckert%26aufirst%3DA.%26aulast%3DSegond%2Bvon%2BBanchet%26aufirst%3DG.%26aulast%3DSopper%26aufirst%3DS.%26aulast%3DPetersen%26aufirst%3DM.%26atitle%3DSpatio-temporal%2520pattern%2520of%2520induction%2520of%2520bradykinin%2520receptors%2520and%2520inflammation%2520in%2520rats%2520dorsal%2520root%2520ganglia%2520after%2520unilateral%2520nerve%2520ligation%26jtitle%3DPain%26date%3D1999%26volume%3D83%26spage%3D487%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Ferreira, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesquero, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araujo, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calixto, J. B.</span><span> </span><span class="NLM_article-title">Evidence for the participation of kinins in Freund’s adjuvant-induced inflammatory and nociceptive responses in kinin B(1) and B(2) receptor knockout mice</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1006</span><span class="NLM_x">–</span> <span class="NLM_lpage">1012</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=1006-1012&author=J.+Ferreiraauthor=M.+M.+Camposauthor=J.+B.+Pesqueroauthor=R.+C.+Araujoauthor=M.+Baderauthor=J.+B.+Calixto&title=Evidence+for+the+participation+of+kinins+in+Freund%E2%80%99s+adjuvant-induced+inflammatory+and+nociceptive+responses+in+kinin+B%281%29+and+B%282%29+receptor+knockout+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerreira%26aufirst%3DJ.%26aulast%3DCampos%26aufirst%3DM.%2BM.%26aulast%3DPesquero%26aufirst%3DJ.%2BB.%26aulast%3DAraujo%26aufirst%3DR.%2BC.%26aulast%3DBader%26aufirst%3DM.%26aulast%3DCalixto%26aufirst%3DJ.%2BB.%26atitle%3DEvidence%2520for%2520the%2520participation%2520of%2520kinins%2520in%2520Freund%25E2%2580%2599s%2520adjuvant-induced%2520inflammatory%2520and%2520nociceptive%2520responses%2520in%2520kinin%2520B%25281%2529%2520and%2520B%25282%2529%2520receptor%2520knockout%2520mice%26jtitle%3DNeuropharmacology%26date%3D2001%26volume%3D41%26spage%3D1006%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Fox, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wotherson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNair, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, J.</span><span> </span><span class="NLM_article-title">Regulation and function of spinal and peripheral neuronal B1 bradykinin receptors in inflammatory mechanical hyperalgesia</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2003&pages=683-691&author=A.+Foxauthor=G.+Wothersonauthor=K.+McNairauthor=L.+Hudsonauthor=S.+Patelauthor=C.+Gentryauthor=J.+Winter&title=Regulation+and+function+of+spinal+and+peripheral+neuronal+B1+bradykinin+receptors+in+inflammatory+mechanical+hyperalgesia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DA.%26aulast%3DWotherson%26aufirst%3DG.%26aulast%3DMcNair%26aufirst%3DK.%26aulast%3DHudson%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DGentry%26aufirst%3DC.%26aulast%3DWinter%26aufirst%3DJ.%26atitle%3DRegulation%2520and%2520function%2520of%2520spinal%2520and%2520peripheral%2520neuronal%2520B1%2520bradykinin%2520receptors%2520in%2520inflammatory%2520mechanical%2520hyperalgesia%26jtitle%3DPain%26date%3D2003%26volume%3D104%26spage%3D683%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Gabra, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirois, P.</span><span> </span><span class="NLM_article-title">Role of bradykinin B1 receptors in diabetes-induced hyperalgesia in streptozotocin-treated mice</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">457</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9k&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1016%2FS0014-2999%2802%2902658-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9k&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=12464357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9k&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADC%252BD38XptFerur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=457&publication_year=2002&pages=115-124&author=B.+H.+Gabraauthor=P.+Sirois&title=Role+of+bradykinin+B1+receptors+in+diabetes-induced+hyperalgesia+in+streptozotocin-treated+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9kR"><div class="casContent"><span class="casTitleNuber">9k</span><div class="casTitle"><span class="NLM_cas:atitle">Role of bradykinin B1 receptors in diabetes-induced hyperalgesia in streptozotocin-treated mice</span></div><div class="casAuthors">Gabra, Bichoy H.; Sirois, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">457</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">115-124</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Insulin-dependent diabetes mellitus (type-1 diabetes) is an inflammatory autoimmune disease assocd. with vascular permeability changes leading to many complications including nephropathy, retinopathy, hypertension, hyperalgesia and neuropathy.  The bradykinin B1 receptor was recently found to be upregulated during the development of the diabetes and to be involved in its complications.  Kinins are known to be important mediators of a variety of biol. effects including cardiovascular homeostasis, inflammation and nociception.  In the present study, we studied the effect of the selective B1 receptor agonist, des-Arg9-bradykinin, and its specific antagonists, Ac-Lys-[d-β Nal7, Ile8]des-Arg9-bradykinin (R-715) and Ac-Orn-[Oic2, αMe Phe5, d-β Nal7, Ile8]des-Arg9-bradykinin (R-954), on diabetic hyperalgesia.  Diabetes was induced in male CD-1 mice by injecting a single high dose of streptozotocin (200 mg kg-1, i.p.) and the nociception was assessed using the hot plate and the tail flick tests, 1 wk following the injection of streptozotocin.  Our results showed that induction of diabetes by streptozotocin provoked a marked hyperalgesia in diabetic mice expressed as about 11% decrease in hot plate reaction time and 26% decrease in tail flick reaction time.  Following acute administration of R-715 (200-800 μg kg-1, i.p.) and R-954 (50-600 μg kg-1, i.p.), this hyperalgesic activity was blocked and the hot plate and tail flick latencies of diabetic mice returned to normal values obsd. in control healthy mice.  In addn., the acute administration of des-Arg9-bradykinin (200-600 μg kg-1, i.p.) significantly potentiated diabetes-induced hyperalgesia, an effect that was totally reversed by R-715 (1.6-2.4 mg kg-1, i.p.) and R-954 (0.8-1.6 mg kg-1, i.p.).  These results provide a major evidence for the implication of the bradykinin B1 receptors in the development of hyperalgesia assocd. with diabetes and suggest a novel approach to the treatment of this diabetic complication using the bradykinin B1 receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqth8OkNO_PibVg90H21EOLACvtfcHk0ljUiMqxaAlgCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptFerur0%253D&md5=16c5089423a1483cd77b566d89dcd3db</span></div><a href="/servlet/linkout?suffix=cit9k&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2902658-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252902658-4%26sid%3Dliteratum%253Aachs%26aulast%3DGabra%26aufirst%3DB.%2BH.%26aulast%3DSirois%26aufirst%3DP.%26atitle%3DRole%2520of%2520bradykinin%2520B1%2520receptors%2520in%2520diabetes-induced%2520hyperalgesia%2520in%2520streptozotocin-treated%2520mice%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D457%26spage%3D115%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">McNair, K.; Kesingland, A.; Urban, L.; Fox, A.</span><span> </span><span class="NLM_article-title">The Role of Central and Pheripheral Bradykinin B1 Receptors in Model of Neuropathic and Inflammatory Pain in the Rat</span> <span class="citation_source-book">British Journal of Pharmacology. Proceedings Supplement</span>; British Pharmacological Society: London,<span class="NLM_x"> </span><span class="NLM_year">2001</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">134</span>, p  <span class="NLM_fpage">158P</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=158P&author=K.+McNair&author=A.+Kesingland&author=L.+Urban&author=A.+Fox&title=British+Journal+of+Pharmacology.+Proceedings+Supplement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMcNair%26aufirst%3DK.%26atitle%3DThe%2520Role%2520of%2520Central%2520and%2520Pheripheral%2520Bradykinin%2520B1%2520Receptors%2520in%2520Model%2520of%2520Neuropathic%2520and%2520Inflammatory%2520Pain%2520in%2520the%2520Rat%26btitle%3DBritish%2520Journal%2520of%2520Pharmacology.%2520Proceedings%2520Supplement%26date%3D2001%26volume%3D134%26spage%3D158P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Levy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zochodne, D. W.</span><span> </span><span class="NLM_article-title">Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2000&pages=265-271&author=D.+Levyauthor=D.+W.+Zochodne&title=Increased+mRNA+expression+of+the+B1+and+B2+bradykinin+receptors+and+antinociceptive+effects+of+their+antagonists+in+an+animal+model+of+neuropathic+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevy%26aufirst%3DD.%26aulast%3DZochodne%26aufirst%3DD.%2BW.%26atitle%3DIncreased%2520mRNA%2520expression%2520of%2520the%2520B1%2520and%2520B2%2520bradykinin%2520receptors%2520and%2520antinociceptive%2520effects%2520of%2520their%2520antagonists%2520in%2520an%2520animal%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DPain%26date%3D2000%26volume%3D86%26spage%3D265%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Ossipov, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malan, T. P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span> </span><span class="NLM_article-title">Spinal and supraspinal mechanisms of neuropathic pain</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">909</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=909&publication_year=2000&pages=12-24&author=M.+H.+Ossipovauthor=J.+Laiauthor=T.+P.+Malanauthor=F.+Porreca&title=Spinal+and+supraspinal+mechanisms+of+neuropathic+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9n&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOssipov%26aufirst%3DM.%2BH.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DMalan%26aufirst%3DT.%2BP.%26aulast%3DPorreca%26aufirst%3DF.%26atitle%3DSpinal%2520and%2520supraspinal%2520mechanisms%2520of%2520neuropathic%2520pain%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2000%26volume%3D909%26spage%3D12%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Dressen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garofalo, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hom, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagodzinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marugg, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neintzel, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiss, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szoke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wone, D. W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span> </span><span class="NLM_article-title">Preparation and optimization of a series of 3-carboxamido-5-phenylacylaminopyrazole bradykinin B1 receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5161</span><span class="NLM_x">–</span> <span class="NLM_lpage">5167</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051292n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5161-5167&author=D.+Dressenauthor=A.+W.+Garofaloauthor=J.+Hawkinsonauthor=D.+Homauthor=J.+Jagodzinskiauthor=J.+L.+Maruggauthor=M.+L.+Neintzelauthor=M.+A.+Pleissauthor=B.+Szokeauthor=J.+S.+Tungauthor=D.+W.+G.+Woneauthor=J.+Wuauthor=H.+Zhang&title=Preparation+and+optimization+of+a+series+of+3-carboxamido-5-phenylacylaminopyrazole+bradykinin+B1+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9o&amp;dbid=16384&amp;doi=10.1021%2Fjm051292n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051292n%26sid%3Dliteratum%253Aachs%26aulast%3DDressen%26aufirst%3DD.%26aulast%3DGarofalo%26aufirst%3DA.%2BW.%26aulast%3DHawkinson%26aufirst%3DJ.%26aulast%3DHom%26aufirst%3DD.%26aulast%3DJagodzinski%26aufirst%3DJ.%26aulast%3DMarugg%26aufirst%3DJ.%2BL.%26aulast%3DNeintzel%26aufirst%3DM.%2BL.%26aulast%3DPleiss%26aufirst%3DM.%2BA.%26aulast%3DSzoke%26aufirst%3DB.%26aulast%3DTung%26aufirst%3DJ.%2BS.%26aulast%3DWone%26aufirst%3DD.%2BW.%2BG.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DPreparation%2520and%2520optimization%2520of%2520a%2520series%2520of%25203-carboxamido-5-phenylacylaminopyrazole%2520bradykinin%2520B1%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5161%26epage%3D5167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Su, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinney, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramson, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, N. J.</span><span> </span><span class="NLM_article-title">2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3946</span><span class="NLM_x">–</span> <span class="NLM_lpage">3952</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800199h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3946-3952&author=D.+S.+Suauthor=J.+L.+Limauthor=E.+Tinneyauthor=B.+L.+Wanauthor=K.+L.+Murphyauthor=D.+R.+Reissauthor=M.+Harrellauthor=S.+S.+O%E2%80%99Malleyauthor=R.+W.+Ramsonauthor=R.+S.+L.+Changauthor=D.+J.+Pettiboneauthor=J.+Yuauthor=C.+Tangauthor=T.+Prueksaritanontauthor=R.+M.+Freidingerauthor=M.+G.+Bockauthor=N.+J.+Anthony&title=2-Aminobenzophenones+as+a+novel+class+of+bradykinin+B1+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9p&amp;dbid=16384&amp;doi=10.1021%2Fjm800199h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800199h%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DD.%2BS.%26aulast%3DLim%26aufirst%3DJ.%2BL.%26aulast%3DTinney%26aufirst%3DE.%26aulast%3DWan%26aufirst%3DB.%2BL.%26aulast%3DMurphy%26aufirst%3DK.%2BL.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DHarrell%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DS.%2BS.%26aulast%3DRamson%26aufirst%3DR.%2BW.%26aulast%3DChang%26aufirst%3DR.%2BS.%2BL.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DBock%26aufirst%3DM.%2BG.%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26atitle%3D2-Aminobenzophenones%2520as%2520a%2520novel%2520class%2520of%2520bradykinin%2520B1%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3946%26epage%3D3952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Player, M. R.</span><span> </span><span class="NLM_article-title">Bradykinin B1 receptors antagonists as potential therapeutic agent for pain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5383</span><span class="NLM_x">–</span> <span class="NLM_lpage">5399</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1000776" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5383-5399&author=H.+Huangauthor=M.+R.+Player&title=Bradykinin+B1+receptors+antagonists+as+potential+therapeutic+agent+for+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9q&amp;dbid=16384&amp;doi=10.1021%2Fjm1000776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1000776%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DPlayer%26aufirst%3DM.%2BR.%26atitle%3DBradykinin%2520B1%2520receptors%2520antagonists%2520as%2520potential%2520therapeutic%2520agent%2520for%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5383%26epage%3D5399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9r"><span><span class="NLM_label">(r) </span><span class="NLM_contrib-group">Fincham, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bressan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fattori, D.</span><span> </span><span class="NLM_article-title">Bradykinin receptor antagonists: a review of the patent literature 2005–2008</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">919</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9r&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1517%2F13543770902994389" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9r&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=19552510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9r&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1eqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=919-941&author=C.+I.+Finchamauthor=A.+Bressanauthor=M.+Parisauthor=C.+Rossiauthor=D.+Fattori&title=Bradykinin+receptor+antagonists%3A+a+review+of+the+patent+literature+2005%E2%80%932008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9rR"><div class="casContent"><span class="casTitleNuber">9r</span><div class="casTitle"><span class="NLM_cas:atitle">Bradykinin receptor antagonists - a review of the patent literature 2005 - 2008</span></div><div class="casAuthors">Fincham, Christopher I.; Bressan, Alessandro; Paris, Marielle; Rossi, Cristina; Fattori, Daniela</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">919-941</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  For >20 years, pharmaceutical companies and academic centers have been developing bradykinin antagonists.  The patent literature on these mols. (up to and including 2004) has been analyzed previously in this journal in two review articles.  The aim of this review is to provide an update (from 2005 to early 2009) on the patenting activity in the field of bradykinin antagonists (including patents on their formulation).  Where possible, the information from the patents has been supplemented with that from the primary literature, clin. trial databases and company websites in an attempt to give a more complete picture.  In the past 4 years, nearly 50 new patents have been filed on bradykinin antagonists, in the case of several filings, only the original source has been considered in this anal., the vast majority of these (>93%) on B1 antagonists.  However, despite this large amt. of work, only one compd., icatibant, a hydrophilic decapeptide selective for the B2 receptor, has reached the market, although it needs to be administered parenterally.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro7cnYKi778bVg90H21EOLACvtfcHk0lhRTxKLQwc2cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1eqtLk%253D&md5=acc208bc3d2d7265c8c4d037f8a719e8</span></div><a href="/servlet/linkout?suffix=cit9r&amp;dbid=16384&amp;doi=10.1517%2F13543770902994389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770902994389%26sid%3Dliteratum%253Aachs%26aulast%3DFincham%26aufirst%3DC.%2BI.%26aulast%3DBressan%26aufirst%3DA.%26aulast%3DParis%26aufirst%3DM.%26aulast%3DRossi%26aufirst%3DC.%26aulast%3DFattori%26aufirst%3DD.%26atitle%3DBradykinin%2520receptor%2520antagonists%253A%2520a%2520review%2520of%2520the%2520patent%2520literature%25202005%25E2%2580%25932008%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D919%26epage%3D941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Marie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruneau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquet, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siatka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larguier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponce, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassault, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groblewski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maigret, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnafous, J. C.</span><span> </span><span class="NLM_article-title">Control of conformational equilibria in the human B2 bradykinin receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">41100</span><span class="NLM_x">–</span> <span class="NLM_lpage">41111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=41100-41111&author=J.+Marieauthor=E.+Richardauthor=D.+Pruneauauthor=J.+L.+Paquetauthor=C.+Siatkaauthor=R.+Larguierauthor=C.+Ponceauthor=P.+Vassaultauthor=T.+Groblewskiauthor=B.+Maigretauthor=J.+C.+Bonnafous&title=Control+of+conformational+equilibria+in+the+human+B2+bradykinin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarie%26aufirst%3DJ.%26aulast%3DRichard%26aufirst%3DE.%26aulast%3DPruneau%26aufirst%3DD.%26aulast%3DPaquet%26aufirst%3DJ.%2BL.%26aulast%3DSiatka%26aufirst%3DC.%26aulast%3DLarguier%26aufirst%3DR.%26aulast%3DPonce%26aufirst%3DC.%26aulast%3DVassault%26aufirst%3DP.%26aulast%3DGroblewski%26aufirst%3DT.%26aulast%3DMaigret%26aufirst%3DB.%26aulast%3DBonnafous%26aufirst%3DJ.%2BC.%26atitle%3DControl%2520of%2520conformational%2520equilibria%2520in%2520the%2520human%2520B2%2520bradykinin%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D41100%26epage%3D41111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Barth, M.; Bondoux, M.; Dodey, P.; Massardier, C.; Thomas, D.; Luccarini, J. M.</span><span> </span><span class="NLM_article-title">Benzenesulphonamide Derivatives, Method for Production and Use Thereof for Treatment of Pain</span>. WO 2004087700,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Barth&author=M.+Bondoux&author=P.+Dodey&author=C.+Massardier&author=D.+Thomas&author=J.+M.+Luccarini&title=Benzenesulphonamide+Derivatives%2C+Method+for+Production+and+Use+Thereof+for+Treatment+of+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarth%26aufirst%3DM.%26atitle%3DBenzenesulphonamide%2520Derivatives%252C%2520Method%2520for%2520Production%2520and%2520Use%2520Thereof%2520for%2520Treatment%2520of%2520Pain%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyrou, V</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luccarini, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junien, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruneau, D.</span><span> </span><span class="NLM_article-title">Antinociceptive pharmacology of <i>N</i>-[[4-(4,5-dihyro-1<i>H</i>-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl)sulfonyl]methylamino]ethoxy]-<i>N</i>-methylacetamide, fumarate, a novel nonpeptidic bradykinin B1 receptor antagonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1124%2Fjpet.105.098368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=16565167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFymtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2006&pages=195-205&author=F.+Porrecaauthor=T.+W.+Vanderahauthor=W.+Guoauthor=M.+Barthauthor=P.+Dodeyauthor=V+Peyrouauthor=J.+M.+Luccariniauthor=J.+L.+Junienauthor=D.+Pruneau&title=Antinociceptive+pharmacology+of+N-%5B%5B4-%284%2C5-dihyro-1H-imidazol-2-yl%29phenyl%5Dmethyl%5D-2-%5B2-%5B%5B%284-methoxy-2%2C6-dimethylphenyl%29sulfonyl%5Dmethylamino%5Dethoxy%5D-N-methylacetamide%2C+fumarate%2C+a+novel+nonpeptidic+bradykinin+B1+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive pharmacology of N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl)sulfonyl]methylamino]ethoxy]-N-methylacetamide, fumarate (LF22-0542), a novel nonpeptidic bradykinin B1 receptor antagonist</span></div><div class="casAuthors">Porreca, F.; Vanderah, T. W.; Guo, W.; Barth, M.; Dodey, P.; Peyrou, V.; Luccarini, J. M.; Junien, J.-L.; Pruneau, D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">195-205</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The antinociceptive pharmacol. of N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl) sulfonyl]methylamino]ethoxy]-N-methylacetamide fumarate (LF22-0542), a novel nonpeptidic B1 antagonist, was characterized.  LF22-0542 showed high affinity for human and mouse B1 receptors with virtually no affinity for the human B2 receptor; a selectivity index of at least 4000 times was obtained when LF22-0542 was profiled throughout binding or cell biol. assays on 64 other G-protein-coupled receptor, 10 ion channels, and seven enzymes.  LF22-0542 was a competitive B1 receptor antagonist and elicited significant antinociceptive actions in the mouse acetic acid-induced writhing assay, as well as in the second phases of formalin-induced nociception in mice and in both the first and second phases of the formalin response in rats.  LF22-0542 was active after s.c. but not p.o. administration.  In B1 receptor knockout (KO) mice, acetic acid and formalin responses were significantly reduced and LF22-0542 had no addnl. effects in these animals.  LF22-0542 alleviated thermal hypersensitivity in both acute (carrageenan) and persistent inflammatory (complete Freund's adjuvant) pain models in rats.  LF22-0542 produced a full reversal of exptl. neuropathic thermal hypersensitivity but was inactive in reversing nerve injury-induced tactile hypersensitivity in rats.  In agreement with this observation, B1 KO mice subjected to peripheral nerve injury did not show thermal hypersensitivity but developed nerve injury-induced tactile hypersensitivity normally.  The data demonstrate the antihyperalgesic actions of a selective systemically administered B1 receptor antagonist and suggest the utility of this class of agents for the treatment of inflammatory pain states and for some aspects of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ_8GEvRI5obVg90H21EOLACvtfcHk0lh7FrSPWRcRAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFymtr8%253D&md5=71a4842dba19157f23fdea8e1a5b4c7d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.098368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.098368%26sid%3Dliteratum%253Aachs%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DBarth%26aufirst%3DM.%26aulast%3DDodey%26aufirst%3DP.%26aulast%3DPeyrou%26aufirst%3DV%26aulast%3DLuccarini%26aufirst%3DJ.%2BM.%26aulast%3DJunien%26aufirst%3DJ.%2BL.%26aulast%3DPruneau%26aufirst%3DD.%26atitle%3DAntinociceptive%2520pharmacology%2520of%2520N-%255B%255B4-%25284%252C5-dihyro-1H-imidazol-2-yl%2529phenyl%255Dmethyl%255D-2-%255B2-%255B%255B%25284-methoxy-2%252C6-dimethylphenyl%2529sulfonyl%255Dmethylamino%255Dethoxy%255D-N-methylacetamide%252C%2520fumarate%252C%2520a%2520novel%2520nonpeptidic%2520bradykinin%2520B1%2520receptor%2520antagonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D318%26spage%3D195%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Sevcik, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halvorson, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsay, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantyh, P. W.</span><span> </span><span class="NLM_article-title">Analgesic efficacy of bradykinin B1 antagonists in a murine bone cancer pain model</span> <span class="citation_source-journal">J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">775</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1016%2Fj.jpain.2005.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=16275602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SrurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=771-775&author=M.+A.+Sevcikauthor=J.+R.+Ghilardiauthor=K.+G.+Halvorsonauthor=T.+H.+Lindsayauthor=K.+Kubotaauthor=P.+W.+Mantyh&title=Analgesic+efficacy+of+bradykinin+B1+antagonists+in+a+murine+bone+cancer+pain+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Analgesic Efficacy of Bradykinin B1 Antagonists in a Murine Bone Cancer Pain Model</span></div><div class="casAuthors">Sevcik, Molly A.; Ghilardi, Joseph R.; Halvorson, Kyle G.; Lindsay, Theodore H.; Kubota, Kazufumi; Mantyh, Patrick W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">771-775</span>CODEN:
                <span class="NLM_cas:coden">JPOAB5</span>;
        ISSN:<span class="NLM_cas:issn">1526-5900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Cancer pain is a significant clin. problem because it is the first symptom of disease in 20% to 50% of all cancer patients, and 75% to 90% of patients with advanced or terminal cancer must cope with chronic pain syndromes related to failed treatment and/or tumor progression.  One of the most difficult to treat cancer pains is metastatic invasion of the skeleton that can generate ongoing and bone breakthrough pain, which represents one of the most debilitating cancer-related events.  Because bradykinin has been shown to be released in response to tissue injury and plays a significant role in driving acute and chronic inflammatory pain, we focused on bradykinin antagonists in a model of bone cancer pain.  In our model of bone cancer, which involves the injection and confinement of 2472 sarcoma cells to the mouse femur, pharmacol. blockade of the bradykinin B1 receptor is effective in reducing pain-related behaviors at both early and advanced stages of bone cancer.  Perspective: Bone cancer pain can be severe and difficult to control fully.  With a mouse model of bone cancer pain we demonstrate that pharmacol. blockade of the bradykinin B1 receptor is effective in reducing bone cancer pain-related behaviors, suggesting that B1 antagonists might be useful in attenuating bone cancer pain in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx4QHDiQL8RLVg90H21EOLACvtfcHk0lh7FrSPWRcRAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SrurrO&md5=6bb3c755a07447ba3397d928419e0107</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2005.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2005.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DSevcik%26aufirst%3DM.%2BA.%26aulast%3DGhilardi%26aufirst%3DJ.%2BR.%26aulast%3DHalvorson%26aufirst%3DK.%2BG.%26aulast%3DLindsay%26aufirst%3DT.%2BH.%26aulast%3DKubota%26aufirst%3DK.%26aulast%3DMantyh%26aufirst%3DP.%2BW.%26atitle%3DAnalgesic%2520efficacy%2520of%2520bradykinin%2520B1%2520antagonists%2520in%2520a%2520murine%2520bone%2520cancer%2520pain%2520model%26jtitle%3DJ.%2520Pain%26date%3D2005%26volume%3D6%26spage%3D771%26epage%3D775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Su, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPardo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ransom, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, M. G.</span><span> </span><span class="NLM_article-title">Discovery of a potent, non-peptide bradykinin B1 receptor antagonist</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">7516</span><span class="NLM_x">–</span> <span class="NLM_lpage">7517</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0353457" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=7516-7517&author=D.+S.+Suauthor=M.+K.+Markowitzauthor=R.+M.+DiPardoauthor=K.+L.+Murphyauthor=C.+M.+Harrellauthor=S.+S.+O%E2%80%99Malleyauthor=R.+W.+Ransomauthor=R.+S.+L.+Changauthor=S.+Haauthor=F.+J.+Hessauthor=D.+J.+Pettiboneauthor=G.+S.+Masonauthor=S.+Boyceauthor=R.+M.+Freidingerauthor=M.+G.+Bock&title=Discovery+of+a+potent%2C+non-peptide+bradykinin+B1+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja0353457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0353457%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DD.%2BS.%26aulast%3DMarkowitz%26aufirst%3DM.%2BK.%26aulast%3DDiPardo%26aufirst%3DR.%2BM.%26aulast%3DMurphy%26aufirst%3DK.%2BL.%26aulast%3DHarrell%26aufirst%3DC.%2BM.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DS.%2BS.%26aulast%3DRansom%26aufirst%3DR.%2BW.%26aulast%3DChang%26aufirst%3DR.%2BS.%2BL.%26aulast%3DHa%26aufirst%3DS.%26aulast%3DHess%26aufirst%3DF.%2BJ.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DMason%26aufirst%3DG.%2BS.%26aulast%3DBoyce%26aufirst%3DS.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DBock%26aufirst%3DM.%2BG.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520non-peptide%2520bradykinin%2520B1%2520receptor%2520antagonist%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D7516%26epage%3D7517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Bastian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loillier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquet, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruneau, D.</span><span> </span><span class="NLM_article-title">Stable expression of human kinin B<sub>1</sub> receptor in 293 cells: pharmacological and functional characterization</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm2016057&amp;key=10.1038%2Fsj.bjp.0701380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm2016057&amp;key=9313952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm2016057&amp;key=1%3ACAS%3A528%3ADyaK2sXmtlyqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=1997&pages=393-399&author=S.+Bastianauthor=B.+Loillierauthor=J.+L.+Paquetauthor=D.+Pruneau&title=Stable+expression+of+human+kinin+B1+receptor+in+293+cells%3A+pharmacological+and+functional+characterization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Stable expression of human kinin B1 receptor in 293 cells: pharmacological and functional characterization</span></div><div class="casAuthors">Bastian, S.; Loillier, B.; Paquet, J. L.; Pruneau, D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">393-399</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">The authors compared the binding properties of [3H]-desArg10-[Leu9]-kallidin, a radiolabeled kinin B1 receptor antagonist, to membranes from IMR-90 human embryonic fibroblasts and from 293 cells transiently or stably transfected with the human B1 receptor.  The dissocn. const. (KD) of [3H]-desArg10-[Leu9]-kallidin and the affinity of several kinin receptor agonists and antagonists were similar between the native and cloned receptor, either transiently or stably expressed in 293 cells.  In IMR-90 cells, the rank order to potency was that expected for a kinin B1 receptor.  The receptors transiently or stably expressed in 293 cells were fully functional with respect to their signaling properties.  Phosphoinositide hydrolysis was increased in a concn.-dependent manner by the B1 receptor agonist, desArg10-kallidin.  Functional coupling to the calcium pathway was also demonstrated for the native and stably expressed human B1 receptor.  In conclusion, the established stable and functional 293 cell clone may provide an important tool for further anal. of the mol. mechanisms involved in binding activation, and coupling of the kinin B1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr494AwChIKN7Vg90H21EOLACvtfcHk0lgMt6dK5X0lcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtlyqsb0%253D&md5=6936385b715a97010559bddd5f2b9103</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0701380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0701380%26sid%3Dliteratum%253Aachs%26aulast%3DBastian%26aufirst%3DS.%26aulast%3DLoillier%26aufirst%3DB.%26aulast%3DPaquet%26aufirst%3DJ.%2BL.%26aulast%3DPruneau%26aufirst%3DD.%26atitle%3DStable%2520expression%2520of%2520human%2520kinin%2520B1%2520receptor%2520in%2520293%2520cells%253A%2520pharmacological%2520and%2520functional%2520characterization%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D122%26spage%3D393%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Bradford, M. M.</span><span> </span><span class="NLM_article-title">A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein–dye binding</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1976&pages=248-254&author=M.+M.+Bradford&title=A+rapid+and+sensitive+method+for+quantification+of+microgram+quantities+of+protein+utilizing+the+principle+of+protein%E2%80%93dye+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBradford%26aufirst%3DM.%2BM.%26atitle%3DA%2520rapid%2520and%2520sensitive%2520method%2520for%2520quantification%2520of%2520microgram%2520quantities%2520of%2520protein%2520utilizing%2520the%2520principle%2520of%2520protein%25E2%2580%2593dye%2520binding%26jtitle%3DAnal.%2520Biochem.%26date%3D1976%26volume%3D72%26spage%3D248%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i40"><a href="/doi/suppl/10.1021/jm2016057">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_67332"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures for all intermediates <b>5a</b>, <b>6f</b>,<b>g</b>, <b>7a</b>–<b>c</b>,<b>e</b>–<b>g</b>, <b>8a</b>–<b>c</b>,<b>e</b>–<b>g</b>, <b>9a</b>–<b>c</b>,<b>e</b>–<b>h</b>, <b>10a</b>–<b>c</b>,<b>e</b>–<b>g</b>, <b>12a</b>–<b>c</b>,<b>e</b>–<b>m</b>,<b>o</b>–<b>r</b>, <b>20b</b>–<b>h</b>, <b>21b</b>–<b>h</b>, and <b>23</b>–<b>26</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm2016057/suppl_file/jm2016057_si_001.pdf">jm2016057_si_001.pdf (154.62 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm2016057&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm2016057%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-6" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm2016057" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1002KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b5acbad03c16","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
